C. Michael White, Pharm.D., FCCP, FCP

Office:University of Connecticut (UConn)

School of PharmacyDepartment of Pharmacy Practice

69 N. Eagleville Road, U-3092Storrs, CT 06269-3092

(860) 341-6513charles.white@uconn.edu

Practice Site:Hartford Hospital

UConn HOPES Group &Evidence-based Practice Center

80 Seymour StreetHartford, CT 06102-5037

Pharmacypractice.uconn.edu/hopes

OBJECTIVE To utilize my skill and passion to make a difference in the care of patients with health related concerns, push forward science, and train outstanding healthcare pratitioners.

To mentor and lead a diverse group of faculty, staff, fellows and students to utilize their education, experience, and passion to push clinical care, science, and the healthcare system forward through scholarship, education, service and public engagement.

EDUCATION1990-1996 Albany College of Pharmacy, 106 New Scotland Avenue, Albany, NY 12208

Degrees: BS Pharmacy, Pharm.D. (Cum Laude)

1996-1998 Hartford Hospital/UConn School of Pharmacy, 80 Seymour Street, Hartford, CT 06102Program: Fellowship in Cardiovascular Outcomes ResearchPreceptors: Moses S.S. Chow, Pharm.D., FCP, FCCP & Jeffery Kluger, MD, FACC

LICENSURE1996-Present R.Ph. State of Connecticut

ACADEMIC APPOINTMENTS University of Connecticut, School of Pharmacy, Storrs, CT

Sep 1996 - Jun 1998 Assistant Professor of Clinical Pharmacy, Adjunct Faculty Jul 1998 - Apr 2003 Assistant Professor of Pharmacy Practice, Tenure-Track Faculty

Apr 2003 - Apr 2008 Associate Professor of Pharmacy Practice, TenureApr 2008 – Present Full Professor of Pharmacy Practice, Tenure

Oct 2010 - Mar 2011 Assistant Department Head of Pharmacy PracticeMar 2011 - Jun 2011 Interim Department Head of Pharmacy Practice

Jul 2011 – Present Department Head of Pharmacy PracticeApril 2019 BOT Distinguished Professor

CLINICAL APPOINTMENTSJul 1998 - Feb 1999 Clinical Pharmacy Specialist in Critical Care/Cardiology, Connecticut Veterans Administration

Health System, West Haven, CT.Feb 1999 - Jul 2007 Co-Director, Arrhythmia and Cardiac Pharmacology Research Group &

Director, Cardiovascular Pharmacology Service, Hartford Hospital, Hartford, CT.Jul 2001 – Jun 2017 Clinical Faculty, Department of Cardiology, MD Fellowship Program, Hartford, CT.

C.M. White, p.1

Jul 2007 – Present Director, University of Connecticut/Hartford Hospital Evidence Based Practice Center, Hartford, CT.

Jul 2007 – Present Co-Director, Health Outcomes, Policy, and Evidence Synthesis Research Group. Hartford, CT

AWARDS/HONORSJun 1995 Rho Chi Honor Society, Albany College of Pharmacy, Albany, NYJun 1995 Merck Pharmacology Award, Albany College of Pharmacy, Albany, NY. Award for Highest

Grades in Pharmacology among Undergraduate Class.May 1996 Cum Laude, Albany College of Pharmacy, Albany, NYDec 1997 Hospital Pharmacist Report, Rhone Poulenc Rorer – Future of Pharmacy National Essay

Award. 32nd Annual American Society of Health-System Pharmacists Midyear Clinical Meeting, December 8-12, 1997. Atlanta, GA

Jan 1998 Astra Clinical Pharmacy Research Award – Honorable MentionSep 1999 Dannemiller Memorial Educational Foundation Publication Award. White CM, Dunn A,

Tsikouris J, et al. Anesthesia and Analgesia 1999;89:585-9. Selected as One of Top Worldwide Anesthesia Articles in 1999.

Oct 2000 Meritorious Achievement Award. Connecticut Society of Health-System Pharmacists. Meridan, CT

Dec 2000 ASHP Research and Education Foundation Award for Drug Therapy Research. White CM, Dunn A, Tsikouris J, et al. Anesthesia and Analgesia 1999; 89:585-9. Selected as Best Research Article in 1999. ASHP Midyear Clinical Meeting. Las Vegas, NV.Reference: AJHP 2000; 57:1745.

Mar 2001 Teacher of the Year, University of Connecticut School of Pharmacy, Storrs, CT.Aug 2001 Fellowship in Cardiovascular Pharmacology Received Approval from the American College of

Clinical Pharmacists. First Cardiology Program in Country With Distinction.2001 Publication in the Lancet was included in the book Cardiovascular Trials Review, Sixth Edition

(Kloner RA, Birnbaum Y, Eds. Le Jacq Communications. Greenwich, CT 2001: Pg 1144-6.) as “one of the best cardiology research studies” from 1990 to the present.

Oct 2001 Selected as Finalist in the “Best Poster” Competition of the American College of Clinical Pharmacists Meeting in Albuquerque, NM.

White CM, Kalus J, Caron M. Impact of an Intravenous and Oral Amiodarone Regimen in Post-Open Heart Surgery: Atrial Fibrillation Suppression Trial II (AFIST II).

Oct 2001 Selected as Finalist in the “Best Resident/Fellow Poster” Competition of the American College of Clinical Pharmacists Meeting in Albuquerque, NM.

Kalus JS, Caron MS, Liu X, Rose HL, Kluger J, White CM. What is the Effect of Amiodarone on P-wave Variables in Cardiac Surgery Patients?

2002 Publication in the Lancet was included in the book Cardiovascular Trials Review, Seventh Edition (Kloner RA, Birnbaum Y, Eds. Le Jacq Communications. Greenwich, CT 2002: Pg 1130-2.) as “one of the best cardiology research studies” from 1990 to the present.

Dec 2002 ASHP Research and Education Foundation Award for Drug Therapy Research. The Atrial Fibrillation Suppression Trial. [White CM, Dunn A, Tsikouris J, et al. Ann Thoracic Surgery 2002;74:69-74. & Giri S, White CM, Dunn AB, et al. Lancet 2001;357:830-6.]

Selected as Best Research Article in 2002. ASHP Midyear Clinical Meeting. Atlanta, GA.Mar 2003 Finalist, Outstanding Faculty Advisor Award. University of Connecticut.Nov 2003 Selected as Finalist in the “Best Poster” Competition of the American College of Clinical

Pharmacists Meeting in Atlanta, GA. Kalus JS, Caron MF, McBride BF, Kluger J, Guertin D, White CM. What is the Impact of Physiologic Increases in Catecholamine Concentrations on Ventricular Effective Refractory Period?

Jan 2004 Metabolife 356® article in JAMA covered on NBC affiliates throughout the country, CNN,

C.M. White, p.2

numerous newspapers, important medical websites including theHeart.org, and WebMD, and Shape Magazine.

Feb 2004 AFIST and AFIST II Studies were Included in a Summary of the Key Articles in Arrhythmia. Cheng JW, Frank L, Garrett SD, et al. Key Articles and Guidelines in Pharmaceutical Management of Arrhythmia. Pharmacotherapy 2004;24:248-279

Mar 2004 Teacher of the Year, University of Connecticut School of Pharmacy, Storrs, CT.May 8, 2004 University of Connecticut School of Pharmacy Commencement Keynote Speaker.

Graduating Class of 2004, Rome Ballroom, Storrs, CTJun 25, 2004 2004 Young Investigator of the Year. American College of Clinical Pharmacy. Given to a

Single Recipient Annually for a Research Program that is Especially Noteworthy in Theme and Productivity.

Dec 2004 ASHP Research and Education Foundation Award for Drug Therapy Research. The Atrial Fibrillation Suppression Trial II. White CM, Caron MF, Kalus JS, et al. Circulation 2003;108[Suppl II]:200-6. Selected as Best Research Article in 2004. ASHP Midyear Clinical Meeting. Orlando, FL.

Apr 2005 Fellow Selected as Finalist in the “Best Resident/Fellow Poster” Competition of the American College of Clinical Pharmacists Meeting in Myrtle Beach, NC. Min B, McBride BF, Kardas M, Ismaili A, Sinha V, Kluger J, White CM. The Electrocardiographic Effects of an Ephedra Free Multicomponent Weight Loss Supplement in Health Volunteers.

Apr 2005 Our Fellows/Students were Selected for 5 of the 6 Finalist Spots in the “Best Resident/Fellow Poster” Competition of the American College of Clinical Pharmacists Meeting in Myrtle Beach, NC.

Apr 2005 Poster Selected as Winner of the ACCP Pharmacoeconomic and Outcomes PRN Best Poster Competition. Myrlte Beach, NCColeman CI, Perkerson KA, Gillespie EL, White CM. Cost-Effectiveness of Statins Administered With or Without Ezetimibe.

Jun 2005 Medical Staff Investigator Prize Competition. Third Place Finish in Contest for Best Publication Resulting from a Hartford Hospital Grant from Year’s 2000-2005. Hartford Hospital Medical Staff, Hartford, CT

Jul 2005 Fellowship Status Awarded with FCCP Designation (Fellow College of Clinical Pharmacy). American College of Clinical Pharmacists Board of Regents.

Oct 2005 Meritorious Achievement Award. Connecticut Society of Health-System Pharmacists. Cromwell, CT

Dec 2005 ASHP Research and Education Foundation Award for Drug Therapy Research. Electrocardiographic and Hemodynamic Assessment of Metabolife 356®. McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. JAMA 2004;291:216-21.Selected as Best Research Article in 2004. ASHP Midyear Clinical Meeting. Las Vegas, NV.

Jan 2006 Statins in Cancer article in JAMA covered on NBC Nightly News, NBC 30 5:30 News, USA Today, Hartford Courant (Front Page), Associated Press (over 150 newspapers), CBS Radio, NPR Radio, and CNN Radio.

Feb 2006 Fellowship Status Awarded with FCP Designation (Fellow in Clinical Pharmacology). American College of Clinical Pharmacologists Board of Regents.

Apr 24, 2006 Teaching Fellow Designation Awarded. University of Connecticut. Highest University Teaching Award. Storrs, CT.

June 19, 2006 Featured in Hartford Courant Article on Teaching Effectiveness. Merrit GA. “PROFESSOR'S COMIC TOUCHES HELP STUDENTS LEARN.” Hartford Courant. https://www.courant.com/news/connecticut/hc-xpm-2006-06-19-0606190018-story.html.

Dec 2006 ASHP Research and Education Foundation Award for Drug Therapy Research. Gillespie E, White CM, Kardas M, Linberg M, Coleman CI. The Impact of ACE Inhibitors and Angiotensin II

C.M. White, p.3

Receptor Blockers on the Development of Type-II Diabetes.Diabetes Care 2005;28:2261-6. Selected as Best Research Article in 2005. ASHP Midyear Clinical Meeting. Anaheim, CA.

Jan 2007 Number 8 on the List of the Top 10 Most Viewed News Stories by Pharmacists from Medscape in 2006. Shah S, White CM, Coleman CI. Echinacea Cuts Cold Incidence. Medscape from WebMD. TopTen@mp.medscape.com

Jun 2007 Aprotinin Safety Evaluation Article is Highlighted in 12 Health News Websites and Released by United Press International.

Jun 2007 Meta-Analysis on Echinacea and the Common Cold in Lancet Infectious Diseases Featured on Today Show, Good Morning America, USA Today, CNN Radio, BBC News, Bloomberg News, Fox 61 News, NBC 30 News, LA Times, Baltimore Sun, The Seattle Times, Over 200 Google Hits.

2005 to 2019 Manuscripts Included/Reviewed in ACP Journal Club.2005: Impact of ACE inhibitors and ARBs on diabetes risk 2005: ECG and Hemodynamic Effects of Ephedra2006: Statins and Cancer2007: Statins Dosing Intensity and Muscle/Liver Safety2008: Drug therapy of Restless Leg Syndrome2009: ACE inhibitors in Stable CAD2019: Asthma Pharmacotherapy Evidence Review

Jul 2008 Rufus A Lyman Award. This award is given for the Best Publication in American Journal of Pharmacy Education in 2007. “Coleman CI, Schlesselmann LS, Lao E, White CM.* An Evaluation of the Number and Quality of Published Scholarly Works By Members of Departments of Pharmacy Practice at Accredited Schools or Colleges of Pharmacy in the United States (2001-2003)American Journal of Pharmacy Education 2007;71:1-5.* = Corresponding Author

Nov 2008 Meta-Analysis of Echinacea for the Common Cold was Reviewed and Included in the Database of Abstracts for Review of Effects (DARE), an international undertaking of the Centre for Reviews and Dissemination (CRD).

Dec 2008 ASHP Research and Education Foundation Award for Drug Therapy Research. “Dale K, White CM, Henyan N, Coleman CI. Impact of Statin Dosing Intensity on Transaminase and Creatine Kinase. American Journal of Medicine 2007;120:706-12.”Selected as Best Research Article in 2007. ASHP Midyear Clinical Meeting. Orlando, CA.

Mar 2009 Phi Lambda Sigma, UCONN Chapter - Honorary Member. Inducted Based on Leadership Provided in Pharmacy Education and Research. School of Pharmacy, January 19, 2009.

Jun 2009 Annals of Internal Medicine Best Reviewer Citation. Rated as a premier reviewer of the Annals of Internal Medicine of calendar year 2008.

Feb 2010 Body of Work on Herbal Medicine Highlighted Assessing the Benefits, Page 28. University of Connecticut President’s Report 2010.

Mar 2010 Comparative Effectiveness Review on ACE Inhibitors and ARBs included in ACP Journal Club. “Baker BL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.* Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease. Annals of Internal Medicine 2009;151:861-71.”

Mar 2010 Annals of Internal Medicine Best Reviewer Citation. Rated as a premier reviewer of the Annals of Internal Medicine of calendar year 2009.

May 2010 University of Connecticut School of Pharmacy Teacher of the Year. Storrs, CT Oct 2010 Comparative Effectiveness Review on Human Growth Hormone in Cystic Fibrosis Given

National Press Coverage in over 400 media sites including the LA Times, Hartford Courant C.M. White, p.4

(Cover Story), Dallas Morning News, Fox 61 News, and others. Oct 2010 Runner-Up: University of Connecticut Academic Affairs Committee Life Raft Debate, Storrs,

CTNov 29, 2010 Finalist: Provost's Award for Excellence in Public Engagement, University of Connecticut,

Storrs, CTJan 2011 Presentation at MedCAC meeting at CMS streamed live on Bloomberg Business Network and

covered in 5 news media outlets including Reuters and MSNBC.Mar 17, 2011 Top 25 Downloaded Article from Pharmacotherapy in 2010.

Reinhart KM, White CM, Baker WL. Prasugrel: A Critial Comparison with Clopidogrel. Pharmacotherapy 2009; 29:1441-51.

Mar 27, 2011 Research Fellow Soyon Lee selected as the recipient of the 2011 Rho Chi Clinical Research Scholarship given to support the salary of a promising second year fellow in a premier program of study in the United States. The recipient must be a Rho Chi member.

Feb 2013 Weekly Ask the Pharmacist Segment Initiatied on Fox 61, Hartford, CT. Weekly live news discussion of drug or medical topics of the week.

Dec 2016

Dec 2018

Recipient: ASHP Research and Education Foundation Award for Sustained Contributions to the Literature. Las Vegas, NV. December 6, 2016.One OpEd and one Media Article Based on My Research Selected as Highlighted Articles of the Year.

Stories that Made The Conversation Unique in 2018. TheConversation.com. Family Medicine 2018 Hot Topics. Debating Kratom, Narcan, Fad Diets. Helio.com.

May 2019 Teacher of the Year, UConn School of Pharmacy, 2019.June 2019 “Featured Faculty.” UConn Website. Selected as One of Eight Faculty Featured at UConn.

https://research.uconn.edu/our-research/featured-faculty/?fbclid=IwAR3TUVKB8QYX1ZT9GICovUc5PihT7CmS35lNDI0Dhm0l3Woky_7RyKE1b4c

Oct 4, 2019 “President Katsouleas Inauguration Faculty Presentations”. Selected as One of Nine UConn Faculty University Wide to Provide 8 Min TED-Style Talk for Inauguration.

Nov 22, 2019 American Society of Clinical Toxicology Question of the Day. “What is the 4X100 cocktail?” was answered by the organization using my review article on kratom in the Am J Health-Syst Pharm.

Dec 2019 ASHP Research and Education Foundation Award for Drug Therapy Research. Sobieraj DM, Baker WL, Nguyen E, Weeda ER, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 Apr 10;319(14):1473-1484. doi: 10.1001/jama.2018.2757. Review.” Selected as Best Research Article in 2018. ASHP Midyear Clinical Meeting. Las Vegas, NV.

February 2020 Authored Three of the “Top Ten Most Read Articles” in Annals of Pharmacotherapy (Numbers 1, 3, and 8).

White CM. Dietary Supplements Pose Real Dangers to Patients. Annals of Pharmacotherapy 2020; https://doi.org/10.1177/1060028019900504.

White CM. Generic Drugs not as Safe as FDA Wants You to Believe. Annals of Pharmacotherapy 2020;54:283-6. https://doi.org/10.1177/1060028019881692.

White CM. Understanding and Preventing (N-Nitrosodimethylamine) NDMA Contamination of Medications. https://doi.org/10.1177/1060028019892222.

April 2020 Two articles identified as “Most Downloaded articles of 2019” by Wiley Publishing. White CM. The Pharmacokinetics and Clinical Utility of Cannabadiol (CBD). J Clin

Pharmacol 2019, 59(7) 923–934. https://doi.org/10.1002/jcph.1387. (Most downloaded article in 2019).

White CM, Chamberlin K, Eisenberg E. Curcumin, a Turmeric Extract, for Oral Lichen C.M. White, p.5

Planus: A Systematic Review. Oral Diseases 2019;25:720-5. DOI: 10.1111/odi.13034. (Top 10 most downloaded).

TEACHING EXPERIENCE

Student/Resident PreceptingJan 1996 - Present Precepted Undergraduate (UConn, Albany College of Pharmacy) and PharmD students

(UConn, SUNY Buffalo, Creighton, Ohio Northern, Mass College of Pharmacy) (n>300). Jul 1998 – 2017 Precepted Pharmacy Practice Residents (Hartford Hospital, Connecticut VAMC) (n=24).

Graduate FellowsAug - Dec 1998 Interim Director of the Cardiovascular Pharmacology Fellowship at Hartford Hospital

Aug 1998 - Jul 1999 Interim Director of the Outcomes Research Fellowship at Hartford HospitalGraduated Fellow: Prabashni Reddy, Pharm.D., Senior Manager at Partners Healthcare, Needham, MA.

Dec 1999 - Jun 2006 Director of the Cardiovascular Outcomes Fellowship at Hartford HospitalGraduated Fellows: Alisha Dunn, Pharm.D. June 1999, Medical Science Liason Manager, Scios PharmaceuticalsJames Tsikouris Pharm.D. June 2000, Assoc Prof Texas Tech University with Tenure. Assoc Prof, University of Pittsburgh.Jessica Song, Pharm.D. June 2001, Assoc Prof with Tenure, Univ of the Pacific, Currently: Assoc Director of Pharmacy at the California Institute of Medical Research. Sna Jose, CA Michael Caron, Pharm.D. June 2002, Scientific Interface Manager, Gilead PharmaceuticalsJames Kalus, Pharm.D. June 2003, Currently Director of Pharmacy, Henry Ford HospitalBrian McBride Pharm.D., June 2004, Asst Prof, Loyola Universit; Currently Medical Science Liason, General Electric Medical Division.Bokyung Min, Pharm.D. July 2005, Lost touch, left country.Stephen Sander, Pharm.D. March 2006, Currently Manager, Outcomes Research, Boringer-Ingelheim Pharmaceuticals, Nickole Henyan, Pharm.D. June 2006, Currently Clinical Specialist, Shore Health System.Krista Dale, Pharm.D. June 2007, Currently Clinical Specialist, Mississippi Medical CenterSachin Shah, Pharm.D. June 2007, Currently Assoc Prof with Tenure, Univ of the Pacific William L Baker, Pharm.D., BCPS. 2008, Currently Assoc Prof with Tenure. UCONN School of Pharmacy [ACCP Young Investigator of the Year]Kurt Reinhart, Pharm.D.2009, Currently Senior Medical Scientific Liason, Glaxo-SmithKline, Wyngate, NC. Ripple Talati, Pharm.D. 2009, Senior Pharmacist, Caremark Formulary Division, Chicago, IL.Olivia Phung, Pharm.D. 2010, Currently Asst Prof, Western University. [ACCP Young Investigator of the Year]

Jun 2006 – Present Co-Director of the Cardiac Outcomes Fellowship at Hartford Hospital Graduated Fellows:Jennifer Colby, Pharm.D., 2011, Scientist, Institute for Comparative Effectiveness Research, Boston, MAWendy Chen, Pharm.D., 2011 Clinical Pharmacist at Beth Israel Deaconess Hospital, Boston, MAJennifer Scholle, Pharm.D., 2011 Clinical Pharmacist, New Britain General Hospital, CT Soyon Lee, Pharm.D., 2012 Scientist, Sanofi, Bridgewater, NJ

C.M. White, p.6

Tawkiful Alam, MD, 2012 Medical Resident, Tennessee Health System, Nashville, TN. Practicing Physician, Tennessee. Rajbir Kaur, Pharm.D., 2013 Clinical Pharmacist, Brigham and Women’s Hospital, Boston, MABrendan Limone, Pharm.D., 2013 Senior Research Analyst, Truven Health Analytics, Boston, MA, Christine Kohn, Pharm.D., 2014-2019 Asst Prof, St Joseph’s University, Hartford, CT. Medical Student 2017.Elizabeth Mearns, Pharm.D., 2015 Research Analyst, Truven Health Analytics, Boston, MAElaine Nguyen, Pharm.D., 2017 Asst Prof, Idaho State University, Pocatello, IDErin Weeda, Pharm.D., 2017 Asst Prof, MUSC, Charleston, SC. Brandon Martinez, Pharm.D., Clinical Pharmacist in Arizona. 2017-2019.Benjamin Miao, Pharm.D., Clinical Scientist. ZS Associates (consulting firm). 2018-2020.Olivia Costa, Pharm.D., Current Fellow 2019-2021.Yuani Roman, MD, MPH, Current Fellow 2019-2021.

Visiting Scholars/Pharm.D. StudentsFeb 1999 - Sep 1999 Preceptor of Two Visiting Scholars (MDs) in Cardiovascular Pharmacology, Hartford, CT

Graduated Scholar: Jianlin Xie, MD, Yianling Sun, MD (September 1999)Feb 2002 - Apr 2003 Preceptor of Visiting Scholar (Pharmacist) in Cardiovascular Pharmacology, Hartford, CT

Graduated Scholar: Liu Xing, MS Pharmacy.Apr 2008 Preceptor of Two French Students from the University de Rennes, Hartford, CT

French Students: Anais Le Rhun, Elodie E RaiderApr 2010 Preceptor of Two French Students from the University of Rennes, Hartford, CT

French Students: Anne-AmélieCuris, Nadege Seznec.Jul 2010 Preceptor of Student from University of Puerto Rico, Hartford, CT

Student: Nahir Rivera

Student Research1999 – Present Preceptor of Undergraduate Research Students, UConn School of Pharmacy, Storrs, CT

Graduated with Honors: Rabab Ammar, Pharm.D. (2 Semesters, May 2001); Agnes Krudysz Pharm.D. & Angie Karapanos Pharm.D. (2 Semesters + 1 Rotation Month, May 2004); Pauline Rafferty (May 2005); Payal Vachhani (Two semesters, 2007-2008, HONORS); Colleen J Teevan (January 2007-2010); Lauren Tuttle (Two Semesters, 2008-2010); Agata Dabek (2011-2012); Katarzyna Zlotnik (2011-2012)Graduated with Distinction: Audrea Hotsko Pharm.D. & Stacey Robertson, Pharm.D. (2 Semesters + 1 Research Month, May 2002); Alexandria Piotrowski, Pharm.D. (2 Semesters + 1 Research Month, May 2003); Deborah Cios, (4 Semesters, September 2004-May 2007); Melissa Kuhn (2011-2012); Jola Mehmeti (2016-2018)Graduated Students: Jenny Chung, Pharm.D. (February 2002); William Baker, Pharm.D. (March 2002); Audrea Hotsko, Pharm.D. and Steven Sander, Pharm.D. (April 2002); Heather Sun, Pharm.D. and Nick Hawryz, Pharm.D. (April 2003); Christopher Fortier, Pharm.D., Vinnita Sinha, Pharm.D. (April 2004); Michael Kardas, Pharm.D.& Agron Ismaili, Pharm.D. (2 Semesters Ending + 1 rotation ending June 2004); Jade Pham, Pharm.D. (July 2004), Jasmine Sahni, Pharm.D. (January 2005); Sean Norton (July 2005); Elizabeth Lucina (April 2006); Aaron Hussey (June 2006); Jennifer Morrone (August 2006); Eang Lao (October 2006); Jenny Lipieki (3 semesters January 2005-May 2007)Current Research Students:

C.M. White, p.7

Preceptor of Research Training Experience, St Joseph’s College, Hartford, CTGraduated Student: Lilia Mandybur (2 Semesters Ending August/December 2001)

UConn Didactic CoursesUndergraduate

1997 – 1998 Pharmacokinetics (Pharmacy 230). Lecturer on Antiarrhythmic Drug Pharmacokinetics

1998 – 1999 Cardiovascular Therapeutics Module (Pharmacy 280). Lectures on Angina/Myocardial Infarction, Hypertension, Thromboembolism, Arrhythmias, Congestive Heart Failure

1998 – 1999 Pharmacy Research Seminar (Pharmacy 201) for Honors Program Students. Lecturer on Research

Pharm.D. Program1998 – 2010 Pharmaceutical Care (PHRM 207). On-Site Lecturer

1998 – 2010 Cardiology Therapeutics Module (PHRM 254). Lectures on Hyperlipidemia, Angina, Myocardial Infarction, Arrhythmias, Congestive Heart Failure

2003 – 2010 Cardiology Therapeutics Module (PHRM 254). Lecture on Cardiovascular Drugs Pharmacokinetics

2005 – 2006 Cardiology Therapeutics Module (Phrm 254): Lecture on Hypertension and Interpreting Acid-Base Disorders.

1999 – 2009 Literature Evaluation and Biostatistics (PHRM 200/PHRX 3000). Course Co-Coordinator and Lecturer.

1999 – 2002 Clinical Pharmacokinetics (PHRM 257). Lecturer on Antiarrhythmic Agents Pharmacokinetics

1999, 2008, 2009, 2019 Pharmacy Research Seminar (PHRM 201, PHAR/PHRX 3012) for Honors Program Students. Single Lecture on Ongoing Personal Research

1999 – 2005 Physical Assessment Course (PHRM 211). Lecturer (ECG Skills/Heart Sounds), Laboratory Instructor (CV exam plus GI exam).

2001 – 2003 Nonprescription Medication Course (PHRM 210). Lecture on Head & Body Lice.

2003 – 2009 Nonprescription Medication Course (PHRM 210). Lecture on Herbs With Cardiac Implications.

2006 – 2007 Drug Induced Diseases (PHRM 258W). Lecture on Drug Induced Cardiac Disease and Preceptor of Major Student Writing Projects

2008 – Present Evidence-Based Practice (PHRX 3095, ELECTIVE). Lectures on Evidence Based Practice and Use of Systematic Review to Discern that Evidence.

C.M. White, p.8

2009 – Present Drug Information II (PHRX3007). Lectures on Case Reports/Series, Applicabilty, and Finding Literature.

2010 – Present Cardiac Module (PHRX 5040). Lectures on Hypertension, Lipids, Angina, Myocardial Infarction, Heart Failure, Arrhythmias. Course Coordinator until 2015.

2010 – 2019 Correlated Pharmacy Problem Solving (CPPS) IV (PHRX 5010). Two active learning sessions on cardiac topics. Course Coordinator until 2016.

2014 – Present Discovering the Leader Within (Phrx 3057 ELECTIVE)/w-Course Leadership (Phrx 4001w-001). Teach entire course.

2015 – Present Nutrition Module (Phrx 3003). Lectures on Macronutrients, Fat Soluble Vitamins, Water Soluble Vitamins, Minerals, Nutritional Assessment, Enteral and Parenteral Nutrition, Nutritional Requirements in Disease. Course Coordinator in 2018.

2016 – Present Fundamentals of Managed Care Pharmacy (Phrx 3095 ELECTIVE). Lectures on the reasons for managed care, job opportunities and responsibilities, different aspects of drug benefits, ethical aspects, and approach. Teach entire 1-credit course.

2018 – Present Developing Pharmacy Leaders (Phrx 4057 ELECTIVE). Lectures on Tenets of Good Leadership (8 lectures) and Profiles in Leadership (3 lectures). Teach entire 1-credit course.

2019 – Present Healthcare Ethics and History (Phrx 4062). Lectures on ethical principles, ethical patient care, codes of conduct and oaths, ethical dilemmas, and major historical changes in pharmacy, medicine, and nursing over time. Teach entire 2-credit course.

2020 - Present Responsible Conduct in Research (GRAD 5910). Lecture on Ethical Imperatives for Human Subjects Research. Teach Single 1-hr Lecture.

UConn General Education or Graduate Courses2017 - Present Reflections in Teaching (GRAD 6002). Three panel discussions on mentoring, careers in

academia, and interviews/job offers.2018 - Present Special Program in Pharmacy (UNIV 1784). 1 Credit; Fall). Single lecture on Pharmacy

Practice based Outcomes Research.2020 - Present Toxic Chemicals & Health (PHAR 1001). 3 Credits; Spring. Single lecture on Dangers of

Performance Enhnacing Chemiicals

UConn Health/School of Medicine2008 – 2010 Core III: Evidence Based Practice. Two Lectures on Evidence-Based Practice and Use of

Meta-Analysis/Systematic Review to Discern Evidence. UCHC, Farmington, CT.2019 Homeweek B. Single lecture + Case Review on Vasopressors, Catecholamines, and Fluids.

UCHC, Farmington, CT

Hartford Hospital Didactic Courses1996 – 2002 Advanced Practice Registered Nurse Certification Program (APRN). Lecturer on

Cardiovascular Therapeutics1996 – 2009 Advanced Cardiac Life Support Certification Program (ACLS). Pharmacology Lecturer.*

C.M. White, p.9

* - Awarded Best ACLS Teaching Program in New England 1999.2001 – 2009 Hartford Hospital Department of Pharmacy Core Competencies Lecture Series. Lectures

on Myocardial Infarction, Congestive Heart Failure, Hyperlipidemia, and Arrhythmias Completed Annually and Video Taped. Video Tapes are Mandatory for New Pharmacist Orientation Period.

2001 – 2009 University of Connecticut School of Medicine Medical Intern and Resident Pharmacology Lectures at Hartford Hospital. Lectures on Myocardial Infarction, Congestive Heart Failure, Hyperlipidemia, and Arrhythmias Completed Annually.

2002 – 2009 Hartford Hospital Division of Cardiology Fellow Lecture Series. Annual Lectures on Research Within our Group and Treatment of Hypertension.

C.M. White, p.10

Scholarly Publications

Quantitative Rankings

Google Scholar Impact: https://scholar.google.com/citations?user=lWAD9d8AAAAJ&hl=en Citations 12,133 h-index 58 i10 Index 207

ResearchGate Impact: www.researchgate.net/profile.C.White2/scores h-index – 58 RG Score - 98th Percentile of all Researchers on ResearchGate

Academic Analytics Impact: Compared vs. other tenure track faculty in pharmacy practice (January 2019). Articles – 94th Percentile Awards – 98th Percentile Books/Chapters – 92nd Percentile Citations – 94th Percentile Conference Proceedings – 96th Percentile

Journals Published In With Impact Factor >10: The Lancet – 59.102 – One Publication JAMA – 51.273 – Five Publications Circulation – 23.054 – Three Publications Annals of Internal Medicine – 19.315 – Three Publications J Am Coll Cardiology – 16.834 – Two Publications Diabetes Care – Impact Factor 10.857 – Two Publications

Most Cited Articles (Citations >100 denote top 2% of all articles): Statins and Cancer Risk: a Meta-Analysis, JAMA (Citations 646) Effect of Statins on Skeletal Muscle Function, Circulation (Citations 407) Biological Variation for B-Type Natriuretic Peptides and Monitoring Implications, Am J Cardiol (Citations 293) Echinacea for the Prevention and Treatment of the Common Cold: a Meta-Analysis (Citations 253) Oral amiodarone for prevention of atrial fibrillation after open heart surgery, (AFIST), Lancet (Citations 242) Impact of ACE Inhibitors or ARBs on the Development of Type 2 Diabetes, Diabetes Care (Citations 241) A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin, J Clin Pharmacol (Citations 234) Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis,

Diabetes Res Clin Pract (Citations 204) Understanding heterogeneity in meta analysis: the role of meta regression. Int J Clin Practice 63 (Citations ‐ ‐

200) The impact of coenzyme Q10 on systolic function in heart failure, J Cardiac Failure (Citations 198) Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann

Pharmacother (Citations 179)Articles with Highest Almetric Score (scores >20 denote prominent papers):

Dietary Supplements Pose Real Danger to Patients (Almetric Score = 540) Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review

(Almetric Score = 495) Pharmacologic and Clinical Assessment of Kratom: An Update (Almetric Score = 417) A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential (Almetric Score =

371) Generic Drugs Not as Safe as FDA Wants you to Believe (Almetric Score = 235) Understanding and Preventing NDMA Contamination (Almetric Score = 211) Association of Inhaled Corticosteroids and LABA in Chronic Asthma (Almetric Score = 128)

C.M. White, p.11

Statins Effect on Skeletal Muscle Function (Almetric Score = 62) Pharmacologic and Critcal Review of Kratom (Almetric Score = 59)

Most Significant Publications As First or Corresponding Author: * Denotes corresponding author

McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.* Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004 Jan 14;291(2):216-21. PMID: 14722148

Award: ASHP Drug Therapy Research Award for Best Publication by a Pharmacist that year.Distinction: Instrumental in FDA’s decision to ban ephedra in the US. National Media Coverage.

White CM, Dunn A, Tsikouris J, Waberski W, Felton K, Freeman-Bosco L, Giri S, Kluger J. An assessment of the safety of short-term amiodarone therapy in cardiac surgical patients with fentanyl-isoflurane anesthesia. Anesth Analg. 1999 Sep;89(3):585-9. PMID: 10475285

Award: Danemiller Award for Top Anesthesia Publication.Award: ASHP Drug Therapy Research Award for Best Publication by a Pharmacist that year.

White CM, Giri S, Tsikouris JP, Dunn A, Felton K, Reddy P, Kluger J. A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg. 2002 Jul;74(1):69-74. PMID: 12118806

Award: ASHP Drug Therapy Research Award for Best Publication by a Pharmacist that year.

White CM, Caron MF, Kalus JS, Rose H, Song J, Reddy P, Gallagher R, Kluger J; Atrial Fibrillation Suppression Trial II. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation. 2003 Sep 9;108 Suppl 1:II200-6. PMID: 12970233

Award: ASHP Drug Therapy Research Award for Best Publication by a Pharmacist that year.Distinction: A commonly used amiodarone regimen for prophylaxis against post-cardiothoracic surgery atrial fibrillation.

White CM, Sander S, Coleman CI, Gallagher R, Takata H, Humphrey C, Henyan N, Gillespie EL, Kluger J. Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol. 2007 Jan 23;49(3):298-303. Epub 2007 Jan 8. PMID: 17239710

Award: ASHP Drug Therapy Research Award for Best Publication by a Pharmacist that year.

Dale KM, Coleman CI, Henyan NN, Kluger J, White CM.* Statins and cancer risk: a meta-analysis. JAMA. 2006 Jan 4;295(1):74-80. PMID: 16391219

Award: ASHP Drug Therapy Research Award for Best Publication by a Pharmacist that year. National Media Coverage. Largest number of citations for any of my articles.

Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.* Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med. 2009 Dec 15;151(12):861-71. doi: 10.7326/0003-4819-151-12-200912150-00162. Review. PMID: 20008762

Distinction: Used to alter national guidelines for myocardial infarction treatment in Japan and inform US performance measures.

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, White CM.* Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics. 2010 Nov;126(5):e1211-26. doi: 10.1542/peds.2010-2007. Epub 2010 Oct 4. Review. PMID: 20921071

C.M. White, p.12

Distinction: Used in CMS national coverage decision Sobieraj DM, Lee S, Coleman CI, Tongbram V, Chen W, Colby J, Kluger J, Makanji S, Ashaye AO, White CM.* Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med. 2012 May 15;156(10):720-7. doi: 10.7326/0003-4819-156-10-201205150-00423. Epub 2012 Mar 12. Review. PMID: 22412039

Distinction: Used as literature set for national guidelines in topic area.

Coleman CI, Schlesselman LS, Lao E, White CM.* Number and impact of published scholarly works by pharmacy practice faculty members at accredited US colleges and schools of pharmacy (2001-2003). Am J Pharm Educ. 2007 Jun 15;71(3):44. PMID: 17619644

Award: Lyman Award for Best Publication in the Journal’s Preceding Year

White CM. Pharmacologic and clinical assessment of kratom. American Journal of Health-System Pharmacy 2018;75(5):261-267. DOI: 10.2146/ajhp161035.

Distinction: Article spawned an OpEd with over 320,000 views, appearance on Dr Oz Show, and other print, radio, and TV media. AJHP Article most read article in journal during the year.

White CM. The Pharmacokinetics and Clinical Utility of Cannabadiol (CBD). J Clin Pharmacol 2019, 59(7) 923–934. https://doi.org/10.1002/jcph.1387. Distinction: This was the most downloaded article in 2019 from the Journal of Clinical Pharmacology. Article had strong national press coverage, inclusion on expert panels in Washington and Colorado, spawned a UConn continuing education article with the most participants in the last five years, spawned an OpEd in The Conversation with strong national press coverage 12,848 views and numerous other national media citations.

White CM. Generic Drugs Not as Safe as FDA Wants You to Believe. Annals of Pharmacotherapy 2020;54:283-286. https://doi.org/10.1177/1060028019881692 Distinction: Article had strong national press coverage (47,987 views), coverage in the Washington Post, and My inclusion in a closed door panel on pharmaceutical quality with the FDA/Duke Margolas Center. Number 3 most read article in the past 6 months in the journal (April 2020)

White CM. Dietary Supplements Pose Real Dangers to Patients. Annals of Pharmacotherapy 2020; https://doi.org/10.1177/1060028019900504. Distinction: Article had strong national press coverage (>112,000 views). Number 1 most read articles in the past 6 months in the Annals of Pharmacotherapy (April 2020).

White CM, Chamberlin K, Eisenberg E. Curcumin, a Turmeric Extract, for Oral Lichen Planus: A Systematic Review. Oral Diseases 2019;25:720-5. DOI: 10.1111/odi.13034. Distinction: Top ten most downloaded article of 2019 in the journal Oral Diseases.

Hernandez AV, MD, Roman YM, Pasupuleti V, Barboza JJ, White CM.* The Use of Chloroquine and Hydroxychloroquine for Prevention or Treatment of COVID-19. Annals of Internal Medicine 2020; https://www.acpjournals.org/doi/10.7326/M20-2496. Distinction: Our evidence review underlies American College of Physicians Practice Points guidance document for physicians and had strong national press including a Boston Globe feature article and 37 other media pieces.

Publication Categories: * Denotes corresponding author

Cardiothoracic or Noncardiac Surgery:C.M. White, p.13

White CM, Dunn A, Tsikouris J, Waberski W, Felton K, Freeman-Bosco L, Giri S, Kluger J. An assessment of the safety of short-term amiodarone therapy in cardiac surgical patients with fentanyl-isoflurane anesthesia. Anesth Analg. 1999 Sep;89(3):585-9. PMID: 10475285

Reddy P, White CM, Song J. Cost-Analysis of Nitroglycerin and Diltiazem for the Prevention of Coronary Bypass Conduit Spasm. Ann Thorac Surg 2001;72:1793-802.

Reddy P, Dunn AB, White CM, Tsikouris JP, Giri S, Kluger J. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery.Pharmacotherapy. 2002 Jan;22(1):75-80. PMID: 11794433

White CM, Giri S, Tsikouris JP, Dunn A, Felton K, Reddy P, Kluger J. A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg. 2002 Jul;74(1):69-74. PMID: 12118806

White CM, Caron MF, Kalus JS, Rose H, Song J, Reddy P, Gallagher R, Kluger J; Atrial Fibrillation Suppression Trial II. Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation. 2003 Sep 9;108 Suppl 1:II200-6. PMID: 12970233

Kluger J, White CM.* Amiodarone prevents symptomatic atrial fibrillation and reduces the risk of cerebrovascular accidents and ventricular tachycardia after open heart surgery: results of the Atrial Fibrillation Suppression Trial (AFIST). Card Electrophysiol Rev. 2003 Jun;7(2):165-7. PMID: 14618044 (Corresponding Author)

Kalus JS, White CM, Caron MF, Coleman CI, Takata H, Kluger J. Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg. 2004 Apr;77(4):1288-92. PMID: 15063253 (Mentor to First Author)

Reddy P, Kalus JS, Caron MF, Horowitz S, Karapanos A, Coleman CI, Kluger J, White CM.* Economic analysis of intravenous plus oral amiodarone, atrial septal pacing, and both strategies to prevent atrial fibrillation after open heart surgery. Pharmacotherapy. 2004 Aug;24(8):1013-9. PMID: 15338850 (Corresponding Author)

Gillespie EL, Perkerson KA, White CM, Coleman CI. Possible impact of aprotinin on post-cardiothoracic surgery atrial fibrillation. Conn Med. 2004 Aug;68(7):439-42. PMID: 15384243

Coleman CI, Perkerson KA, Gillespie EL, Kluger J, Gallagher R, Horowitz S, White CM.* Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother. 2004 Dec;38(12):2012-6. Epub 2004 Oct 26. PMID: 15507494 (Corresponding Author)

Kalus JS, Caron MF, White CM, Mather JF, Gallagher R, Boden WE, Kluger J. Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol. 2004 Dec 1;94(11):1423-5. PMID: 15566917 (Mentor to First Author)

Sander S, White CM.* The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation. Conn Med. 2005 Feb;69(2):91-4. No abstract available. PMID: 15779605 (Corresponding Author)

Perkerson KA, Gillespie EL, White CM, Kluger J, Takata H, Kardas M, Ismaili A, Coleman CI. Impact of prophylactic amiodarone on length of hospital stay, stroke, and atrial fibrillation after cardiothoracic surgery. Pharmacotherapy. 2005 Mar;25(3):320-4. PMID: 15843278

C.M. White, p.14

Gillespie EL, Gryskiewicz KA, White CM, Kluger J, Humphrey C, Horowitz S, Coleman CI. Effect of aprotinin on the frequency of postoperative atrial fibrillation or flutter. Am J Health Syst Pharm. 2005 Jul 1;62(13):1370-4. PMID: 15972379

Gillespie EL, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM.*Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother. 2005 Sep;39(9):1409-15. Epub 2005 Jun 28. PMID: 15985471 (Corresponding Author)

Gillespie EL, White CM, Kluger J, Sahni J, Gallagher R, Coleman CI. A hospital perspective on the cost-effectiveness of beta-blockade for prophylaxis of atrial fibrillation after cardiothoracic surgery. Clin Ther. 2005 Dec;27(12):1963-9. PMID: 16507383

Henyan N, White CM, Gillespie E, Coleman CI, Kluger J. The Impact of Gender on Survival Among Patients With Implantable Cardioverter-Defibrillators for Primary Prevention Against Sudden Cardiac Death. Journal of Internal Medicine 2006;260:467-73.

Gillespie EL, White CM, Kluger J, Rancourt JA, Gallagher R, Coleman CI. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Pharmacotherapy. 2006 Apr;26(4):499-504. PMID: 16553508

Patel AA, White CM, Gillespie EL, Kluger J, Coleman CI. Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm. 2006 May 1;63(9):829-37. PMID: 16638947 (Mentor to First Author)

Gryskiewicz KA, Gillespie EL, White CM, Kluger J, Gallagher R, Coleman CI. Impact of Hispanic ethnicity on the likelihood of developing postoperative atrial fibrillation. Conn Med. 2006 Feb;70(2):77-9. PMID: 16768058

White CM, Sander S, Coleman CI, Gallagher R, Takata H, Humphrey C, Henyan N, Gillespie EL, Kluger J. Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol. 2007 Jan 23;49(3):298-303. Epub 2007 Jan 8. PMID: 17239710

Coleman CI, Makanji S, Kluger J, White CM. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation. Ann Pharmacother. 2007 Mar;41(3):433-7. Epub 2007 Mar 6. PMID: 17341525 (Corresponding Author)

White CM, Kluger J, Lertsburapa K, Faheem O, Coleman CI. Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg. 2007 May;31(5):817-20. Epub 2007 Mar 12. PMID: 17350856

Baker WL, White CM, Kluger J, Denowitz A, Konecny CP, Coleman CI. Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm. 2007 Apr;4(4):461-8. Epub 2006 Dec 6. PMID: 17399635

Baker WL, White CM. Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies. Ann Pharmacother. 2007 Apr;41(4):587-98. Epub 2007 Mar 20. Review. PMID: 17374620 (Corresponding Author)

Coleman CI, Rigali VT, Hammond J, Kluger J, Jeleniowski KW, White CM.* Evaluating the safety implications of aprotinin use: the Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS). J Thorac Cardiovasc Surg.

C.M. White, p.15

2007 Jun;133(6):1547-52. PMID: 17532955 (Corresponding Author)

Coleman CI, Lucek DM, Hammond J, White CM.* Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin. 2007 Aug;23(8):1783-90. PMID: 17597556 (Corresponding Author)

Anglade MW, Kluger J, White CM, Aberle J, Coleman CI. Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study. Curr Med Res Opin. 2007 Nov;23(11):2849-55. PMID: 17919359

Coleman CI, Kluger J, Dale K, Sander S, Gallagher R, Reinhart K, Henyan N, White CM.* Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III). Expert Opin Pharmacother. 2008 Jan;9(1):7-13. PMID: 18076334 (Corresponding Author)

Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, Coleman CI. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg. 2008 Feb;135(2):405-11. doi: 10.1016/j.jtcvs.2007.08.049. PMID:18242276

Ruffin RT Jr, Kluger J, Baker WL, Wills SM, White CM, Coleman CI. Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF Suppression Trials (AFIST) I, II and III. Curr Med Res Opin. 2008 Apr;24(4):1131-6. doi: 10.1185/030079908X280671 . Epub 2008 Mar 10. PMID: 18334081

Sood N, Coleman CI, Kluger J, White CM, Padala A, Baker WL. The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth. 2009 Feb;23(1):22-7. doi: 10.1053/j.jvca.2008.06.009. Epub 2008 Aug 30. PMID: 18834823

Talati R, Reinhart KM, White CM, Phung OJ, Sedrakyan A, Kluger J, Coleman CI.Outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery: a meta-analysis. Ann Pharmacother. 2009 Jul;43(7):1181-8. doi: 10.1345/aph.1L706. Epub 2009 Jun 16. PMID: 19531697 (Mentor to First Author)

Baker WL, White CM, Coleman CI. Benefits and Risks of Corticosteroid Prophylaxis Letter. Circulation 2009;120:e163.

Banach M, Kourliouros A, Reinhart KM, Benussi S, Mikhailidis DP, Jahangiri M, Baker WL, Galanti A, Rysz J, Camm JA, White CM, Alfieri O. Postoperative atrial fibrillation - what do we really know? Curr Vasc Pharmacol. 2010 Jul;8(4):553-72. Review. PMID: 19538179

White CM, Talati R, Phung OJ, Baker WL, Reinhart K, Sedrakyan A, Kluger J, Coleman CI. Benefits and risks associated with beta-blocker prophylaxis in noncardiac surgery. Am J Health Syst Pharm. 2010 Apr 1;67(7):523-30. doi: 10.2146/ajhp090088. Review. PMID: 20237379

Colby JA, Chen WT, Baker WL, Coleman CI, Reinhart K, Kluger J, White CM. Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery. Am J Health Syst Pharm. 2011 Sep 1;68(17):1632-9. doi: 10.2146/ajhp100703. PMID: 21856809 (Corresponding Author)

Alam T, Clyne CA, White CM.* Pharmacologic and nonpharmacologic thromboprophylactic strategies in atrial fibrillation. J Comp Eff Res. 2012 May;1(3):225-39. doi: 10.2217/cer.12.21. Review. PMID: 24237406 (Corresponding Author)

C.M. White, p.16

Baker WL, Coleman CI, White CM, Kluger J. Use of preoperative CHA2 DS2 -VASc score to predict the risk of atrial fibrillation after cardiothoracic surgery: a nested case-control study from the Atrial Fibrillation Suppression Trials (AFIST) I, II, and III. Pharmacotherapy. 2013 May;33(5):489-95. doi: 10.1002/phar.1235. Epub 2013 Mar 21. PMID: 23649811

Li, R, White CM, Mehmeti, J, Martin, ST, Hobbs, LC. Impact of a Perioperative Prophylaxis Guideline on Post–Cardiothoracic Surgery Atrial Fibrillation (Article). Annals of Pharmacotherapy 2017. Volume 51, Issue 9, 1 September, Pages 743-750. DOI: 10.1177/1060028017709290.

Natural Products/Dieting:

White CM, Fan C, Chow M. An evaluation of the hemostatic effect of externally applied notoginseng and notoginseng total saponins. J Clin Pharmacol. 2000 Oct; 40(10):1150-3. PMID: 11028254

Caron MF, White CM.* Evaluation of the antihyperlipidemic properties of dietary supplements. Pharmacotherapy. 2001 Apr; 21(4):481-7. PMID: 11310521 (Corresponding Author)

Ammar R, Song JC, Kluger J, White CM.* Evaluation of electrocardiographic and hemodynamic effects of caffeine with acute dosing in healthy volunteers. Pharmacotherapy. 2001 Apr; 21(4):437-42. PMID: 11310517 (Corresponding Author)

Caron MF, Song J, Ammar R, Kluger J, White CM.* An evaluation of the change in electrocardiographic P-wave variables after acute caffeine ingestion in normal volunteers. J Clin Pharm Ther. 2001 Apr; 26(2):145-8. PMID: 11350538 (Corresponding Author)

White CM, Fan C, Song J, Tsikouris JP, Chow M. An evaluation of the hemostatic effects of hydrophilic, alcohol, and lipophilic extracts of notoginseng. Pharmacotherapy. 2001 Jul; 21(7):773-7. PMID: 11444574Caron MF, Hotsko AL, Robertson S, Mandybur L, Kluger J, White CM.* Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother. 2002 May;36(5):758-63. PMID: 11978148 (Corresponding Author)

Caron MF, Kluger J, Tsikouris JP, Ritvo A, Kalus JS, White CM.* Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide. Pharmacotherapy. 2003 Mar;23(3):296-300. PMID: 12627926 (Corresponding Author)

Kalus JS, Piotrowski AA, Fortier CR, Liu X, Kluger J, White CM.* Hemodynamic and electrocardiographic effects of short-term Ginkgo biloba. Ann Pharmacother. 2003 Mar;37(3):345-9. PMID: 12639160 (Corresponding Author)

Kalus JS, Spencer AP, Tsikouris JP, Chung JO, Kenyon KW, Ziska M, Kluger J, White CM.* Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J Health Syst Pharm. 2003 Nov 15;60(22):2308-12. PMID: 14652979 (Corresponding Author)

Coleman CI, Kalus JS, Caron MF, Kluger J, White CM.* Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients. Am J Health Syst Pharm. 2004 Apr 1;61(7):685-8. No abstract available. PMID: 15119574 (Corresponding Author)

Coleman CI, Kalus JS, White CM, Spencer AP, Tsikouris JP, Chung JO, Kenyon KW, Ziska M, Kluger J, Reddy P. Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation. Pharmacoeconomics. 2004;22(13):877-83. PMID: 15329032

C.M. White, p.17

McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.* Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004 Jan 14;291(2):216-21. PMID: 14722148 (Corresponding Author)

Min B, White CM.* Hawthorn. Conn Med. 2004 Mar;68(3):161-4. Review. PMID: 15058505 (Corresponding Author)

McBride BF, Guertin D, White CM, Kluger J. Inappropriate implantable cardioverter defibrillator discharge following consumption of a dietary weight loss supplement. Pacing Clin Electrophysiol. 2004 Sep;27(9):1317-20. PMID: 15461726 (Mentor to First Author)

Henyan N, White CM.* Adjunctive intravenous magnesium to reduce toxicity and enhance efficacy of class III antiarrhythmic agents. Conn Med. 2004 Nov-Dec;68(10):627-9. PMID: 15626138 (Corresponding Author)

Min B, McBride BF, Kardas MJ, Ismali A, Sinha V, Kluger J, White CM.* Electrocardiographic effects of an Ephedra-Free, multicomponent weight-loss supplement in healthy volunteers. Pharmacotherapy. 2005 May;25(5):654-9. PMID: 15899726 (Corresponding Author)

Min B, McBride BF, Kardas MJ, Ismali A, Sinha V, Kluger J, White CM.* Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement. Am J Health Syst Pharm. 2005 Aug 1;62(15):1582-5. PMID: 16030367 (Corresponding Author)

Min B, McBride BF, Kardas MJ, Ismali A, Sinha V, Kluger J, White CM.* Hemodynamic impact of an ephedra-free multicomponent weight-loss supplement. Am J Health Syst Pharm. 2005 Aug 1;62(15):1582-5. PMID: 16030367 (Corresponding Author)

Henyan NN, Gillespie EL, White CM, Kluger J, Coleman CI. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: a meta-analysis. Ann Thorac Surg. 2005 Dec;80(6):2402-6. PMID: 16305929 (Mentor to First Author)

Fan C, Song J, White CM.* A comparison of the hemostatic effects of notoginseng and yun nan bai yao to placebo control. J Herb Pharmacother. 2005;5(2):1-5. PMID: 16260405 (Corresponding Author)

Min B, Cios D, Kluger J, White CM.* Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy. 2005 Dec;25(12):1719-24. PMID: 16305290 (Corresponding Author)

McBride BF, Min B, Kluger J, Guertin D, Henyan NN, Coleman CI, Silver BB, White CM.* An evaluation of the impact of oral magnesium lactate on the corrected QT interval of patients receiving sotalol or dofetilide to prevent atrial or ventricular tachyarrhythmia recurrence. Ann Noninvasive Electrocardiol. 2006 Apr;11(2):163-9. PMID: 16630091 (Corresponding Author)

Sander S, Coleman CI, Patel AA, Kluger J, White CM.* The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail. 2006 Aug;12(6):464-72. PMID: 16911914 (Corresponding Author)

Caron MF, Dore DD, Min B, Kluger J, Boguk I, White CM.* Electrocardiographic and blood pressure effects of the ephedra-containing TrimSpa thermogenic herbal compound in healthy volunteers. Pharmacotherapy. 2006 Sep;26(9):1241-6. PMID: 16945045 (Corresponding Author)

C.M. White, p.18

Shah S, White CM.* Focus on Rimonabant: A Novel CB1 Receptor Antagonist for the Treatment of Obesity. Formulary 2006;41:561-9. (Corresponding Author)

Tercius AJ, Kluger J, Coleman CI, White CM.* Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter. Pacing Clin Electrophysiol. 2007 Nov;30(11):1331-5. PMID: 17976094 (Corresponding Author)

Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007 Jul;7(7):473-80. PMID: 17597571 (Mentor to First Author)

Shah SA, Schlesselman L, Cios D, Lipeika J, Patel AA, Kluger J, White CM.* Effects of echinacea on electrocardiographic and blood pressure measurements. Am J Health Syst Pharm. 2007 Aug 1;64(15):1615-8. PMID: 17646564 (Corresponding Author)

Shah SA, Clyne CA, Henyan N, Migeed M, Yarlagadda R, Silver BB, Kluger J, White CM.* Impact of magnesium sulfate on serum magnesium concentrations and intracellular electrolyte concentrations among patients undergoing radio frequency catheter ablation. Conn Med. 2008 May;72(5):261-5. PMID:18593060 (Corresponding Author)

Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008 Jan;31(1):41-3. Epub 2007 Oct 1. PMID: 17909085

Baker WL, White CM, Coleman CI. The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literature. Conn Med. 2008 Sep;72(8):465-8. Review. No abstract available. PMID: 18798380

Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM.* Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008 Dec;42(12):1766-71. doi: 10.1345/aph.1L319. Epub 2008 Nov 18. PMID:19017826 (Corresponding Author)

Baker WL, Kluger J, White CM, Dale KM, Silver BB, Coleman CI. Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator. Ann Pharmacother. 2009 Apr;43(4):569-76. doi: 10.1345/aph.1L640. Epub 2009 Mar 31. PMID: 19336644

Saranitzky E, White CM, Baker EL, Baker WL, Coleman CI. Feverfew for migraine prophylaxis: a systematic review. J Diet Suppl. 2009;6(2):91-103. doi: 10.1080/19390210902861809. Review. PMID: 22435410 (Mentor to First Author)

Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI. The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med. 2009 Mar-Apr;7(2):157-63. doi: 10.1370/afm.917. PMID: 19273871 (Mentor to First Author)

Phung OJ, Makanji SS, White CM, Coleman CI. Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc. 2009 May;109(5):865-73. doi: 10.1016/j.jada.2009.02.014. Review. PMID: 19394473 (Mentor to First Author)

Reinhart KM, Talati R, White CM, Coleman CI. The impact of garlic on lipid parameters: a systematic review and meta-analysis. Nutr Res Rev. 2009 Jun;22(1):39-48. doi: 10.1017/S0954422409350003. Review. PMID: 19555517 (Mentor to First Author)

Baker WL, Tercius A, Anglade M, White CM, Coleman CI. A meta-analysis evaluating the impact of chitosan on serum lipids in hypercholesterolemic patients. Ann Nutr Metab. 2009;55(4):368-74. doi: 10.1159/000258633. Epub 2009 Nov 13. PMID: 19923803

C.M. White, p.19

Roman, Y.M., Dominguez, M.C., Easow, T.M., Pasupuleti, V., White, C.M., Hernandez, A.V. Effects of intermittent versus continuous dieting on weight and body composition in obese and overweight people: a systematic review and meta-analysis of randomized controlled trials. International Journal of Obesity 2018; DOI: 10.1038/s41366-018-0204-0.

White CM, Chamberlin K, Eisenberg E. Curcumin, a Turmeric Extract, for Oral Lichen Planus: A Systematic Review. Oral Diseases 2019;25:720-5. DOI: 10.1111/odi.13034.

White CM, Lee JY. The Impact of Turmeric or Its Curcumin Extract on Liver Health: A Systematic Review of Clinical Trials. Pharmacy Practice 2019;17:1350-5. https://doi.org/10.18549/PharmPract.2019.1.1350.

White CM, Pasupuleti V, Roman Y, et al. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. Pharmacologic Research 2019; https://doi.org/10.1016/j.phrs.2019.104280.

Arrhythmias/Electrocardiology/Electrophysiology:

Chen BP, White CM, Fan C, Kluger J, Chow MS. The effect of amiodarone on the ventricular fibrillation threshold. Pharmacotherapy. 1999 Jul; 19(7):832-7. PMID: 10417031

Zhou L, White CM, Chen BP, Chow MS, Fan C, Kluger J. A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a swine model. J Cardiovasc Pharmacol. 1999 Sep; 34(3):440-5. PMID: 10471005

Tsikouris JP, White CM, Kluger J. Optimizing oral dosing and monitoring of noncardiac toxicities with chronic amiodarone therapy. Conn Med. 2000 Jan; 64(1):35-8. PMID: 10697362 (Mentor to First Author)

Song JC, White CM.* Dofetilide (Tikosyn). Conn Med. 2000 Oct; 64(10):601-4. PMID: 11100632 (Corresponding Author)

Murthy DR, White CM, Katten D, Ahlberg AW, Salloum A, Heller GV. Effect of intravenous metoprolol or intravenous metoprolol plus glucagon on dobutamine-induced myocardial ischemia. Pharmacotherapy. 2000 Nov; 20(11):1303-9. PMID: 11079278

Chow MS, White CM, Lau CP, Fan C, Tang MO. Evaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation. J Clin Pharmacol. 2001 Jan;41(1):92-6. PMID: 11144999

Xie J, Dunn A, Tsikouris JP, Sun Y, Fan C, Kluger J, Chow MS, White CM.* A placebo controlled evaluation of the antifibrillatory effects of carvedilol. J Electrocardiol. 2001 Jan; 34(1):25-30. PMID: 11239367 (Corresponding Author) (Mentor to First Author)

Caron MF, White CM.* Intravenous amiodarone in cardiac arrest. Conn Med. 2001 Feb; 65(2):81-2. PMID: 11265606 (Corresponding Author)

Kluger J, Giedrimiene D, White CM, Verroneau J, Giedrimas E. A comparison of the QT and QTc dispersion among patients with sustained ventricular tachyarrhythmias and different etiologies of heart disease. Ann Noninvasive Electrocardiol. 2001 Oct; 6(4):319-22. PMID: 11686913

Caron MF, Kluger J, White CM.* Amiodarone in the new AHA guidelines for ventricular tachyarrhythmias. Ann Pharmacother. 2001 Oct; 35(10):1248-54. PMID: 11675855 (Corresponding Author)

C.M. White, p.20

Tsikouris JP, Kluger J, Song J, White CM.* Changes in P-wave dispersion and P-wave duration after open heart surgery are associated with the peak incidence of atrial fibrillation. Heart Lung. 2001 Nov-Dec; 30(6):466-71. PMID: 11723451 (Corresponding Author)

Markelon J, Caron M, Song J, White CM.* Tips for Safely Withdrawing Other Antiarrhythmics Before Initiating Dofetilide. Formulary 2001;36:471. (Corresponding Author)

Caron M, Song J, White CM.* Antiarrhythmic Classifications in the 2000 Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2001;104:e22. (Corresponding Author)

White CM,* Grant E, Quintilliani R. QTc Interval Effects of Moxifloxacin. Clinical Infectious Diseases 2001;33:1441-2. (Corresponding Author)

White CM. Antipsychotics and QTc interval prolongation. Conn Med. 2002 Aug;66(8):461-3. PMID: 12407956

Giedrimiene D, Giri S, White CM, Giedrimas E, Kluger J. The immediate and short-term effect of successful percutaneous coronary intervention on repolarization in acute myocardial infarction patients. Ann Noninvasive Electrocardiol. 2002 Oct;7(4):357-62. PMID: 12431314

White CM. Venlafaxine in EP Procedure? Clinical Case Review Featured in Clinical Twisters Segment. Drug Topics 2003;147:HSE11.

Cheng JW, Frank L, Garrett SD, Lu Y, Sanoski CA, White CM.* Key articles and guidelines in pharmacotherapeutic management of arrhythmias. Pharmacotherapy. 2004 Feb;24(2):248-79. PMID: 14998224

Kalus JS, Kluger J, Caron MF, Liu X, Humphrey C, White CM.* An evaluation of postoperative P-wave variables after cardiothoracic surgery. J Electrocardiol. 2004 Apr;37(2):127-32. PMID: 15127380 (Corresponding Author)

Madias JE, Song J, White CM, Kalus JS, Kluger J. Response of the ECG to short-term diuresis in patients with heart failure. Ann Noninvasive Electrocardiol. 2005 Jul;10(3):288-96. PMID: 16029379

Min B, Kluger J, Kalus JS, Guertin D, McBride BF, White CM.* The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability. Ann Noninvasive Electrocardiol. 2005 Jul;10(3):305-11. PMID: 16029381 (Corresponding Author)

Kalus JS, White CM, Caron MF, Guertin D, McBride BF, Kluger J. The impact of catecholamines on defibrillation threshold in patients with implanted cardioverter defibrillators. Pacing Clin Electrophysiol. 2005 Nov;28(11):1147-56. PMID: 16359280 (Mentor to First Author)

Kalus JS, Coleman CI, White CM.* The impact of suppressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol. 2006 Jan;46(1):21-8. PMID: 16397280 (Corresponding Author)

Dale K, White CM.* The use of intravenous amiodarone for chemical conversion of atrial fibrillation. Conn Med. 2006 Aug;70(7):433-7. Review. PMID: 16937720 (Corresponding Author)

Dale KM, Lertsburapa K, Kluger J, White CM.* Moxifloxacin and torsade de pointes.Ann Pharmacother. 2007 Feb;41(2):336-40. Epub 2007 Feb 6. PMID: 17284508 (Corresponding Author)

Shah SA, Sander S, Cios D, Lipeika J, Kluger J, White CM.* Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial. Ann Pharmacother. 2007 Mar;41(3):420-5.

C.M. White, p.21

Epub 2007 Mar 6. PMID: 17341532 (Corresponding Author)

Dale KM, White CM.* Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother. 2007 Apr;41(4):599-605. Epub 2007 Mar 27. Review. PMID: 17389667 (Corresponding Author)

Baker WL, White CM.* Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation. Conn Med. 2007 Apr;71(4):205-9. PMID: 17487005 (Corresponding Author)

Shah SA, Kluger J, White CM.* Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes. Pharmacotherapy. 2007 Sep;27(9):1297-305. Review. PMID: 17723083 (Corresponding Author)

Mc Bride BF, Kalus JS, Guertin DC, Dale KM, Kluger J, White CM.* Impact of catecholamines on the QTc interval in patients at high risk of sudden death. Conn Med. 2007 Sep;71(8):465-8. PMID: 17902384 (Corresponding Author)

White CM. Is dronedarone effective for the prevention of recurrent atrial fibrillation? Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):136-7. Epub 2007 Dec 18. PMID: 18087298

McBride BF, White CM, Kalus JS, Guertin DC, Clyne CA, Baker WL, Kluger J. The impact of carvedilol on the defibrillation threshold. Heart Lung. 2008 Jan-Feb;37(1):67-71. doi: 10.1016/j.hrtlng.2007.04.005. PMID: 18206529 (Mentor to First Author)

Giedrimas A, Giedrimiene D, Guertin D, White CM, Clyne CA, Kluger J. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention. Conn Med. 2008 Jun-Jul;72(6):329-33. PMID: 18610705

Coleman CI, White CM, Baker WL. Focus on Dronedarone: A New Iodone-Free Benzofuran Derivative of Amiodarone. Formulary 2009;44:40-6.

Bhavnani SP, Kluger J, Coleman CI, White CM, Guertin D, Shafi NA, Yarlagadda RK, Clyne CA. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm. 2010 Jun;7(6):755-60. doi: 10.1016/j.hrthm.2010.02.039. Epub 2010 Mar 6. PMID: 20211275.

White C.M., Nguyen, E. Novel Use of Ranolazine as an Antiarrhythmic Agent in Atrial Fibrillation. Annals of Pharmacotherapy 2017; Volume 51, Issue 3, Pages 245-252. DOI: 10.1177/1060028016673073.

Thrombosis:

White CM. Heparin dosing: a comparison of weight-based dosing vs standard dosing. Conn Med. 1997 Feb; 61(2):103-4. PMID: 9066199

White CM. The Use of Aspirin for the Prevention and Treatment of Coronary Artery Disease. US Pharmacist 1997;22:116-134.

White CM, Fan C, Chen BP, Kluger J, Chow MS. Assessment of the drug interaction between alteplase and nitroglycerin: an in vitro study. Pharmacotherapy. 2000 Apr; 20(4):380-2. PMID: 10772366

Tsikouris J, White CM.* Focus on Tenectaplase. Formulary 2000;35:647-53. (Corresponding Author)

C.M. White, p.22

Folstad J, Caron MF, Nguyen I, White CM. Assessment of weight-based versus standard dosing of heparin in patients with unstable angina. J Clin Pharm Ther. 2001 Aug; 26(4):283-6. PMID: 11493371 (Corresponding Author)

Kalus JS, White CM.* Monitoring antifactor Xa activity of the low-molecular-weight heparins in the clinical setting: who, why, how, and when? Conn Med. 2002 Dec;66(12):749-52. PMID: 12532610 (Corresponding Author)

Sander S, White CM. Focus on Ximelagatran: A New Oral Anticoagulant. Formulary 2004;39:398-404. (Corresponding Author)

White CM. Thrombin-directed inhibitors: pharmacology and clinical use. Am Heart J. 2005 Jan;149(1 Suppl):S54-60. Review. PMID: 15644794

Sander S, White CM, Coleman CI. Comparative safety and efficacy of urokinase and recombinant tissue plasminogen activator for peripheral arterial occlusion: a meta-analysis.Pharmacotherapy. 2006 Jan;26(1):51-60. PMID: 16506349

Patel AA, Clyne CA, Henyan NN, White CM, Zembrowski BF, Migeed M, Yarlagadda R, Kluger J, Coleman CI. The use of protamine after radiofrequency catheter ablation: a pilot study. J Interv Card Electrophysiol. 2007 Mar;18(2):155-8. Epub 2007 Feb 23. PMID: 17318446 (Mentor to First Author)

Patel AA, White CM, Coleman CI. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention. Conn Med. 2007 Feb;71(2):93-5. Review. No abstract available. PMID: 17393902 (Mentor to First Author)

Talati R, Colemen CI, White CM.* Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. Conn Med. 2008 May;72(5):275-9. Review. PMID: 18593063 (Corresponding Author)

LaSala A, Bower B, Windemuth A, White CM, Kocherla M, Seip R, Duconge J, Ruaño G. Integrating genomic based information into clinical warfarin (Coumadin) management: an illustrative case report. Conn Med. 2008 Aug;72(7):399-403. Erratum in: Conn Med. 2008 Oct;72(9):572. PMID: 18763667

Baker WL, White CM.* Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes. Am J Cardiovasc Drugs. 2009;9(4):213-29. doi: 10.2165/1131209-000000000-00000. Review. PMID: 19655817 (Corresponding Author)

Reinhart KM, White CM, Baker WL. Prasugrel: a critical comparison with clopidogrel. Pharmacotherapy. 2009 Dec;29(12):1441-51. doi: 10.1592/phco.29.12.1441. Review. PMID: 19947804 (Mentor to First Author)

Scholle JM, White CM.* Bivalirudin: a review of pharmacology and therapeutic use. Conn Med. 2010 Nov-Dec;74(10):595-7. Review. No abstract available. PMID: 21189716 (Corresponding Author)

Chen WT, White CM, Phung OJ, Kluger J, Ashaye AO, Sobieraj DM, Makanji S, Tongbram V, Baker WL, Coleman CI. Association between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review. Mayo Clin Proc. 2011 Jun;86(6):509-21. doi: 10.4065/mcp.2010.0755. Review. PMID: 21628615 (Mentor to First Author)

Chen WT, White CM, Phung OJ, Kluger J, Ashaye A, Sobieraj D, Makanji S, Tongbram V, Baker WL, Coleman CI. Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract. 2011 Jul;65(7):749-63. doi: 10.1111/j.1742-1241.2011.02694.x. Review. PMID: 21676118 (Mentor to First Author)

C.M. White, p.23

Talati R, White CM.* Dabigitran: a new orally available anticoagulant for prevention of strokes and thrombosis in patients with atrial fibrillation. Formulary 2011;46:44-53. (Corresponding Author)

Lee S, White CM.* Upcoming oral factor Xa inhibitors for venous thromboembolism prophylaxis in patients undergoing major orthopedic surgery: rivaroxaban (Xarelto) and apixaban (Eliquis) review. Conn Med. 2012 Jan;76(1):39-42. Review. PMID: 22372178 (Corresponding Author)

White CM, Lee J. MTM essentials for anticoagulant management in cardiovascular disease. Drug Topics. 2014;6:42-48.

Sobieraj DM, Lee S, Coleman CI, Tongbram V, Chen W, Colby J, Kluger J, Makanji S, Ashaye AO, White CM.* Prolonged versus standard-duration venous thromboprophylaxis in major orthopedic surgery: a systematic review. Ann Intern Med. 2012 May 15;156(10):720-7. doi: 10.7326/0003-4819-156-10-201205150-00423. Epub 2012 Mar 12. Review. PMID: 22412039 (Corresponding Author)

Sobieraj DM, Coleman CI, Tongbram V, Lee S, Colby J, Chen WT, Makanji SS, Ashaye A, Kluger J, White CM.* Venous Thromboembolism Prophylaxis in Orthopedic Surgery [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar. PMID: 22536611 (Corresponding Author)

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM.* Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy. 2012 Sep;32(9):799-808. doi: 10.1002/j.1875-9114.2012.01106.x. Epub 2012 Jun 28. Review. PMID: 22744711 (Corresponding Author)

Sobieraj DM, White CM, Alikhanov S, Winkler S, Mediouni M, Kluger J, Coleman CI. The impact of antiplatelet and anticoagulant therapies on gastrointestinal symptoms in patients with atrial fibrillation: a systematic review. Ann Pharmacother. 2012 Sep;46(9):1220-31. doi: 10.1345/aph.1R064. Epub 2012 Aug 28. Review. PMID: 22932307

Sobieraj DM, Coleman CI, Tongbram V, Chen W, Colby J, Lee S, Kluger J, Makanji S, Ashaye A, White CM. Comparative effectiveness of combined pharmacologic and mechanical thromboprophylaxis versus either method alone in major orthopedic surgery: a systematic review and meta-analysis. Pharmacotherapy. 2013 Mar;33(3):275-83. doi: 10.1002/phar.1206. Epub 2013 Feb 11. Review. PMID: 23401017 (Corresponding Author)

Mearns ES, Kohn CG, Song JS, Hawthorne J, Meng J, White CM, Raut MK, Schein JR, Coleman CI. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients. Thromb Res. 2014 Aug;134(2):310-9. doi: 10.1016/j.thromres.2014.05.035. Epub 2014 Jun 2. Review. PMID: 24935672 (Mentor to First Author)

Mearns ES, White CM, Kohn CG, Hawthorne J, Song JS, Meng J, Schein JR, Raut MK, Coleman CI. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014 Jun 24;12:14. doi: 10.1186/1477-9560-12-14. eCollection 2014. PMID: 25024644 (Mentor to First Author)

Weeda ER, White CM, Peacock WF, Coleman CI. Rates of Major Bleeding With Rivaroxaban in Real-World Studies of Nonvalvular Atrial Fibrillation Patients: A Meta-Analysis. Curr Med Res Opin. 2016 Mar 2:1-11. [Epub ahead of print] PMID: 26934003 (Mentor to First Author).

Nguyen E, White CM, Patel MR, Fields LE, Peacock WF, Crivera C, Coleman CI. Doses of apixaban and rivaroxaban prescribed in real-world United States cardiology practices compared to registration trials. Curr Med Res Opin. 2016 Apr 1:1-3. PMID: 27009372 (Mentor to First Author)

C.M. White, p.24

Sobieraj DM, White CM, Parker M, Bookhart BK, Coleman CI. Quality measures for anticoagulation care. Curr Med Res Opin. 2016 Jul 11:1-8. PMID: 27279550.

Schein JR, White CM, Nelson WW, Kluger J, Mearns ES, Coleman CI. Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences. Thromb J. 2016 Jun 13;14:14. doi: 10.1186/s12959-016-0088-y. eCollection 2016. Review. PMID: 27303213.

Miao B, Miller M, Lovelace B, Beaubrun M, McNeil-PoseyK, Alberts MJ, Peacock WF, White CM, Coleman CI.Burden-of-Illness Associated With Bleeding-Related Hospitalizations Among High Thrombotic Risk Patients: Findings from the Nationwide Readmission Database. Under Preparation.

Costa O, Alberts MJ, White CM, Coleman CI. Methodological and Reporting Quality in Case Series Describing Andexanet Alfa and Four-Factor Prothrombin Complex Concentrate Use in the Management of Oral Factor Xa Inhibitor-Associated Bleeding. Under Preparation.

Cardiovascular Disease:

White CM, Chow MS. Beyond ACE inhibition: The Role of Angiotensin II Type 1 Receptor Blockers in Cardiovascular Medicine. Formulary 1996;31:1058-64.

White CM, Chow MS. The Role of Positive Inotropic Agents in Severe Heart Failure. Formulary 1997;32:255-266.

White CM, Chow MS. Future Pharmacotherapeutic Options in the Treatment of Heart Failure. US Pharmacist 1997;22:117-130.

White CM. Catecholamines and their blockade in congestive heart failure. Am J Health Syst Pharm. 1998 Apr 1; 55(7):676-82. PMID: 9558423

White CM, Ferraro-Borgida MJ, Fossati AT, McGill CC, Ahlberg AW, Feng YJ, Heller GV, Chow MS. The pharmacokinetics of intravenous estradiol--a preliminary study. Pharmacotherapy. 1998 Nov-Dec; 18(6):1343-6. PMID: 9855336

White CM, Ferraro-Borgida MJ, Moyna NM, McGill CC, Ahlberg AW, Thompson PD, Chow MS, Heller GV. The pharmacokinetics of intravenous testosterone in elderly men with coronary artery disease. J Clin Pharmacol. 1998 Sep;38(9):792-7. PMID: 9753206

White CM, Quercia R. Stability of Extemporaneously Prepared Sterile Testosterone Solution in 0.9% Sodium Chloride Solution Large-Volume Parenterals in Plastic Bags. Int J Pharm Compd. 1999 March-April;3(2):156-157. PMID: 23985556

Song J, White CM. Beta-adrenoceptor blockers in heart failure. Conn Med. 1999 Dec; 63(12):719-22. PMID: 10659472 (Corresponding Author)

White CM. Angiotensin-converting-enzyme inhibition in heart failure or after myocardial infarction. Am J Health Syst Pharm. 2000 Oct 1; 57 Suppl 1:S18-25. PMID: 11030019

Reddy P, White CM, Dunn AB, Moyna NM, Thompson PD. The effect of testosterone on health-related quality of life in elderly males - a pilot study. J Clin Pharm Ther. 2000 Dec; 25(6):421-6. PMID:11123495

Caron M, White CM.* Focus on Nesiritide – An Update. Formulary 2001;36:639-43. (Corresponding Author)

C.M. White, p.25

Thompson PD, Ahlberg AW, Moyna NM, Duncan B, Ferraro-Borgida M, White CM, McGill CC, Heller GV. Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am Heart J. 2002 Feb;143(2):249-56. PMID: 11835027

Song J, Kalus JS, Caron MF, Kluger J, White CM.* Effect of diuresis on P-wave duration and dispersion. Pharmacotherapy. 2002 May;22(5):564-8. PMID: 12013354 (Corresponding Author)

Duncan B, Moyna NM, Heller GV, McGill C, Katten D, Finta L, Velusamy M, Kelsey A, Wieczorek S, Wu AH, White CM. A 24-hour comparison of serum growth hormone concentrations in patients with heart failure versus healthy controls. Pharmacotherapy. 2003 Feb;23(2):147-52. PMID: 12587802 (Corresponding Author)

McBride BF, White CM.* Acute decompensated heart failure: a contemporary approach to pharmacotherapeutic management. Pharmacotherapy. 2003 Aug;23(8):997-1020. Review. PMID: 12921247 (Corresponding Author)

Wu AH, Smith A, Wieczorek S, Mather JF, Duncan B, White CM, McGill C, Katten D, Heller G. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol. 2003 Sep 1;92(5):628-31. PMID: 12943894

Perkerson KA, Coleman CI, White CM.* Aldosterone receptor antagonists in the treatment of heart failure. Conn Med. 2003 Aug;67(7):397-400. Review. PMID: 14502862 (Corresponding Author)

McBride BF, White CM.* Levosimendan: implications for clinicians. J Clin Pharmacol. 2003 Oct;43(10):1071-81. Review. PMID: 14517189 (Corresponding Author)

Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese I, Mather JF, McGill CC, Heller GV. Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol. 2003 Oct 15;42(8):1475-83. PMID: 14563595

McBride BF, White CM.* Are there ethnic differences in heart failure medication response? Conn Med. 2003 Nov-Dec;67(10):605-8. Review. PMID: 14677341 (Corresponding Author)

McBride BF, White CM.* Anemia management in heart failure: a thick review of thin data. Pharmacotherapy. 2004 Jun;24(6):757-67. Review. PMID: 15222666 (Corresponding Author)

McBride BF, White CM.* Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET. J Clin Pharmacol. 2005 Jan;45(1):6-24. Review. PMID: 15601801 (Corresponding Author)

Coleman CI, McKay RG, Boden WE, Mather JF, White CM.* Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals. Clin Ther. 2006 Jul;28(7):1054-62. PMID: 16990084 (Corresponding Author)

Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.* Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med. 2009 Dec 15;151(12):861-71. doi: 10.7326/0003-4819-151-12-200912150-00162. Review. PMID: 20008762 (Corresponding Author)

Coleman CI, Baker WL, Kluger J, Reinhart K, Talati R, Quercia R, Mather J, Giovenale S, White CM.* Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard

C.M. White, p.26

Medical Therapy for Treating Stable Ischemic Heart Disease [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2009 Oct. PMID: 20704041 (Corresponding Author)

Reinhart K, White CM.* Focus on Bucindolol. Formulary 2009;44:166-71. (Corresponding Author)

Baker WL, Colby JA, Tongbram V, Talati R, Silverman IE, White CM, Kluger J, Coleman CI. Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med. 2011 Feb 15;154(4):243-52. doi: 10.7326/0003-4819-154-4-201102150-00306. Epub 2011 Jan 17. Review. PMID: 21242342

Baker WL, Colby JA, Tongbram V, Talati RA, Silverman IE, White CM, Kluger J, Coleman CI. Neurothrombectomy Devices for Treatment of Acute Ischemic Stroke [Internet]. Rockville (MD): Agency for Healthcare Research and Quality; 2011 Jan. PMID: 21433335

White CM, Greene L. Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease. J Manag Care Pharm. 2011 Jun;17(5 Suppl):S1-15. Review. PMID: 21780334

Coleman CI, Colby JA, White CM. Mechanical Thrombectomy Devices in Acute Coronary Syndromes Topic Refinement. Effective Healthcare Program, Agency for Healthcare Research and Quality. Project #: 290-2007-10067-I. www.effectivehealthcare.ahrq.gov

Sobieraj DM, White CM, Kluger J, Tongbram V, Colby J, Chen WT, Makanji SS, Lee S, Ashaye A, Coleman CI. Systematic review: comparative effectiveness of adjunctive devices in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention of native vessels. BMC Cardiovasc Disord. 2011 Dec 20;11:74. doi: 10.1186/1471-2261-11-74. Review. PMID: 22185559

Sobieraj DM, White CM, Kluger J, Tongbram V, Colby J, Chen WT, Makanji SS, Lee S, Ashaye A, Quercia R, Mather J, Giovenale S, Coleman CI. Adjunctive Devices for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec. PMID: 22379634

White C.M., Baker WL. MTM essentials of heart failure management. Drug Topics. 2014;6:48-55.

Nguyen E, Weeda ER, White CM.* A Review of New Pharmacologic Treatments for Patients with Chronic Heart Failure with Reduced Ejection Fraction. J Clin Pharmacol. 2015 Dec 2. doi: 10.1002/jcph.677. PMID: 26626162 (Corresponding Author)

Weeda ER, Nguyen E, White CM.* The Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease. Ann Pharmacother. 2016 Feb 25. pii: 1060028016631571. [Epub ahead of print]. PMID: 26917820 (Corresponding Author)

Martinez, B.K., White, CM* The Emerging Role of Inflammation in Cardiovascular Disease. Annals of Pharmacotherapy Volume 52, Issue 8, 1 August 2018, Pages 801-809. DOI: 10.1177/1060028018765939.

Martinez BK, White CM. Pharmacologic Considerations in the Management of Acute Coronary Syndrome in Elderly Patients. Exp Opin Pharmacother 2019;20:1787-90. https://doi.org/10.1080/14656566.2019.1639670.

Roman Y, Hernandez-Diaz A, White CM.* The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease. Annals of Pharmacotherapy 2020; https://doi.org/10.1177/1060028020922994.

C.M. White, p.27

Methods Work:

Phung OJ, White CM, Baker WL, Coleman CI. Assessing the usefulness of health-related quality-of-life trials: a clinician's perspective using two COPD examples. Ann Pharmacother. 2009 Sep;43(9):1496-505. doi: 10.1345/aph.1M211. Epub 2009 Aug 18. Review. PMID: 19690221 (Mentor to First Author)

Coleman CI, Talati R, White CM.* A clinician's perspective on rating the strength of evidence in a systematic review. Pharmacotherapy. 2009 Sep;29(9):1017-29. doi: 10.1592/phco.29.9.1017. PMID: 19698007 (Corresponding Author)

Baker WL, White CM, Cappelleri JC, Kluger J, Coleman CI; Health Outcomes, Policy, and Economics (HOPE) Collaborative Group. Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract. 2009 Oct;63(10):1426-34. doi: 10.1111/j.1742-1241.2009.02168.x. Review. PMID: 19769699

White CM, Ip S, McPheeters M, Carey TS, Chou R, Lohr KN, Robinson K, McDonald K, Whitlock E. Using Existing Systematic Reviews To Replace De Novo Processes in Conducting Comparative Effectiveness Reviews. Methods Guide for Effectiveness and Comparative Effectiveness Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008-2009 Oct 05. PMID: 21433402

Coleman CI, Phung OJ, Cappelleri JC, Baker WL, Kluger J, White CM, Sobieraj DM. Use of Mixed Treatment Comparisons in Systematic Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Aug. PMID: 23035302

Viswanathan M, Carey TS, Belinson SE, Berliner E, Chang S, Graham E, Guise JM, Ip SS, Maglione MA, McCrory D, McPheeters M, Newberry SJ, Sista P, White CM.* Identifying and Managing Nonfinancial Conflicts of Interest for Systematic Reviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 May. PMID: 23844449 (Corresponding Author)

Sobieraj DM, Cappelleri JC, Baker WL, Phung OJ, White CM, Coleman CI. Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open. 2013 Jul 21;3(7). pii: e003111. doi: 10.1136/bmjopen-2013-003111. Print 2013. PMID: 23878173

Viswanathan M, Carey TS, Belinson SE, Berliner E, Chang SM, Graham E, Guise JM, Ip S, Maglione MA, McCrory DC, McPheeters M, Newberry SJ, Sista P, White CM. A proposed approach may help systematic reviews retain needed expertise while minimizing bias from nonfinancial conflicts of interest. J Clin Epidemiol. 2014 Nov;67(11):1229-38. doi: 10.1016/j.jclinepi.2014.02.023. Epub 2014 Jul 9. PMID: 25022723

Limone BL, Baker WL, Mearns ES, White CM, Kluger J, Coleman CI. Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation. J Clin Epidemiol. 2014 Oct;67(10):1093-102. doi: 10.1016/j.jclinepi.2014.05.013. Epub 2014 Jul 10. Review. PMID: 25018102 (Mentor to First Author)

White CM, Sanders Schmidler GD, Butler M, Wang Z, Robinson K, Mitchell MD, Berkman N, Henderson J, Fiordalisi C, Hartling L, Newberry SJ, Guise JM, Borsky A, Niebuhr D, Pham D, Gozu A, Iyer S, Bañez L. Understanding Health-Systems' Use of and Need for Evidence To Inform Decisionmaking [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Oct. PMID: 29611913.

Cornman DH, White CM.* Discerning the Perception and Impact of Patients Involved in Evidence-based Practice Center Key Informant Interviews [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Sep. PMID: 29528607

C.M. White, p.28

White CM, Sanders Schmidler G. Understanding the How Health Systems View the Pros and Cons of Different Evidence Types. Growth Evidence. November 2018. Available at: https://growthevidence.com/understanding-how-health-systems-view-the-pros-and-cons-of-different-evidence-types/.

White CM. Commentary and Review of “Alexander S, Pillay R, Smith B. A Systematic Review of the Experiences of Vulnerable People Participating in Research on Sensitive Topics”. Int J Nurs Stud. 2018 Sep 3;88:85-96. doi: 10.1016/j.ijnurstu.2018.08.013.

White CM, Coleman CI, Jackman K, Roman YM. AHRQ Series on Improving Translation of Evidence: Linking Evidence Reports and Performance Measures to Help Learning Health Systems Use New Information for Improvement. Joint Commission Journal on Quality and Patient Safety 2019;45(10):706-10. https://doi.org/10.1016/j.jcjq.2019.05.002.

White CM,* Coleman CI, Jackman K. Assessing the Impact of Indexing Performance Measure Codes on the Perceived Value of EPC Reports to Health Systems. Methods Research Report. (Prepared by the University of Connecticut Evidence-based Practice Center under Contract No. 290-2015-00012-I.) AHRQ Publication No. 18-EHC022-EF. Rockville, MD: Agency for Healthcare Research and Quality. September 2018. Posted final reports are located on the Effective Health Care Program search page. DOI: https://doi.org/10.23970/AHRQEPCMETHENGAGEASSESS

Hernandez-Diaz AH, Roman YM, White CM.* Developing Criteria and Associated Instructions for Consistent and Useful Quality Improvement Study Data Extraction for Health Systems. AHRQ, In Press.

Hernandez-Diaz AH, Roman YM, White CM.* Creating Quality Improvement Evidence Synthesis for Health Systems. JGIM, In Press.

Fiordalisi C, Schoelles K, Lavenberg J, Koster M, Chang S, Borsky A, Umscheid C, White CM, Lin J, Murad MH, Sanders-Schmidler, Borsky A, Chang S, Aldape SM, Guise JM. Characterizing Evidence Needs of Health Systems. J Clin Epidemiol, Submitted.

Pulmonary Disease/COVID-19:

White CM. Drug Induced Respiratory Depression. US Pharmacist 1996;21:970-85.

Milch LM, White CM, Wolfe S. Focus of Fluticasone. Formulary 1996;31:1165-77.

Coleman CI, Reddy P, Laster-Bradley NM, Dorval S, Munagala B, White CM.* Prescriber and pharmacist responses to intervention letters for Connecticut Medicaid beneficiaries with asthma. Am J Health Syst Pharm. 2003 Jun 1;60(11):1142-4. No abstract available. PMID: 12816025 (Corresponding Author)

Coleman CI, Reddy P, Laster-Bradley NM, Dorval S, Munagala B, White CM. Effect of practitioner education on adherence to asthma treatment guidelines. Ann Pharmacother. 2003 Jul-Aug;37(7-8):956-61. PMID: 12841800 (Corresponding Author)

Sobieraj DM, White CM, Coleman CI. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004. PMID: 18803985

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, White CM.* Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics. 2010

C.M. White, p.29

Nov;126(5):e1211-26. doi: 10.1542/peds.2010-2007. Epub 2010 Oct 4. Review. PMID: 20921071 (Corresponding Author)

Phung O, Coleman CI, White CM.* Recombinant Human Growth Hormone in Cystic Fibrosis Topic Refinement. Effective Healthcare Program, Agency for Healthcare Research and Quality. Project #: 290-2007-10067-I. www.effectivehealthcare.ahrq.gov (Corresponding Author)

Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, Quercia R, Mather J, Giovenale S, White CM.* Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Oct. PMID: 21938797 (Corresponding Author)

Sobieraj DM, Baker WL, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE. Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar. PMID: 29741837.

Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 Apr 10;319(14):1485-1496. doi: 10.1001/jama.2018.2769. Review.

Sobieraj DM, Baker WL, Nguyen E, Weeda ER, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE. Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018 Apr 10;319(14):1473-1484. doi: 10.1001/jama.2018.2757. Review. Erratum in: JAMA. 2018 May 8;319(18):1939. PMID: 29554174.

Wick J, White CM, Aeschlimann J. SARS-CoV-2 and COVID-19: A Primer for Pharmacists and Technicians. You Asked For It CE, UConn School of Pharmacy. 2020; pg 1-12. Available at: https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/03/CORONAVIRUS-MAR2020-FINAL.pdf.

Aeschlimann J, Giari K, White CM. UConn UPDATE #1: SARS-CoV-2 and COVID-19. You Asked For It CE, UConn School of Pharmacy. 2020; pg 1-12. Available at: https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/03/CORONAVIRUS-UPDATE-1-30MAR2020-FINAL.pdf.

Doyno C, Wick JY, White CM, Aeschlimann JR. UConn UPDATE #2: SARS-CoV-2 and COVID-19. You Asked For It CE, UConn School of Pharmacy. 2020; pg 1-12. Available at: https://pharmacy.uconn.edu/wp-content/uploads/sites/2740/2020/04/CORONAVIRUS-UPDATE-2-13APR2020-FINAL-1.pdf

Wick J, White CM, Aeschlimann J. UConn UPDATE #3: SARS-CoV-2 and COVID-19. You Asked For It CE, UConn School of Pharmacy. 2020; pg 1-12. Available at:

Hernandez AV, MD, Roman YM, Pasupuleti V, Barboza JJ, White CM.* The Use of Chloroquine and Hydroxychloroquine for Treatment of COVID-19: Agency of Healthcare Research and Quality. Internal Document for US Govt Purposes. 4/12/2020.

Hernandez AV, MD, Roman YM, Pasupuleti V, Barboza JJ, White CM.* Update 1 - The Use of Chloroquine and Hydroxychloroquine for Treatment of COVID-19: Agency of Healthcare Research and Quality. Internal Document for US Govt Purposes. 5/1/2020.

C.M. White, p.30

Hernandez AV, MD, Roman YM, Pasupuleti V, Barboza JJ, White CM.* The Use of Chloroquine and Hydroxychloroquine for Prevention or Treatment of COVID-19. Annals of Internal Medicine 2020; https://www.acpjournals.org/doi/10.7326/M20-2496.

Piscoya A, Ng-Sueng LF, del Riego AP, Cerna-Viacava R, Pasupuleti V, Roman YM, Thota P, White CM, Hernandez AV.Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis.doi:https://doi.org/10.1101/2020.05.26.20109595 https://www.medrxiv.org/content/10.1101/2020.05.26.20109595v1

Lipids/Muscle Disorders/Exercise:

White CM. Treatment of Hypercholesterolemia. US Pharmacist 1996;21:76-90.

White CM, Chow MS. A Review of HMG CoA Reductase Inhibitors. US Pharmacist 1998;23:HS19-HS30.

White CM. Pharmacological effects of HMG CoA reductase inhibitors other than lipoprotein modulation. J Clin Pharmacol. 1999 Feb; 39(2):111-8. PMID: 11563401

White CM. An Evaluation of CYP 3A4 Drug Interactions with HMG CoA Reductase Inhibitors. Formulary 2000;35:343-52.

White CM. Pharmacokinetic implications of HMG CoA reductase inhibitors. Conn Med. 2000 Sep; 64(9):533-5. PMID: 11055086

Song JC, White CM.* Do HMG-CoA reductase inhibitors affect fibrinogen? Ann Pharmacother. 2001 Feb; 35(2):236-41. PMID: 11215845 (Corresponding Author)

Thompson PD, Moyna NM, White CM, Weber KM, Giri S, Waters DD. The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation. Atherosclerosis. 2002 Apr;161(2):301-6. PMID: 11888512

White CM. A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin. J Clin Pharmacol. 2002 Sep;42(9):963-70. Review. PMID: 12211221

White CM. HMG CoA Reductase Inhibitor Induced Muscle Toxicity: Risks, Monitoring, and Management. Formulary 2002;37:583-93.

Coleman CI, Linberg M, Perkerson K, White CM. Focus on: Simvastatin/Ezetimibe. Formulary 2004;39:437-44. (Corresponding Author)

Dale KM, Coleman CI, Henyan NN, Kluger J, White CM.* Statins and cancer risk: a meta-analysis. JAMA. 2006 Jan 4;295(1):74-80. PMID: 16391219 (Corresponding Author)

Coleman CI, White CM.* A comparison of different protease inhibitors on coronary heart disease risk. Conn Med. 2007 Jan;71(1):15-7. PMID: 17288101 (Corresponding Author)

Patel AA, White CM, Shah SA, Dale KM, Kluger J, Coleman CI. The relationship between statin use and atrial fibrillation. Curr Med Res Opin. 2007 May;23(5):1177-85. PMID: 17519085

C.M. White, p.31

Dale KM, White CM, Henyan NN, Kluger J, Coleman CI. Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med. 2007 Aug;120(8):706-12. PMID: 17679130 (Mentor to First Author)

Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O'Fallon KS, Gadarla M, Thompson PD. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis. 2008 Sep;200(1):121-5. doi: 10.1016/j.atherosclerosis.2007.12.029. Epub 2008 Feb 7. PMID: 18261731

Coleman CI, Kluger J, Bhavnani S, Clyne C, Yarlagadda R, Guertin D, White CM.* Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm. 2008 Apr;5(4):507-10. doi: 10.1016/j.hrthm.2007.12.023. Epub 2007 Dec 27. PMID: 18362016 (Corresponding Author)

Coleman CI, Reinhart K, Kluger J, White CM.* The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2008 May;24(5):1359-62. doi: 10.1185/030079908X292029 . Epub 2008 Apr 1. Review. PMID: 18384710 (Corresponding Author)

Baker WL, Talati R, White CM, Coleman CI. Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2010 Jan;87(1):98-107. doi: 10.1016/j.diabres.2009.10.008. Epub 2009 Nov 12. PMID: 19913318

Thompson PD, Parker BA, Clarkson PM, Pescatello LS, White CM, Grimaldi AS, Levine BD, Haller RG, Hoffman EP. A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. Prev Cardiol. 2010 Summer;13(3):104-11. doi: 10.1111/j.1751-7141.2009.00063.x. PMID: 20626664

Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, Chipkin S, Pescatello LS, Simpson K, White CM, Thompson PD. Effect of statins on skeletal muscle function. Circulation. 2013 Jan 1;127(1):96-103. doi: 10.1161/CIRCULATIONAHA.112.136101. Epub 2012 Nov 26. PMID: 23183941

Parker BA, Gregory SM, Lorson L, Polk D, White CM, Thompson PD. A randomized trial of coenzyme Q10 in patients with statin myopathy: rationale and study design. J Clin Lipidol. 2013 May-Jun;7(3):187-93. doi: 10.1016/j.jacl.2013.02.002. Epub 2013 Feb 26. PMID: 23725917

Ballard KD, Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, Chipkin S, Pescatello LS, Simpson K, White CM, Thompson PD. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance. Atherosclerosis. 2013 Sep;230(1):121-4. doi: 10.1016/j.atherosclerosis.2013.07.001. Epub 2013 Jul 13. PMID: 23958263

White CM. MTM Essentials for Cholesterol Management. Drug Topics 2014;1:52-61.

Taylor BA, Lorson L, White CM, Thompson PD. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2015 Feb;238(2):329-35. doi: 10.1016/j.atherosclerosis.2014.12.016. Epub 2014 Dec 17. PMID: 25545331.

Taylor BA, Panza G, Pescatello LS, Chipkin S, Gipe D, Shao W, White CM, Thompson PD. Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C. J Lipids. 2014;2014:140723. doi: 10.1155/2014/140723. Epub 2014 Jul 17. PMID: 25136459.

Ballard KD, Lorson L, White CM, Thompson PD, Taylor BA. Effect of Simvastatin on Arterial Stiffness in Patients with Statin Myalgia. Adv Prev Med. 2015;2015:351059. doi: 10.1155/2015/351059. Epub 2015 Jul 15. PMID: 26257959

C.M. White, p.32

Panza GA, Taylor BA, Thompson PD, Erhard L, Capizzi JA, Grimaldi AS, Cole SM, Chipkin S, Keadle J, White CM, Pescatello LS. The Effect of Atorvastatin on Habitual Physical Activity among Healthy Adults. Med Sci Sports Exerc. 2016 Jan;48(1):1-6. doi: 10.1249/MSS.0000000000000740. PMID: 26197031

White CM. Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and Alirocumab. Ann Pharmacother. 2015 Dec;49(12):1327-35. doi: 10.1177/1060028015608487. Epub 2015 Sep 30. Review. PMID: 26424774

Panza, G.A., Taylor, B.A., Thompson, P.D., White, C.M., Pescatello, L.S.. Physical activity intensity and subjective well-being in healthy adults. J Health Psychol 2017;DOI: 10.1177/1359105317691589.

Zaleski, A.L., Taylor, B.A., Pescatello, L.S., Dornelas, E.A., White, C.M., Thompson, P.D. Influence of Baseline Psychological Health on Muscle Pain during Atorvastatin Treatment (Article). Journal of Cardiovascular Nursing. Volume 32, Issue 6, 1 November 2017, Pages 544-550. DOI: 10.1097/JCN.0000000000000382.

Taylor BA, Lorson L, White CM, Thompson PD. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain. Atherosclerosis. 2017 Jan;256:100-104. doi: 10.1016/j.atherosclerosis.2016.11.011. Epub 2016 Nov 12. PMID: 27993387

Ash GI, Taylor BA, Thompson PD, MacDonald HV, Lamberti L, Chen MH, Farinatti P, Kraemer WJ, Panza GA, Zaleski AL, Deshpande V, Ballard KD, Mujtaba M, White CM, Pescatello LS. The antihypertensive effects of aerobic versus isometric handgrip resistance exercise. J Hypertens. 2017 Feb;35(2):291-299. doi: 10.1097/HJH.0000000000001176. PMID: 27861249

Taylor, B.A., Panza, G., Ballard, K.D., White, C.M., Thompson, P.D.. Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin. Journal of Clinical Lipidology 2018; DOI: 10.1016/j.jacl.2018.05.018

White, C.M., Weeda, E.R., Nguyen, E. Should an LDL-Cholesterol Target–Based Approach Be Readopted?(Review) Annals of Pharmacotherapy. Volume 52, Issue 2, 1 February 2018, Pages 175-184. DOI: 10.1177/1060028017722009.

Taylor, B.A., Dager, A.D., Panza, G.A., Zaleski, A.L., Meda, S., Book, G., Stevens, M.C., Tartar, S., White, C.M., Polk, D.M., Pearlson, G.D., Thompson, P.D.. The effect of high-dose atorvastatin on neural activity and cognitive function (Article). American Heart Journal Volume 197, March 2018, Pages 166-174. DOI: 10.1016/j.ahj.2017.10.027.

White, C.M. The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia. (Article). Journal of Cardiovascular Pharmacology and Therapeutics Volume 23, Issue 4, 1 July 2018, Pages 301-308. DOI: 10.1177/1074248418769040.

White, C.M. Reply: Should an LDL Cholesterol Target–Based Approach Be Readopted?(Letter) Annals of Pharmacotherapy Volume 52, Issue 7, 1 July 2018, Page 708. DOI: 10.1177/1060028018766321.

Blanchard, A.R., Taylor, B.A., Thompson, P.D., Lepley, L.K., White, C.M., Corso, L.M., Zaleski, A.L., Pescatello, L.S. The influence of resting blood pressure on muscle strength in healthy adults (Article). Blood Pressure Monitoring Volume 23, Issue 4, 1 August 2018, Pages 185-190. DOI: 10.1097/MBP.0000000000000325.

Zaleski A, Taylor B, Armstrong B, Puglisi M, Clarkson P, Chipkin S, White CM, Thompson PD, Pescatello LS. Associations of 25-Hydroxyvitamin D With the Blood Pressure Response to Maximal Exercise Among Healthy Adults. International

C.M. White, p.33

Journal of Sport Nutrition and Exercise Metabolism 2019; https://doi.org/10.1123/ijsnem.2017-0424.

Taylor BA, Panza G, Ballard KD, White CM, Thompson PD. Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin. Journal of clinical lipidology 2018;12(5):1305-1312. https://doi.org/10.1016/j.jacl.2018.05.018.

Substances of Abuse/Overdose Treatment:

White CM. A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol. 1999 May;39(5):442-7. Review. PMID: 10234590

White CM. How MDMA's Pharmacology and Pharmacokinetics Drive Desired Effects and Harms. J Clin Pharmacol 2014;54:245-52. DOI: 10.1002/jcph.266

White CM. 3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder. Ann Pharmacother. 2014 Apr 16;48(7):908-915. PMID: 24740469

White CM. Mephedrone and 3,4-Methylenedioxypyrovalerone (MDPV): Synthetic Cathinones With Serious Health Implications. J Clin Pharmacol. 2016 Mar 31. doi: 10.1002/jcph.742. [Epub ahead of print] Review. PMID: 27029951

White CM. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids 2017; Journal of Clinical Pharmacology; Volume 57, Issue 3, 2017, Pages 297-304. DOI: 10.1002/jcph.827

White CM. Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-Hydroxybutyrate. J Clin Pharmacol. 2017 Jan;57(1):33-39. doi: 10.1002/jcph.767. Epub 2016 Jun 28. Review. PMID: 27198055

White, CM. Pharmacologic and clinical assessment of kratom. (Review) American Journal of Health-System Pharmacy Volume 75, Issue 5, 1 March 2018, Pages 261-267. DOI: 10.2146/ajhp161035

White, CM. The Pharmacology, Pharmacokinetics, Efficacy, and Adverse Events Associated With Kava. Journal of Clinical Pharmacology 2018; DOI: 10.1002/jcph.1263.

White CM. The Pharmacokinetics and Clinical Utility of Cannabadiol (CBD). J Clin Pharmacol 2019; https://doi.org/10.1002/jcph.1387.

White CM. Loperamide: a Readily Available but Dangerous Opioid. J Clin Pharmacol 2019; https://doi.org/10.1002/jcph.1449.

White CM. Cannabadiol: A Tale of Two Drugs. UConn Continuing Education. 2019. Available at: https://ce.pharmacy.uconn.edu/wp-content/uploads/sites/2102/2019/05/CBD-MAY2019-FINAL.pdf.

White, CM. Pharmacologic and clinical assessment of kratom, an update. AJHP 2019; https://doi.org/10.1093/ajhp/zxz221.

Friedman A, Mobasheri D, White CM. An Overview of Topical CBD for Pain and Inflammation. In Progress.

Hemodynamics/Hypertension:

C.M. White, p.34

White CM, Chow MS. Reassessing the Risks of Calcium Channel Blockers In Medicine. Formulary 1997;32:1146-65.

White CM. Calcium channel blockers in left ventricular dysfunction or congestive heart failure. Conn Med. 1997 Oct; 61(10):659-61. PMID: 9375452

White CM. Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors. Pharmacotherapy. 1998 May-Jun; 18(3):588-99. PMID: 9620109

White CM, Chow MS, Fan C, Kluger J, Bazunga M. Efficacy of intravenous granisetron in suppressing the bradycardia and hypotension associated with a rabbit model of the Bezold-Jarisch reflex. J Clin Pharmacol. 1998 Feb;38(2):172-7. PMID: 9549649.

White CM, Chow MSS. Applying Principles of Chronotherapy to Drug Delivery Systems and Dosage Times. Formulary 1998;33:208-220.

White CM, Tsikouris JP. A review of pathophysiology and therapy of patients with vasovagal syncope. Pharmacotherapy. 2000 Feb; 20(2):158-65. PMID: 10678294

Song JC, White CM. Pharmacologic, pharmacokinetic, and therapeutic differences among angiotensin II receptor antagonists. Pharmacotherapy. 2000 Feb; 20(2):130-9. PMID: 10678291 (Corresponding Author)

Tsikouris JP, Kluger J, Chow MS, White CM. Usefulness of intravenous granisetron for prevention of neurally mediated hypotension upon head upright tilt testing. Am J Cardiol. 2000 May 15; 85(10):1262-4. PMID: 10802016 (Corresponding Author)

Song J, White CM*. Focus on Omapatrilat. Formulary 2001;36:698-707. (Corresponding Author)

Caron M, Kuti J, Quintilliani R, White CM.* Focus on Drotrecogin Alpha (Activated): A New Approach to Treating Sepsis. Formulary 2001;36:784-95. (Corresponding Author)

Song J, White CM.* Focus on Olmesartan Medoxomil (Cs-866): An Angiotensin Receptor Blocker for Treatment of Hypertension. Formulary 2001;36:487-99. (Corresponding Author)

Kalus J, White CM.* Focus on Lercanidipine: a Long-Acting Dihydropyridine Calcium Channel Blocker. Formulary 2002;37:234-8. (Corresponding Author)

Coleman C, Reddy P, Song J, White CM.* Focus on Eplerenone: The First Selective Aldosterone Receptor Antagonist for the Treatment of Hypertension. Formulary 2002;37:514-24. (Corresponding Author)

McBride BF, White CM.* Ranolazine: A Novel Metabolic Modulator for the Treatment of Chronic Stable Angina. Formulary 2003;38:461-6. (Corresponding Author)

Kalus JS, White CM.* A comprehensive review of antihypertensive agents providing renal protection. Conn Med. 2001 Oct; 65(10):587-91. PMID: 11702517 (Corresponding Author)

Song JC, White CM.* Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet. 2002;41(3):207-24. Review. PMID: 11929321 (Corresponding Author)

Haider J, Kalus JS, White CM, Narula DD, Guertin DC, Caron MF, Kluger J. The effect of head-upright tilt table testing for C.M. White, p.35

vasovagal syncope on P-wave duration. J Electrocardiol. 2002 Oct;35(4):303-6. PMID: 12395356

Kalus JS, White CM.* Amlodipine versus Angiotensin-receptor blockers for nonhypertension indications. Ann Pharmacother. 2002 Nov;36(11):1759-66. Review. PMID: 12398574 (Corresponding Author)

McBride BF, White CM, Campbell M, Frey BM. Nicardipine to control neonatal hypertension during extracorporeal membrane oxygen support. Ann Pharmacother. 2003 May;37(5):667-70. PMID: 12708943 (Mentor to First Author)

Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care. 2005 Sep;28(9):2261-6. PMID: 16123505

Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care. 2005 Sep;28(9):2261-6. PMID: 16123505

Henyon N, White CM.* Focus on Ranolazine: An Update. Formulary 2005;40:323-328. (Corresponding Author)

Reinhart K, White CM. Focus on Sitaxsentan. Formulary 2007;42:295-301. (Corresponding Author)

White CM, Baker W, Coleman CI. Renin Inhibiton: Taking RAAS Blockade to a Whole New Level. Drug Store News 2007;9:47-51.

Coleman CI, Baker WL, Kluger J, White CM.* Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens. 2008 Apr;26(4):622-9. doi: 10.1097/HJH.0b013e3282f3ef5e. PMID: 18327066 (Corresponding Author)

Reinhart K, Salerno E, White CM.* Pulmonary arterial hypertension: an overview of current pharmacologic treatment. Conn Med. 2008 Oct;72(9):531-4. Review. PMID:18833870 (Corresponding Author)

Phung OJ, Baker WL, White CM, Coleman CI. Focus on Clevidipine. Formulary 2009;44:102-7.

White CM. Comparative effectiveness of renin-angiotensin system inhibitors in hypertension.J Comp Eff Res. 2012 Mar;1(2):125-7. doi: 10.2217/cer.12.2. PMID: 24237372

Salvo M, White CM.* Reconciling Multiple Hypertension Guidelines to Promote Effective Clinical Practice. Ann Pharmacother. 2014 Jun 20;48(9):1242-1248. PMID: 24951309 (Corresponding Author)

Abraham HM, White CM, White WB. The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases. Drug Saf. 2015 Jan;38(1):33-54. doi: 10.1007/s40264-014-0239-7. PMID: 25416320

Movement Disorders/Epilepsy:

White CM, Gailey RA, Levin GM, Smith T. Seizure resulting from a venlafaxine overdose. Ann Pharmacother. 1997 Feb; 31(2):178-80. PMID: 9034419

White CM. Additional Venlafaxine Case Report. The Annals of Pharmacotherapy 1997;31:791.

C.M. White, p.36

White CM, Dicks RS. Focus on Rivastigmine: An Acetylcholinesterase Inhibitor for Patients with Alzheimer’s Disease. Formulary 1999;34:493-9.

Coleman CI, Gillespie EL, White CM. Probable topical permethrin-induced neck dystonia. Pharmacotherapy. 2005 Mar;25(3):448-50. PMID: 15843294 (Corresponding Author)

Talati R, White CM, Coleman CI. Focus on Rotigitine. Formulary 2007;42:633-46.

Baker WL, White CM, Coleman CI. Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med. 2008 May-Jun;6(3):253-62. doi: 10.1370/afm.845. Review. PMID: 18474889

Baker WL, Silver D, White CM, Kluger J, Aberle J, Patel AA, Coleman CI. Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord. 2009 May;15(4):287-94. doi: 10.1016/j.parkreldis.2008.07.004. Epub 2008 Sep 6. PMID: 18774743

Talati R, Reinhart K, Baker W, White CM, Coleman CI. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors. Parkinsonism Relat Disord. 2009 Aug;15(7):500-5. doi: 10.1016/j.parkreldis.2008.12.007. Epub 2009 Jan 22. PMID: 19167259 (Mentor to First Author)

Talati R, White CM, Coleman CI. Eslicarbazepine: a Novel Antiepileptic Agent Designed for Improved Efficacy and Safety. Formulary 2009;44:357-61.

Talati R, White CM, Coleman CI. Status epilepticus: a review of current pharmacologic treatments. Conn Med. 2009 Oct;73(9):525-8. Review. No abstract available. PMID: 19860272

Baker WL, Talati R, Tongbram V, Chen W, Coleman CI, White CM.* Comparative Effectivness of Antiepileptic Agents Topic Refinement. Effective Healthcare Program, Agency for Healthcare Research and Quality. Project #: 290-2007-10067-I. www.effectivehealthcare.ahrq.gov. 2010. (Corresponding Author)

Talati R, Scholle JM, Phung OJ, Baker WL, Baker EL, Ashaye A, Kluger J, Quercia R, Mather J, Giovenale S, Coleman CI, White CM.* Effectiveness and Safety of Antiepileptic Medications in Patients With Epilepsy [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Dec. PMID: 22359775 (Corresponding Author)

Talati R, Scholle JM, Phung OP, Baker EL, Baker WL, Ashaye A, Kluger J, Coleman CI, White CM.* Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy. 2012 Apr;32(4):314-22. doi: 10.1002/j.1875-9114.2012.01099.x. Review. PMID: 22461121 (Corresponding Author)

Diabetes/Renal Disease:

Coyle JD, Gardner SF, White CM.* The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. Ann Pharmacother. 2004 Oct;38(10):1731-8. Epub 2004 Sep 7. Review. PMID: 15353571 (Corresponding Author)

Patel AA, White CM, Coleman CI. Focus on Exubra, an Inhaled Insulin. Formulary 2005;40:429-36.

Kuti EL, Baker WL, White CM.* The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker. Curr Med Res Opin. 2007 Jun;23(6):1239-44. Epub 2007 Apr 23. PMID: 17559720 (Corresponding Author)

C.M. White, p.37

Chen W, Lee S, Colby J, Kluger J, Ashaye A, Tongbram V, Baker E, Mather J, Coleman CI, White CM.* The Impact of Pre-Transplant Red Blood Cell Transfusions in Renal Allograft Rejection [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar 07. PMID: 25375017 (Corresponding Author)

Mearns ES, Sobieraj DM, White CM, Saulsberry WJ, Kohn CG, Doleh Y, Zaccaro E, Coleman CI. Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis. PLoS One. 2015 Apr 28;10(4):e0125879. doi: 10.1371/journal.pone.0125879. eCollection 2015. PMID: 25919293 (Mentor to First Author)

Collagen Vascular Diseases:

Coleman CI, Reddy P, White CM. Budesonide: its role in Crohn's disease therapy. Conn Med. 2002 Sep;66(9):523-6. Review. PMID: 12369546 (Corresponding Author)

Phung OJ, Coleman CI, Kugelman L, White CM. The impact of biologic agents to treat plaque psoriasis. Conn Med. 2009 Feb;73(2):79-83. Review. PMID: 19263738 (Corresponding Author)

Phung OJ, White CM, Coleman CI. Focus on Ustekinumab. Formulary 2009;44:72-6.

Baker EL, Coleman CI, Reinhart KM, Phung OJ, Kugelman L, Chen W, White CM, Mamolo CM, Cappelleri JC, Baker WL. Effect of Biologic Agents on Non-PASI Outcomes in Moderate-to-Severe Plaque Psoriasis: Systematic Review and Meta-Analyses. Dermatol Ther (Heidelb). 2012 Dec;2(1):9. doi: 10.1007/s13555-012-0009-3. Epub 2012 Jun 19. PMID: 23205332

Lee S, Coleman CI, Limone B, Kaur R, White CM, Kluger J, Sobieraj DM. Biologic and Nonbiologic Systemic Agents and Phototherapy for Treatment of Chronic Plaque Psoriasis [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov. PMID: 23285484 (Mentor to First Author).

Nasogastric/Enteral Tube Drug Administration:

Dunn A, White CM, Reddy P, Quercia RA, Chow MS. Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro. Am J Health Syst Pharm. 1999 Nov 15; 56(22):2327-30. PMID: 10582827 (Mentor to First Author)

Song JC, Quercia RA, Fan C, Tsikouris J, White CM. Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension. Am J Health Syst Pharm. 2001 Apr 15; 58(8):689-94. PMID: 11329761 (Corresponding Author)

White CM, Kalus JS, Quercia R, Fortier C, Piotrowski A, Roach A, Sostek MB. Delivery of esomeprazole magnesium enteric-coated pellets through small caliber and standard nasogastric tubes and gastrostomy tubes in vitro. Am J Health Syst Pharm. 2002 Nov 1;59(21):2085-8. PMID: 12434721

Shah SA, Sander S, Coleman CI, White CM. Delivery of esomeprazole magnesium through nasogastric and gastrostomy tubes using an oral liquid vehicle as a suspending agent in vitro. Am J Health Syst Pharm. 2006 Oct 1;63(19):1882-7. PMID:16990636 (Corresponding Author)

Phung OJ, Quercia RA, Keating K, Baker WL, Bell JL, White CM, Coleman CI. Improved glucose control associated with

C.M. White, p.38

i.v. chromium administration in two patients receiving enteral nutrition. Am J Health Syst Pharm. 2010 Apr 1;67(7):535-41. doi: 10.2146/ajhp090109. PMID: 20237381 (Mentor to First Author)

Drug Safety/Cost, Pharmacist Value/Education, Other Clinicians:

White CM. Prevention of suboptimal beta-blocker treatment in patients with myocardial infarction. Ann Pharmacother. 1999 Oct; 33(10):1063-72. PMID: 10534220

White CM. Ensuring that patients receive full cardiac pharmacotherapy services: a pharmacist's call to arms. Ann Pharmacother. 2006 Dec;40(12):2248-50. Epub 2006 Oct 31. PMID: 17077170

Patel AA, Kuti EL, Dale KM, Shah, SA, White CM, Coleman CI. Effect of a Medication Assistance Program on Clinical Outcomes in Patients with Diabetes. Formulary 2006;41:518-22.

Coleman CI, Schlesselman LS, Lao E, White CM.* Number and impact of published scholarly works by pharmacy practice faculty members at accredited US colleges and schools of pharmacy (2001-2003). Am J Pharm Educ. 2007 Jun 15;71(3):44. PMID: 17619644 (Corresponding Author)

Coleman CI, Schlesselmann L, White CM.* Journal publications by pharmacy practice faculty evaluated by institution and region of the United States (2001-2003). Pharm Pract (Granada). 2007 Oct;5(4):151-6. PMID: 25170351 (Corresponding Author)

White CM, Schlesselmann L. Instructing pharmacy students with interactive clinical cases. Am J Health Syst Pharm. 2008 Sep 1;65(17):1598-9. doi: 10.2146/ajhp070457. PMID: 18714099

Reinhart K, Corbo T, Ewen E, White CM.* The impact of ethnicity and gender on agreement of severe allergy history between inpatient and outpatient electronic medical records. Pharm Pract (Granada). 2008 Oct;6(4):197-200. Epub 2008 Dec 15. PMID: 25157294 (Corresponding Author)

White CM. Pharmacists need recognition as providers to enhance patient care. Ann Pharmacother. 2014 Feb;48(2):268-73. doi: 10.1177/1060028013511786. PMID: 24259647.

White CM. Potential benefits and risks of value-based pricing of prescription drugs. Connecticut Medicine 2017;81(10):587-595.

White CM. Nurses must be aware of the potential for causing distress when recruiting vulnerable populations to research projects. Evidence-Based Nursing 2019. http://dx.doi.org/10.1136/ebnurs-2018-103027

White CM. Generic Drugs Not as Safe as FDA Wants You to Believe. Annals of Pharmacotherapy 2020;54:283-286. https://doi.org/10.1177/1060028019881692

White CM. Understanding and Preventing (N-Nitrosodimethylamine) NDMA Contamination of Medications. Annals of Pharmacotherapy 2020;6:611-14. doi:10.1177/1060028019892222.

White CM. Dietary Supplements Pose Real Dangers to Patients. Annals of Pharmacotherapy 2020; https://doi.org/10.1177/1060028019900504.

White CM. How Cell Line Contamination can Befuddle the Clinical Pharmacologist. J Clin Pharmacology 2020; DOI:10.1002/jcph.1569. https://doi.org/10.1002/jcph.1569

C.M. White, p.39

White CM. Current System of Conducting Drug Trials in Developing Countries is Dangerous. Ann Pharmacother 2020; https://doi.org/10.1177/1060028020906484

Holle LM, Levine J, Buckley T, White CM, White C, Hadfield MJ. Pharmacist Intervention in Colorectal Cancer Screening Initiative (PICCSI). J Am Pharm Assoc, In Press.

White CM. Counterfeit Drugs are a Global Challenge. Journal of the American Pharmacists Asociation, 2020; https://doi.org/10.1016/j.japh.2020.04.020.

BOOKS

Apr 2018 White, CM. (2018). The Part-Time Diet: Conquering the Weight Loss Plateau. Seattle, WA, United States: Kindle Direct Publishers, Amazon.com. Retrieved from https://www.amazon.com/s/ref=nb_sb_noss?url=search-alias%3Dstripbooks&field-keywords=The+PArt+Time+Diet+C.+Michael+White.

BOOK CHAPTERS

Feb 2001 Chow MSS, White CM. Cardiac Arrhythmias, Chapter 18. In: Koda-Kimble MA, Young LY (Eds). Applied Therapeutics: The Clinical Use of Drugs. 7th Edition. Lippincott Williams & Wilkins, Philadelphia, PA. 2001: pg 18.1-18.36.

Apr 2002 Chow MSS, White CM. Cardiac Arrhythmias, Chapter 17. In: Koda-Kimble MA, Young LY (Eds). Handbook of Applied Therapeutics. 7th Edition. Lippincott Williams & Wilkins Philadelphia, PA 2001: pg 17.1-17.16.

Aug 2002 White CM. Cardiac Arrhythmias, Chapter 5. In: Jeffrey S (Ed). Geriatric Pharmacy Certification Program Review Coursebook, 3 rd Edition . American Society of Consultant Pharmacists, Alexandria, VA. Accessed at GeriatricPharmacyReview.com.

Jan 2004 White CM, McBride B, Kalus J. Dyslipidemias, Chapter 2. In: Schumock GT, Brungage DM, et al (Eds). Pharmacotherapy Self Assessment Program, Fifth Edition, Book 1 Cardiology. American College of Clinical Pharmacy Inc, Kansas City. MO. 2004: pg 165-190.

Aug 2004 White CM, Song J, Chow MSS. Cardiac Arrhythmias, Chapter 20. In: Koda-Kimble MA, Young LY (Eds). Applied Therapeutics: The Clinical Use of Drugs. 8th Edition. Lippincott Williams & Wilkins, NY, NY. 2004; Pg 20.1-20.33.

Apr 2005 Caron M, White CM. Fundamental Concepts in Pharmacokinetics and Pharmacodynamics of Fibrinolytic Agents. In: Becker RC, Harrington RA (Eds). Clinical, Interventional, and Investigational Thrombocardiology. Marcell Dekker, Inc, New York, NY. 2005

Apr 2005 Caron M, Kalus J, McBride B, White CM. Fundamental Concepts in Pharmacokinetics and Pharmacodynamics of Antithrombotic Agents. In: Becker RC, Harrington RA (Eds). Clinical, Interventional, and Investigational Thrombocardiology Marcell Dekker, Inc, New York, NY. 2005

Apr 2005 White CM, Song J, Chow MSS. Cardiac Arrhythmias, Chapter 20. In: Koda-Kimble MA, Young LY (Eds). Handbook of Applied Therapeutics. 8th Edition. Lippincott Williams & Wilkins, NY, NY. 2005; Pg 20.1-

C.M. White, p.40

20.15.

Jun 2005 White CM. Cardiac Arrhythmias, Chapter 5. In: Jeffrey S (Ed). Geriatric Pharmacy Certification Program Review Coursebook, 4 th Edition . American Society of Consultant Pharmacists, Alexandria, VA. Accessed at GeriatricPharmacyReview.com.

Aug 2005 White CM, McBride BF, Kalus J. Dyslipidemia Algorithms. In: Kishi W. A Guide to Clinical Decision-Making: The PSAP Algorithms, Third Edition. American College of Clinical Pharmacy Inc, Kansas City, MO 2005.

Apr 2006 White CM. Careers in Pharmacy. In: Castagno JM. (Ed). Lands and Peoples: The New Book of Popular Science. Scholastic Library Publishing, Danbury, CT. pg 462-64.

Apr 2006 Davis G, White CM. Medications and Drugs. In: Castagno JM. (Ed). Lands and Peoples: The New Book of Popular Science. Scholastic Library Publishing, Danbury, CT. 2006: pg 460-7.

Apr 2006 Rhines K, White CM. Drug Delivery Technology. In: Castagno JM. (Ed). Lands and Peoples: The New Book of Popular Science. Scholastic Library Publishing, Danbury, CT. 2006: pg 468-75.

Jan 2007 White CM, Coleman CI. Drug Induced Cardiac Diseases. In: Schumock GT, Brungage DM, et al (Eds). Pharmacotherapy Self Assessment Program, Sixth Edition, Book 1 Cardiology. American College of Clinical Pharmacy Inc, Kansas City. MO. 2007: Pg 39-56.

Jul 2007 White CM, Song J, Kluger J. Research Considerations in Cardiovascular Therapeutic Areas. Chapter 12. In: Even RP, Smith LJ (Eds). Drug and Biologic Development. Springer Verlag, Inc., New York, NY. 2007:Pg 275-91.

Sep 2007 White CM, Song J, Kalus J. Cardiac Arrhythmias, Chapter 20. In: Koda-Kimble MA, Young LY (Eds). Applied Therapeutics: The Clinical Use of Drugs. 9th Edition. Lippincott Williams & Wilkins, NY, NY. 2007 pg 20.1 to 20.33.

Sep 2008 White CM, Song J, Kalus JS. Cardiac Arrhythmias. In: Koda-Kimble MA, Young LY (Eds). Handbook of Applied Therapeutics. 9th Edition. Lippincott Williams & Wilkins, NY, NY. 2008.

Jan 2010 White CM, Ip S, McPheeters M, Carey T, Chou R, Lohr K, Robinsom K. Chapter 12. Using Exisiting Systematic Reviews in Comparative Effectiveness Reviews. In: EPC Methods Guide for Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=60

May 2010 Reinhart K, White CM. Antiarrhythmic Drugs. In: Smith KM, Rich DM, Henyan NN (Eds). Clinical Drug Data, 11th Edition. McGraw-Hill, NY, NY 2010. Pg 395-419.

Sep 2012 White CM, Song J, Kalus J. Cardiac Arrhythmias, Chapter 20. In: Alldredge BK, Corelli RL, Ernst ME (Eds). Applied Therapeutics: The Clinical Use of Drugs. 10th Edition. Lippincott Williams & Wilkins, NY, NY. 2012 pg. 20.1-20.35.

Aug 2013 McBride BF, White CM. Renin-Angiotensin-Aldosterone-System (RAAS) Mediators, Chapter 27. In: D’Amato-Kubiet, Sherry D, Henyan N. (Eds) Pharmacology for Nursing. Lipincott McGraw-Hill, New York, NY. 2013 pg 155-68.

C.M. White, p.41

Aug 2013 McBride BF, White CM. Diuretics, Chapter 28. In: D’Amato-Kubiet, Sherry D, Henyan N. (Eds) Pharmacology for Nursing. Lipincott McGraw-Hill, New York, NY. 2013 pg 168-84.

Dec 2013 Coleman CI, Limone BL, Nelson WW, Kluger J, White CM. Upper Gastrointestinal Symptoms and Cardiovascular Disease.Chapter 8: In, Shaffer E, Curley M. Dyspepsia – Advances in Understanding and Management. Inteck Open Science Books. NY, NY. DOI: 10.5772/56564 http://www.intechopen.com/books/dyspepsia-advances-in-understanding-and-management/upper-gastrointestinal-symptoms-and-cardiovascular-disease

Jul 2018 White CM, Baker WL. Cardiovascular Mediciations and Exercise, Chapter 4, In Thompson PD, Fernandez AB (Eds). Exercise and Sport’s Cardiology. Volume 3. World Scientific, Chennai, India,

Sep 2018 White CM, Song J, Kalus J. Cardiac Arrhythmias, Chapter 20. In: Alldredge BK, Corelli RL, Ernst ME (Eds). Applied Therapeutics: The Clinical Use of Drugs. 11th Edition. Lippincott Williams & Wilkins, NY, NY. 2018 pg. 20.1-20.35.

White CM, Song J, Kalus J. Cardiac Arrhythmias, Chapter 20. In: Alldredge BK, Corelli RL, Ernst ME (Eds). Applied Therapeutics: The Clinical Use of Drugs. 12th Edition. Lippincott Williams & Wilkins, NY, NY. 2021 pg. 20.1-20.35.

MODULES (1 Published)Jun 2001 White CM, Dunn A, Reddy P. Angina Pectoris Disease State Management Module. University of

Kentucky College of Pharmacy, Lexington, KY. 2001.

RESEARCH PRESENTATIONSAbstracts/Presentations:

National/InternationalApril 1997 White CM, Fan C, Bazunga M, Chow MS, Kluger J. Granisetron Use In A Hemorrhagic Rabbit

Model to Prevent the Bezold-Jarisch Reflex.Poster Presentation: American College of Clinical Pharmacy Spring Practice and Research Forum. April 6-9, 1997. Panama City, FLAbstract Published: Pharmacotherapy 1997;17:[Abstract]182, #5

December 1997 White CM, Chow MSS. Cost Effectiveness of Focused Rounding in a Cardiac Intensive Care Unit.Poster Presentation: 32nd Annual American Society of Health-System Pharmacists Midyear Clinical Meeting, December 8-12, 1997. Atlanta, GAAbstract Published: International Pharmaceutical Abstracts 1997;34:[Abstract] 3412752.

September 1998 White CM, Ferraro-Borgida MJ, Moyna NM, McGill CC, Ahlberg AW, Thompson PD, Chow MS, Heller GV. Pharmacokinetics of IV Testosterone in Men With Coronary Artery Disease. Poster Presentation: American College of Clinical Pharmacologists/Royal College of Physicians and Surgeons of Canada, Annual Meeting. September 24-27, 1998. Toronto, CanadaAbstract Published: Journal of Clinical Pharmacology 1998;38:883 [#612.]

September 1998 White CM, Ferraro-Borgida MJ, Fossati AT, McGill CC, Ahlberg AW, Heller GV, Chow MS. C.M. White, p.42

Pharmacokinetics of IV Estradiol - A Preliminary StudyPoster Presentation: American College of Clinical Pharmacologists/Royal College of Physicians and Surgeons of Canada, Annual Meeting. September 24-27, 1998. Toronto, CanadaAbstract Published: Journal of Clinical Pharmacology 1998;38:883. [#611]

November 1998 Dunn A, White CM, Reddy P, Chow MSS, Kluger J. Efficacy and Safety of Ibutilide for Cardioversion in Patients with Atrial Fibrillation or Flutter: Maintenance of Sinus Rhythm Until Discharge.Poster Presentation: American College of Clinical Pharmacists Winter Meeting. November 8-11, 1998. Cincinnati, OH.Abstract Published: Pharmacotherapy 1998;18:1140

December 1998 Dunn A, White CM, Reddy P, Quercia R, Chow MSS. An In-Vitro Evaluation of The Delivery of Omeprazole and Lansoprazole Granules Through Nasogastric Tubes With Water and Apple Juice.Platform Presentation: 33rd Annual American Society of Health-System Pharmacists Midyear Meeting December 6-10, 1998, Las Vegas, NV.Abstract Published: International Pharmaceutical Abstracts 1998;33:SRF-3.

December 1998 Nguyen IT. Folstad JE, White CM. A Retrospective Study of Atorvastatin’s Efficacy Compared to Previous Lipid Lowering Regimens.Poster Presentation: 33rd Annual American Society of Health-System Pharmacists Midyear Meeting December 6-10, 1998, Las Vegas, NV.

December 1998 Kapadia VK, Folstad JE, White CM. Use of Losartan in Hypertensive Patients Who Developed Cough/Angioedema due to ACE Inhibitors.Poster Presentation: 33rd Annual American Society of Health-System Pharmacists Midyear Meeting December 6-10, 1998, Las Vegas, NV.

March 1999 Dunn A, Reddy P, White CM, Chow MSS, Kluger J. Pharmacoeconomic Analysis of Ibutilide Versus Electrical Cardioversion for Patients with Atrial Fibrillation or Flutter.Poster Presentation: American College of Cardiology Meeting. Annual Meeting, March 1999, New Orleans, LAAbstract Published: J Am Coll Cardiol 1999;33:105A.

March 1999 Murthy DR, Katten D, Ahlberg AW, White MP, White CM, Waters DD, Heller GV. Impact of Glucagon Administration on Dobutamine Stress Testing Using Tc-99m Sestamibi Single Photon Emission Computed Tomographic (SPECT) Imaging in Patients Receiving Acute Beta Adrenergic Receptor Blockade.Poster Presentation: American College of Cardiology Annual Meeting, March 1999, New Orleans, LAAbstract Published: J Am Coll Cardiol 1999;33:417A.

March 1999 Ferraro-Borgida M, Thompson P, Moyna N, Ahlberg AW, White CM, McGill CC, Hasan O, Waters D, Heller GV. Physiologic Doses of Intravenous Testosterone Improve Exercise and Adenosine-Induced Myocardial Perfusion Defects in Elderly Men with Coronary Artery Disease.Poster Presentation: American College of Cardiology Annual Meeting, March 1999, New

C.M. White, p.43

Orleans, LAAbstract Published: J Am Coll Cardiol 1999;33:426A.

March 1999 Fossati AT, Ferraro-Borgida MJ, Ahlberg AW, White CM, McGill C, Mann A, Waters DD, Heller GV. The Acute Administration of 17bb-Estradiol Decreases the Size of Adenosine-Induced Myocardial Perfusion Defects in Post-Menopausal Women with Coronary Artery Disease. Poster Presentation: American College of Cardiology Annual Meeting, March 1999, New Orleans, LAAbstract Published: J Am Coll Cardiol 1999;33:425A.

May 1999 White CM, Tsikouris J, Kluger J. Use of Granisetron to Prevent Neurally Mediated Syncope.Poster Presentation: North American Society of Pacing and Electrophysiology Annual Meeting, May 12-15, 1999, Toronto, ON, CanadaAbstract Published: PACE 1999;22(Part2):79[#366].

September 1999 Fan C, Chow MSS, Nightingale C, White CM. The Hemostatic Effect of Externally Applied Notoginseng. Poster Presentation: American College of Clinical Pharmacology Annual Meeting, September 16-18, 1999, Rockville, MD.Abstract Published: J Clin Pharmacol 1999;39:979.

November 1999 Giri S, White CM, Dunn A, Felton K, Freeman-Bosco L, Tsikouris J, Kluger J. Efficacy and Safety of Adjuvant Preoperative Oral Amiodarone to Prevent Atrial Fibrillation After Open Heart Surgery in Elderly Patients Receiving Postoperative Beta-Blockade. Poster Presentation: American Heart Association 72nd Scientific Sessions, November 7-10, 1999, Atlanta, GA.Abstract Published: Circulation 1999;100:I-453.

November 1999 White CM, Giri S, Dunn A, Tsikouris J, Freeman-Bosco L, Felton K, Kluger J. Feasibility of a Rapid 24-Hour Loading Regimen of Oral Amiodarone with Beta-Blockers in Elderly Patients Prior to Open Heart Surgery.Poster Presentation: American Heart Association 72nd Scientific Sessions, November 7-10, 1999, Atlanta, GA.Abstract Published: Circulation 1999;100:I-595.

December 1999 Tsikouris J, Dunn A, Fan C, Chow MSS, Kluger J, White CM. Amiodarone and Desethylamiodarone Plasma Concentration After Different Amiodarone Strategies in the Open Heart Surgery Population. Poster Presentation: American Society of Health-Systems Pharmacists 34th Annual Midyear Clinical Meeting. December 3-7, 1999, Orlando, FL.Abstract Published: International Pharmaceutical Abstracts 1999;34[Abstract 3613034]:2275.Note: Featured Abstract with CE Questions and Learning Objectives.

March 2000 Tsikouris JP, White CM, Dunn A, Giri S, Kluger J. Changes in P-Wave Dispersion and P-Wave Duration Following Open Heart Surgery Correlate With the Peak Incidence of Atrial Fibrillation. Poster Presentation: American College of Cardiology Meeting. March 14, 2000, Anaheim, CA.Abstract Published: J am Coll Cardiol 2000;34:140A.

C.M. White, p.44

March 2000 Moyna NM, Ahlberg AW, White CM, Ferraro-Borgida M, McGill CC, Heller GV, Thompson PD. Intravenous Testosterone Has No Effect on Cardiovascular and Ventilatory Responses to Exercise in Elderly Men with Coronary Artery Disease. Poster Presentation: American College of Cardiology Meeting. March 14, 2000, Anaheim, CA.Abstract Published: J Am Coll Cardiol 2000;34:173A.

March 2000 Xie J, Dunn A, Sun Y, Tsikouris J, White CM, Fan C, Kluger J, Chow MSS. Comparative Effects of Beta-Blockers on Ventricular Fibrillation Threshold.Poster Presentation: American Society of Clinical Pharmacology and Therapeutics Annual Meeting. March 17, 2000, Los Angeles, CA.Abstract Published: Clinical Pharmacology & Therapeutics 2000;67:147 [PIII-21].

May 2000 Reddy P, White CM, Dunn A, Moyna N, Thompson PD. Does Testosterone Affect Health-Related Quality of Life in Elderly Males? - A Pilot StudyPoster Presentation: International Society for Pharmacoeconomics and Outcomes Research Meeting. May 21-24, 2000, Arlington, VA.

September 2000 Reardon J, Amato P, Cooper B, Malo-Schlegal S, White CM. Assessment of an Influenza Standing Order Protocol for Acutely Hospitalized Patients. Poster Presentation: World Congress on Lung Health, August 30 – September 3, 2000, Florence, Italy.

November 2000 Reddy P, Dunn A, Tsikouris J, White CM, Giri S, Felton K, Freeman-Bosco L, Kluger J. An Economic Comparison of Amiodarone Versus Placebo in the Prevention of Atrial Fibrillation After Open Heart Surgery.Poster Presentation: American College of Clinical Pharmacy Annual Meeting, November 2000.Abstract Published: Pharmacotherapy 2000;20:1231.

November 2000 Kluger J, White CM, Dunn AB, Freeman-Bosco L, Felton K, Gillam L, Giri S. Which Independent Variables Predict Post-Open Heart Surgery Atrial Fibrillation in Elderly Patients?Poster Presentation: American Heart Association Meeting. November 2000Abstract Published: Circulation 2000;102:II-554 [Abstract 2694].

November 2000 Kluger J, White CM, Dunn AB, Felton K, Freeman-Bosco L, Tsikouris JP, Wilcox HA, Giri S. Oral Amiodarone for the Prevention of Atrial Fibrillation After Open Heart Surgery in the Elderly.Platform Presentation: American Heart Association Meeting. November 2000Abstract Published: Circulation 2000;102:II-679 [Abstract 3286].

December 2000 Song JC, Quercia R, Fan C, Tsikouris J, White CM. A Pharmacokinetic Comparison of Omeprazole Granules and a Simplified Omeprazole Suspension. Poster Presentation: American Society of Health-Systems Pharmacists 35th Annual Midyear Clinical Meeting. December 2000, Las Vegas, NVAbstract Citation Published: AJHP 2000;57:1912.

December 2000 Song J, Tsikouris J, Fan C, Chow MSS, White CM. An Evaluation of the Hemostatic Effects of

C.M. White, p.45

Yu-Nan-Bai-Yau.Poster Presentation: American Society of Health-Systems Pharmacists 35th Annual Midyear Clinical Meeting. December 2000. Las Vegas, NVAbstract Citation Published: AJHP 2000;57:1909.

December 2000 Ammar R, Song J, White CM. Evaluation of the Electrocardiographic and Hemodynamic Effects of Caffeine.Poster Presentation: American Society of Health-Systems Pharmacists 35th Annual Midyear Clinical Meeting. December 2000. Las Vegas, NV

March 2001 White CM, Fan C, Song J, Tsikouris JP, Chow MSS. Comparative Hemostatic Effects of Hydrophilic, Alcohol, and Lipophilic Extractions of Notoginseng.Poster Presentation: American College of Clinical Pharmacists 2001 Spring Practice and Research Forum. Salt Lake City, Utah, April 22-25, 2001.Abstract Citation Published: Pharmacotherapy 2001;21:372-3 [Abstract 44].

March 2001 Caron M, Song J, Ammar R, Kluger J, White CM. Evaluation of Caffeine’s Effects on Electrocardiographic P-Wave Variables and Hemodynamics.Poster Presentation: American College of Clinical Pharmacists 2001 Spring Practice and Research Forum. Salt Lake City, Utah, April 22-25, 2001.Abstract Citation Published: Pharmacotherapy 2001;21:367 [Abstract 8].

November 2001 White CM, Duncan B, Moyna N, McGill C, Katten D, Ahlberg A, Finta L, Cortes C, Heller GV. Is There an Endogenous Growth Hormone Deficiency in NYHA Class II and III Congestive Heart Failure Patients?Oral Presentation: American Heart Association Scientific Sessions. November 11-14, 2001, Anaheim, CA.Abstract Citation Published: Circulation 2001;104:II-763 [Abstract # 3594].

December 2001 Song J, Caron M, Kluger J, White CM. The Usefulness of Intravenous Magnesium Sulfate to Decrease the Arrhythmogenic Potential of Ibutilide in Patients with Atrial Fibrillation.Poster Presentation: ASHP Midyear Clinical Meeting . December 2-6, 2001, New Orleans, LAAbstract Citation Published: AJHP 2001;58:1979.

December 2001 White CM, Giri S, Dunn A, Tsikouris J, Kluger J. Predictors of Cerebrovascular Accidents After Open Heart Surgery. Poster Presentation: ASHP Midyear Clinical Meeting . December 2-6, 2001, New Orleans, LAAbstract Citation Published: AJHP 2001;58:1979.

December 2001 Folstad J, Caron M, Chioffe S, White CM. Evaluation of Outcomes in a Pharmacist Managed Lipid Clinic. Poster Presentation: ASHP Midyear Clinical Meeting . December 2-6, 2001, New Orleans, LAAbstract Citation Published: AJHP 2001;58:1978.

December 2001 Hotsko AL, Robertson S, Caron M, Mandybur L, Kluger J, White CM. The Electrocardiographic Effects of Panax Ginseng in Normal Volunteers.Poster Presentation: ASHP Midyear Clinical Meeting . December 2-6, 2001, New Orleans, LA

December 2001 Robertson S, Hotsko AL, Caron M, Kluger J, White CM. Hemodynamic Effects of Panax

C.M. White, p.46

Ginseng in Normal Volunteers. Poster Presentation: ASHP Midyear Clinical Meeting. December 2-6, 2001, New Orleans, LA.

October 2002 White CM, Kalus J, Quercia R, Fortier C, Piotrowski A, Roach A, Sostek M. Esomeprazole Capsule Contents Suspended in Water Can Be Efficiently Delivered Through Nasogastric and Gastrostomy Tubes.Poster Presentation: American College of Gastroenterology. October 22, 2002, Seattle, WA.Abstract Citation Published: American Journal of Gastroenterology 2002;97:518-9.

October 2002 White CM, Kalus JS, Caron MF, Song J, Rose H, Tsikouris J, Kluger J. Impact of an Intravenous and Oral Amiodarone Regimen in the Post-Open heart Surgery Atrial Fibrillation Suppression trial II (AFIST II). Poster Presentation: American College of Clinical Pharmacists. Oct 21, 2002, Alberquerque, NM.Abstract Citation Published: Pharmacotherapy 2002;22:1328.

October 2002 White CM, Kalus J, Quercia R, Fortier C, Piotrowski A, Roach A, Sostek M. Esomeprazole Capsule Contents Suspended in Water Can Be Efficiently Delivered Through Nasogastric and Gastrostomy Tubes.Poster Presentation: American College of Clinical Pharmacists (Encore Presentation). Oct 22, 2002, Albuquerque, NM.Abstract Citation Published: Pharmacotherapy 2002;22:1328.

October 2002 Reddy P, Kalus JS, Caron MS, Kluger J, White CM. Pharmacoeconomic Analysis of AFIST II. Poster Presentation: American College of Clinical Pharmacists. Oct 21, 2002, Alberquerque, NM.Abstract Citation Published: Pharmacotherapy 2002;22:1329.

October 2002 Kalus JS, Caron MS, Liu X, Rose HL, Kluger J, White CM. What is the Effect of Amiodarone on P-wave Variables in Cardiac Surgery Patients?Poster Presentation: American College of Clinical Pharmacists. Oct 21, 2002, Alberquerque, NM.Abstract Citation Published: Pharmacotherapy 2002;22:1328.

November 2002 Caron MF, White CM, Kalus JS, Rose H, Song J, Narula D, Tsikouris JP, Kluger J.The Impact of Amiodarone, Bachmann’s Bundle Pacing, or Both Strategies in the Post-Open Heart Surgery Atrial Fibrillation Suppression Trial II (AFIST II). Platform Presentation: American Heart Association. November 19, 2002, Chicago, IL.Abstract Citation Published: Circulation 2002; 106:686.

November 2002 Kalus JS, Spencer AP, Chung J, Kluger J, White CM. Does Magnesium Prophylaxis Alter Ibutilide’s Therapeutic Efficacy in Atrial Fibrillation Patients?. Platform Presentation: American Heart Association. November 20, 2002. Chicago, IL.Abstract Citation Published: Circulation 2002; 106:II-634.

November 2002 Kalus JS, Caron M, Malay R, Liu X, White CM, Narula D, Rose H, Song J, Kluger J. Does Bachmann’s Bundle Pacing Affect the Risk of Developing Postoperative Atrial Fibrillation and Electrocardiographic P-wave Parameters.Poster Presentation: American Heart Association. November 19, 2002, Chicago, IL.

C.M. White, p.47

Abstract Citation Published: Circulation 2002; 106:578.

December 2002 Piotrowski A, Fortier C, Kalus J, Liu X, White CM. An Evaluation of the Hemodynamic Effects of Ginkgo Biloba.Poster Presentation: American Society of Health System Pharmacists. December 10, 2002, Atlanta, GAAbstract Citation Published: AJHP 2002;59:2002.

December 2002 Fortier C, Piotrowski A, Kalus J, Liu X, White CM. An Evaluation of the Electrocardiographic Effects of Ginkgo Biloba.Poster Presentation: American Society of Health System Pharmacists. December 10, 2002, Atlanta, GAAbstract Citation Published: AJHP 2002;59:2002.

December 2002 Caron MF, Kalus JS, Rose HL, Kluger J, White CM. Is Fluid Volume a Predictor of Post-Cardiac Surgery Atrial Fibrillation?Poster Presentation: American Society of Health-Systems Pharmacy Midyear Meeting. December 2002, Atlanta, GAAbstract Citation Published: AJHP 2002;59:2002.

December 2002 Coleman CI, Reddy P, Kalus J, Chung JO, White CM. The Impact of Prophylactic Magnesium on Cost of Therapy, Efficacy and Adverse Drug Reactions in Patients Receiving Ibutilide for Chemical Cardioversion of Atrial Fibrillation.Poster Presentation: American Society of Health-Systems Pharmacy Midyear Meeting. December 2002, Atlanta, GAAbstract Citation Published: AJHP 2002;59:2010.

December 2002 Kalus JS, Caron MF, Rose HL, Kluger J, White CM. Does Amiodarone Prevent Atrial Fibrillation in Patients Undergoing Off-Pump Cardiac Surgery?Poster Presentation: American Society of Health-Systems Pharmacy Midyear Meeting. December 2002, Atlanta, GAAbstract Citation Published: AJHP 2002;59:2001.

February 2003 Kluger J, Kalus JS, Caron MC, White CM, Rose H, Liu X. P-Wave Variables in Patients with Atrial Fibrillation After Cardiac Surgery. Poster Presentation: XII World Congress on Cardiac Pacing & Electrophysiology. February 19-22, 2003. Hong Kong, China.

February 2003 Kluger J, Caron MF, White CM, Tsikouris JP, Kalus JS, Ritvo A. The Impact of IV Magnesium on QT and QTc Intervals in Patients Receiving Ibutilide.Poster Presentation: XII World Congress on Cardiac Pacing & Electrophysiology. February 19-22, 2003. Hong Kong, China.

May 2003 Coleman CI, Reddy P, Laster-Bradley NM, Dorval S, White CM. The Effect of a Letter Based Educational Program for Prescribers and Pharmacists on Adherence to National Asthma Guidelines and Healthcare Utilization. Poster Presentation: Presented at: the International Society of Pharmacoeconomics and Outcomes Researchers, 8th Annual International Meeting, May 18-21, 2003, Arlington, VA

C.M. White, p.48

May 2003 McBride BF, Takata H, Gallagher RC, Kalus JS, Caron MF, White CM , Rose HL, Kluger J. Does Atrial Septal Pacing Prevent Atrial Fibrillation FollowingCardiothoracic Surgery? Platform Presentation: NASPE, May 17, 2003, Washington, DC.

November 2003 Kalus JS, Caron MF, McBride BF, Kluger J, Guertin D, WhiteCM. What is the Impact of Physiologic Increases in Catecholamine Concentrations on Ventricular Effective Refractory Period?Poster Presentation: American College of Clinical Pharmacy Meeting. November 5, 2003, Atlanta, GA---BEST POSTER FINALISTAbstract Citation Published: Pharmacotherapy 2003;23:1329.

November 2003 Kalus JS, Caron MF, Kluger J, Guertin D, McBride B, White CM. The Defibrillation Threshold Effects of Catectolamines Trial: DTECT.Oral Presentation: American College of Clinical Pharmacy - Cardiology PRN meeting. November 3, 2003, Atlanta, GA

November 2003 Kalus JS, Caron MF, Kluger J, Guertin D, McBride B, White CM. What is the Impact of Elevated Catecholamine Concentrations on Defibrillation Threshold in Patients with Implanted Cardioverter-Defibrillators?Podium Presentation: American College of Clinical Pharmacy Meeting. November 4, 2003, Atlanta, GAAbstract Published: Pharmacotherapy 2003;23:1374.

November 2003 McBride BF, Karapanos A, Krudsz A, White CM, Kluger J. The Electrocardiographic and Hemodynamic Effects of Metabolife 356®.Oral Presentation: American Heart Association.Abstract Published: Circulation 2003;108(Suppl IV): IV-15A.

November 2003 Kalus JS, White CM, Caron MF, Mather JF, Boden WE, Kluger J. What is the Impact of Fluid Balance on the Incidence of Atrial Fibrillation after Cardiothoracic Surgery?Poster Presentation: American Heart Association Meeting. November 9, 2003, Orlando, FLAbstract Published: Circulation 2003;108(suppl IV):IV-328.

December 2003 Krudysz A, Karapanos AK, Mc Bride B, Kluger J, White CM. Does Metabolife 356 Induce Electrocardiographic or Temperature Changes in Healthy Subjects?Poster Presentation: American Society of Health-Systems Pharmacy Midyear Meeting. December 2003

December 2003 Karapanos AK, Krudysz A, Mc Bride B, Kluger J, White CM. The Impact of Metabolife 356 on Hemodynamics in Healthy Volunteers.Poster Presentation: American Society of Health-Systems Pharmacy Midyear Meeting. December 2003

December 2003 White CM, McBride BF, Kalus JS, Caron MF, Kluger J. The Impact of Catecholamines on the Corrected QT Interval. Poster Presentation: American Society of Health-Systems Pharmacy Midyear Meeting. December 2003

C.M. White, p.49

March 2004 Kalus JS, White CM, Guertin D, Caron MF, McBride B, Kluger J. Does Elevating Catecholamine Concentrations Impact the Defibrillation Threshold?Poster Presentation: American College of Cardiology Meeting. March 2004.Abstract Published: J Am Coll Cardiol 2004;43(Suppl A):15A.

March 2004 Coleman CI, Kalus JS, White CM, Kluger J. A Decision-Tree Model Comparing First-Line Electrical Cardioversion to Ibutilide With or Without Magnesium Prophylaxis in the Treatment of Atrial Fibrillation.Poster Presentation: American College of Cardiology Meeting. March 2004.Abstract Published: J Am Coll Cardiol 2004;43(Suppl A):136A.

April 2004 Reddy P, Kalus JS, Caron MF, Horowitz S, Karapanos A, Coleman CI, Kluger J, White CM. Economic Analysis Of Amiodarone, Atrial Septal Pacing, Amiodarone Plus Atrial Septal Pacing Versus Standard Of Care To Prevent Atrial Fibrillation After Open-Heart Surgery. Poster Presentation: The International Society of Pharmacoeconomics and Outcomes Researchers, 9th Annual International Meeting 2004, Arlington, VA. Abstract Published: Value in Health 2004 (PCV31).

May 2004 Dyckman W, Morgan E, Mitchel J, White CM. Topical Administration of Pharmacologic Agents for the Treatment of Arterial Spasm in a Porcine Model. Platform Presentation: Quad Symposium, Crowne Plaza, Albany, NY May 19, 2004.

October 2004 Perkerson K, Gillespie E, White CM, Kluger J, Takada H, Coleman CI. Impact of Amiodarone on Length of Stay and Stroke After Cardiothoracic Surgery.Poster Presentation: American College of Clinical Pharmacy MeetingAbstract Published: Pharmacotherapy 2004;24:1426.

November 2004 Perkerson K, White CM, Gillespie E, Kluger J, Humphrey C, Coleman CI. Impact of Beta-Blockers on Length of Stay and Atrial Fibrillation Among Patients With Cardiothoracic Surgery.Poster Presentation: American Heart Association, New Orleans, LA Abstract Published: Circulation 2004;110(17)[supplIII]: [abstract 3268]

November 2004 McBride BF, Kalus JS, Kluger J, Guertin D, Clyne C, White CM. A Comparison of Metoprolol and Carvedilol on the Defibrillation Threshold of Patients Receiving Catecholamines.Platform Presentation: American Heart Association, New Orleans, LAAbstract Published: Circulation 2004;

December 2004 Min B, Kalus JS, Kluger J, Guertin D, McBride BF, White CM. Do Catecholamines Impact Ventricular Fibrillation Cycle Length and Its Variability?Poster Presentation: ASHP Midyear Clinical Meeting, Orlando, FLAbstract Published: AJHP 2004;61:2201

December 2004 Kardas M, Ismaili A, McBride BF, Sinha V, Min B, White CM, Kluger J. Does Ephedra Free Metabolife Impact Hemodynamics?Poster Presentation: ASHP Midyear Clinical Meeting. Orlando FLAbstract Published: AJHP 2004;61:2201

March 2005 Kluger J, McBride BF, Min B, Guertin D, Coleman CI, Silver B, White CM. Can Oral

C.M. White, p.50

Magnesium Reduce the QTc Interval of Patients Receiving Class III Antiarrhythmics?. Poster Presentation: American College of Cardiology, Orlando, FL, March 6-9, 2005Abstract Published: JACC 2005;45(3):94A

March 2005 Kluger J, McBride BF, Kalus JS, White CM, Guertin D, Clyne CA. The Impact of Catecholamines on the Defibrillation Threshold of Patients Receiving Carvedilol.Poster Presentation: American College of Cardiology Orlando, FL, March 6-9, 2005Abstract Published: JACC 2005;45(3):109-110A

March 2005 Gillespie E, Coleman CI, Sander S, Kluger J, Gryskiewicz KA, White CM. Amiodarone's Impact on Postoperative Outcomes: A Meta-AnalysisPoster Presentation: American College of Cardiology, Orlando, FL, March 6-9, 2005Abstract Published: JACC 2005;45(3):355A

April 2005 White CM. Arrhythmia Research: An Overview of AFIST, AdMag and DTECT Trials. Keynote Speaker, 2005 Young Investigators Award.American College of Clinical Pharmacists, Myrtle beach, SC. April 10, 2005

April 2005 Min B, Kardas M, Ismiali A, Sinh V, McBride BF, Kluger J, White CM. Does Ephedra-Free Metabolife Impact Electrocardiographic Variables?Poster Presentation: American College of Clinical PharmacistsAbstract Published: Pharmacotherapy 2005;25:456.

April 2005 Gillespie EL, Perkerson KA, White CM, Kluger J, Coleman CI. Does Aprotinin Reduce the Incidence of Postoperative Atrial Fibrillation?Poster Presentation: American College Clinical Pharmacy, Spring Research Forum, Myrtle Beach, SC, April 10-13, 2005Abstract Published: Pharmacotherapy 2005;3:455

April 2005 Kardas M, Gillespie EL, White CM, Coleman CI. Use of Angiotensin Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for the Prevention of Diabetes Mellitus: a Meta-Analysis.Poster Presentation: American College Clinical Pharmacy, Spring Research Forum, Myrtle Beach, SC, April 10-13, 2005Abstract Published: Pharmacotherapy 2005;3:460

April 2005 Coleman CI, Perkerson KA, Gillespie EL, White CM. Cost-Effectiveness of Statins Administered With or Without Ezetimibe.Poster Presentation: American College Clinical Pharmacy, Spring Research Forum, Myrtle Beach, SC, April 10-13, 2005Abstract Published: Pharmacotherapy 2005;3:470

April 2005 Kalus J, White CM, Coleman CI. Renin Angiotensin System Inhibition for Conversion of Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: a Meta-AnalysisPoster Presentation: American College Clinical Pharmacy, Spring Research Forum, Myrtle Beach, SC, April 10-13, 2005Abstract Published: Pharmacotherapy 2005;3:456

April 2005 Henyan N, Gillespie EL, White CM, Kluger J, Coleman CI. Can Intravenous Magnesium

C.M. White, p.51

Reduce Post-Cardiothoracic Surgery Atrial Fibrillation and Length of Hospital Stay?Poster Presentation: American College Clinical Pharmacy, Spring Research Forum, Myrtle Beach, SC, April 10-13, 2005Abstract Published: Pharmacotherapy 2005;3:455

April 2005 Sander S, White CM, Coleman CI. Comparative Safety and Efficacy of Urokinase and Recombinant Tissue Plasminogen Activator in Peripheral Arterial Occlusion: a Meta-AnalysisPoster Presentation: American College Clinical Pharmacy, Spring Research Forum, Myrtle Beach, SC, April 10-13, 2005Abstract Published: Pharmacotherapy 2005;3:462

October 2005 Gillespie EL, Sander S, Henyan N, White CM, Coleman CI. A Cost-benefit Analysis of an Outpatient, Pharmacy-Managed Medication Assistance Program for Indigent Patients.Poster Presentation: American College Clinical Pharmacy Annual Meeting, San Francisco, CA, October 22-25, 2005Abstract Published: Pharmacotherapy 2005;25:1476.

October 2005 Coleman CI, White CM. Do Different Antipsychotic Agents Used to Treat Schizophrenia have Varying Effects on the Risk of Coronary Heart Disease?Poster Presentation: American College Clinical Pharmacy Annual Meeting, San Francisco, CA, October 22-25, 2005.Abstract Published: Pharmacotherapy 2005;25:1465.

November 2005 Gillespie E, White CM, Kluger J, Gallagher R, Rancourt J, Coleman CI. Is Prophylactic Beta-Blockers a Cost-Effective Strategy to Reduce Post-Cardiothoracic Surgery Atrial Fibrillation.Poster Presentation: American Heart Association, November 2005. Dallas, TXAbstract Published: Circulation 2005;112[Suppl II]:II-331.

November 2005 Gillespie E, White CM, Kluger J, Takada H, Rancourt JA, Coleman CI. Is Amiodarone a Cost Effective Prophylactic Strategy to Reduce Post-Cardiothoracic Surgery Atrial Fibrillation?Poster Presentation: American Heart Association, November 2005Abstract Published: Circulation 2005;112[Suppl II]:II-578.

December 2005 Gillespie E, White CM, Coleman CI. Do Different Protease Inhibitors Used for Human Immunodeficiency Virus Have Varying Effects on Coronary Heart Disease Risk? [Abstract #H-348]Poster Presentation: ICAAC, December 2005.. Washington, DCSelected for Pre-Meeting Media Coverage by ICAAC Selection Committee

December 2005 Sander S, Coleman, CI, White CM. Does Coenzyme Q10 Improve Myocardial Systolic Function in Heart Failure: A Meta-Analysis.Poster Presentation: American Society of Health Systems Pharmacists, December 2005, Las Vegas, NV.

December 2005 Henyan N, White CM, Coleman CI. The Impact of Oral Magnesium on Blood Pressure and Blood Cholesterol: A Meta-Analysis.Poster Presentation: American Society of Health Systems Pharmacists, December 2005, Las Vegas, NV.

C.M. White, p.52

March 2006 Henyan NN, White CM, Gillespie EL, Smith K, Coleman CI, Kluger J. Does Gender Alter the Efficacy of Implantable Cardioverter Defibrillators?Poster Presentation: American College of Cardiology Annual Meeting. March 2006, Atlanta, GA. Abstract Published:

March 2006 Dale KM, Coleman CI, Henyan NN, Kluger J, White CM. Does Aggressive Statin Dosing Increase Muscle and Liver Risk? Poster Presentation: American College of Cardiology 55th Annual Scientific Sessions. March 2006, Atlanta, GA. Abstract Published:

September 2006 Shah S, White CM, Rinaldi M, Coleman CI. Evaluation of Echinacea for the Prevention and Treatment of the Common Cold: A Meta-Analysis of Randomized, Controlled Trials. Poster Presentation: American College of Clinical Pharmacology, 35th Annual Meeting, September 17-19, 2006. Cambridge, MA.Abstract Published: J Clin Pharmacol. 2006 Sep;46(9):1076

September 2006 Shah, S, Sander S, Coleman CI, White CM. In-Vitro Esomeprazole Delivery Through Nasogastric and Gastrostomy Tubes Using Oraplus® as a Suspending Agent.Poster Presentation: American College of Clinical Pharmacology, 35th Annual Meeting, September 17-19, 2006. Cambridge MA.Abstract Published: J Clin Pharmacol. 2006 Sep;46(9):1076

October 2006 Patel AA, White CM, Coleman CI. Can Statin Use Impact Atrial Fibrillation Occurrence and Recurrence?: A Meta-Analysis.Poster Presentation: American College of Clinical Pharmacy, 2006 Annual Meeting. St Louis, MO. Abstract Published: Pharmacotherapy 2006;26:1535. Pharmacotherapy.org

December 2006 Lucek D, White CM, Coleman CI. Does the Preoperative Use of Statins Reduce the Incidence of Infection Following Cardiac Surgery?Poster Presentation: American Society of Health-Systems Pharmacists, Anaheim, CA.

December 2006 Dale K, Coleman CI, Shah S, Patel AA, Kluger J, White CM. Does Gender Impact Statin Efficacy?Poster Presentation: American Society of Health-Systems Pharmacists, Anaheim, CA.Abstract Published: AJHP 2006;63:2000.

March 2007 Coleman CI, Rigali VT, Baker W, Hammond J, Kluger J, White CM. An Evaluation of the Safety of Aprotinin Use: the Retrospective Evaluation of Aprotinin in CardioThoracic Surgery (REACTS).Poster Presentation: American College of Cardiology Annual Meeting. March 2006. New Orleans, LA.Abstract Published: J Am Coll Cardiol 2007;49[Suppl A]:207A

March 2007 Lertsburapa K, Coleman CI, Faheem O, White CM, Kluger J. Can Preoperative Statin Use Reduce Atrial Fibrillation After Cardiac Surgery?

C.M. White, p.53

Poster Presentation: American College of Cardiology Annual Meeting. March 2006. New Orleans, LA.Abstract Published: J Am Coll Cardiol 2007;49[Suppl A]:304A

March 2007 Dale K, Coleman CI, Kluger J, White CM. Does the Use of Amiodarone Impact the Ability of Anterior Fat Pad Retention to Prevent Post-Operative Atrial Fibrillation.Poster Presentation: American College of Cardiology Annual Meeting. March 2007. New Orleans, LA.Abstract Published: J Am Coll Cardiol 2007;49[Suppl A]:312A

April 2007 Lucek DM, White CM, Kluger J, Hammond J, Coleman CI. Does the Preoperative Use of Statins Reduce the Incidence of Infection Following Cardiac Surgery?Poster Presentation: American College of Clinical Pharmacists Spring Meeting., Memphis, TN

April 2007 Coleman CI, White CM, Lertsburapa K, Faheem O, Kluger J, Lucek D. Does Dosing Intensity Effect a Statin’s Ability to Reduce Post-Cardiac Surgery Atrial Fibrillation?Poster Presentation: American College of Clinical Pharmacists Spring Meeting., Memphis, TN

May 2007 Tercius A, Coleman CI, White CM, Kluger J. Does Intravenous Magnesium Sulfate Impact the Ability of Intravenous Ibutilide to Convert Atrial Fibrillation?Platform Presentation: Heart Rhythm Society, May 11, 2007, Denver, CO.

July 2007 Coleman CI, Schlesselmann LS, Lao E, White CM.* An Evaluation of the Number and Quality of Published Scholarly Works By Members of Departments of Pharmacy Practice at Accredited Schools or Colleges of Pharmacy in the United States (2001-2003)Poster Presentation: AACP Annual Meeting, 2007.

July 2007 Schlesselmann LS, Coleman CI, White CM Evaluation of Student Career Plans of Pharmacy Students.Poster Presentation: AACP Annual Meeting, 2007.

July 2007 Schlesselmann LS, Coleman CI, White CM Evaluation of a Pharmacist Interactive Clinical Case Series.Poster Presentation: AACP Annual Meeting, 2007.

November 2007 Ruffin R, Kluger J, Baler WL, White CM, Coleman CI. Effect of Perioperative Nonsteroidal Anti-inflammatory Drug Use on Post-Cardiothoracic Surgery Outcomes: A Nested Cohort Study from the Atrial Fibrillation Suppression Trials (AFIST) I, II and III.Podium Presentation: American Heart Association 2007 Scientific Sessions, November 2007.Abstract Published: Circulation 2007;116(16):682-683.

November 2007 Anglade M, Kluger J, White CM, Aberle J, Coleman CI. Thiazolidinedione use and postoperative atrial fibrillation: a US nested case-control study.Podium Presentation: American Heart Association 2007 Scientific Sessions, November 2007.Abstract Published: Circulation 2007;116(16):637-637.

November 2007 Bhavani S, Kluger J, White CM, Clyne CA, Guertin D, Coleman CI. Statin Therapy is Associated with Reductions in Atrial Tachyarrhythmias and Inappropriate Shock Frequency in Patients with an Implantable Cardioverter Defibrillator: A Prospective Cohort Study.

C.M. White, p.54

Poster Presentation: American Heart Association 2007 Scientific Sessions, November 2007.Abstract Published: Circulation 2007;116(16):728-728.

March 2008 Soberiej DM, White CM, Coleman CI. Benefits and Risks of Adjunctive Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Meta-Analysis. Poster Presentation: American College of Clinical Pharmacy Spring Meeting, Memphis, TN.

March 2008 Bhavnani S, Coleman CI, Guertin D, Baker W, Cambell P, White CM, Zaeem F, Yarlagadda R, Clyne C, Kluger J. Predictors of Long Term Survival Among Patients Receiving Implantable Cardioverter-Defibrillators. Poster Presentation: American College of Cardiology Annual Meeting, March 2008, Orlando, FL.Abstract Published: Journal of the American College of Cardiology 2008;51(10):A346.

May 2008 Bhavnani S, Coleman CI, Guertin D , Baker W, Cambell P, White CM, Yarlagadda R, Clyne C, Kluger J. Is Sotalol Effective and Safe in Patients with Implantable Cardioverter Defibrillators and Singificnat Left Ventricular Dysfunction? Poster Presentation: Heart Rhythm Society, Orlando, FL..

June 25, 2008 Talati R, Reinhart K, Patel AA, Baker WL, Coleman CI. Adding a Dopamine Agonist to Pre-Existing Levodopa Therapy Versus Levodopa Therapy Alone in Advanced Parkinson’s Disease: A Meta-Analysis.Poster Presentation: The Movement Disorder Society's (MDS) 12th International Congress of Parkinson's Disease and Movement Disorders, June 2008; Chicago, ILAbstract Published: Movement Disorders 2008;23(1)[suppl]:S201

November 2008 Talati R, Reinhart K, White CM, Kluger J, Coleman CI. Do the Benefits of Post-Operative Beta-Blockade Outweigh the Harms in Patients Undergoing Non-Cardiac Surgery.Poster Presentation: American Heart Association, New Orleans, LA.

March 23, 2009 White CM. Review of Reviews Methods Chapter Work.Poster Presentation: Agency for Healthcare Research and Quality, Rockville, MD

April 15, 2009 Bhavnani SP, Coleman CI, Shafi NA, White CM, Guertin D, Yarlagadda R, Clyne CA, Kluger J. The Prognastic Impact of Controlled Shocks on Morbidity or Mortalityamong Patients with Implantable Cardioverter-Defibrillators. Poster Presentation: Heart Rhythm Society, Boston, MA.

March 15, 2010 Huddy KB, Bhavani SP, Coleman CI, Guertin D, White CM, Clyne CI, Kluger J. Does previous coronary revascularization in patients with an implantable cardioverter defibrillator and ischemic myopathy improve outcomes? Poster Presentation: American College of Cardiology. Georgia World Congress Center, Atlanta, GA.

March 16, 2010 Bhavani SP, Coleman CI, Guertin D, White CM, Clyne CI, Kluger J. Clinical predictors of early mortality among patients with implantable cardioverter defibrillators: the enduring value of the Charlson Co-Morbidity Index. Poster Presentation: American College of Cardiology. Georgia World Congress Center, Atlanta, GA.

C.M. White, p.55

October 7, 2010 White CM. Applying Existing Evidence to Osteopathic Practice. National Web Conference: American Osteopathic Association.

November 23, 2010 White CM. ACE Inhibitors and ARBs in Patients with Stable Ischemic Heart Disease and Preserved Left Ventricular Function. National Web Conference: Academy Health.

February 13, 2011 Chen W, Kluger J, Lee S, Colby J, Coleman C, White CM. The Impact of Pretransplant Transfusions on Renal Allograft Rejection.MedCAC Advisory Meeting, Centers for Medicaid and Medicare Services, Bethesda, MD.Streamed Live on Bloomberg Business Network.

November 30, 2011 Chen W, Kluger J, Lee S, Colby J, Coleman C, White CM. The Impact of Pretransplant Transfusions on Renal Allograft Rejection.CMS Regional Director Meeting, Bethesda, MD.

March 2012 Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, Chipkin S, Pescatello LS, Simpson K, White CM, Thompson PD. The Effect of Statins on Skeletal Muscle Function.Poster Presentation: American College of Cardiology March 2012., Chicago, IL Abstract Published: Journal of the American College of Cardiology 2012;59:1624.

April 10, 2012 White CM. Impact of Natural Products on Heart Health.UCONN Alumni Association Meeting, West Hartford Campus, CT.

April 24, 2012 White CM. Comparative Effectiveness of Antiepilaptic Medications.CMS Local Coverage Decision Meeting, Bethesda, MD, April 24, 2012.

April 24, 2012 White CM. Comparative Effectiveness of Adnjunctive Protection Devices in Patients with ACS Undergoing PCI of Native Vessels.CMS Local Coverage Decision Meeting, Bethesda, MD, April 24, 2012.

October 24, 2012 Baker WL, White CM, Coleman CI, Kluger J. Increasing CHA2DS2-VASc Score is Associated with Post-Cardiothoracic Surgery Atrial Fibrillation. American College of Clinical Pharmacy Meeting, Hollywood, FL, October 24, 2012.

March 29, 2014 Baker WL, Kluger J, White CM, Coleman CI. The Impact of Oral Magnesium L-Lactate on Occurrence of Ventricular Arrhythmias Among Patients with Implantable Cardioverter-Defibrillators.American College of Cardiology, Washington, DC March 29, 2014

November 17, 2014 Taylor B, Lorson L, White CM, Thompson PD. Coenzyme Q10 Does Not Reduce Pain in Patients With Confirmed Statin Myalgia. American Heart Association, Chicago, IL. November 17, 2014.

February 17, 2015 Leblanc A, Taylor BA, Capizzi JA, Clarkson PM, White CM, Thompson PD, Pescatello LS. Relationships Between Physical Activity and Muscular Strength Among Healthy Adults Across the Lifespan. New England Chapter of the American College of Sports Medicine. Boston, MA. February 17, 2015

C.M. White, p.56

June 5, 2015 Coleman CI, White CM, Sobieraj DM. Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes. American Diabetes Association, Orlando, Fl, June 5, 2015.

November 16, 2015 Zaleski AL, Taylor BA, Pescatello LS, Panza GA, Capizzi JA, Grimaldi AS, White CM, Thompson PD. Psychosocial Wellbeing Does Not Affect Muscle Pain and Quality of Life During Atorvastatin Treatment. American Heart Association 2015 Annual Meeting. Orlando, FL. November 16, 2015.

May 26, 2016White CM. Best Practices for Engaging Patients in the Effective Healthcare Program. Agency for Healthcare Research and Quality, Bethesda, MD, May 26, 2016.

October 16, 2016 Taylor BA, Pescatello LS, Panza GA, White CM, Thompson PD. Effect of vitamin D on blood pressure at rest and in response to maximal exercise. New England American College of Sports Medicine, Providence, RI.

June 1, 2016 Panza GA, Taylor BA, White CM, Pescatello LS. Physical activity intensity and well-being in healthy adults. American College of Sports Medicine, Boston, MA.

June 6, 2017White CM. Evidence-based Practice Center Determination of Health-Systems Evidence Needs. Agency for Healthcare Research and Quality, Bethesda, MD, June 6, 2017.

June 12, 2017 White CM. Discerning the Perception and Impact of Patients Involved in Evidence-based Practice Center Key Informant Interviews. Agency for Healthcare Research and Quality, Bethesda, MD, June 12, 2017.

Oct 30, 2017 White CM. The Proposed Use of Quality Measure Indexing to Enhance Useability of AHRQ Reports by Health-Systems. Agency for Healthcare Research and Quality, Bethesda, MD, June 6, 2017.

May 26, 2018 White, C. M.. Peking University 10th Anniversary of Traditional Chinese Medicine Symposium, "The PRISM of HOPES: Research in Pharmacy Practice." (May 26, 2018). Peking University, Beijing, China.

June 1, 2018 Mitchell MD, White CM, Guise J-M, et al. PP22 How Do Health System Leaders Use Evidence To Inform Action? International Journal of Technology Assessment in Health Care. 2018;34(S1):74-75. doi:10.1017/S0266462318001940.(June 1, 2018). Vancouver, Canada.

March 22, 2018 Holle, L, Joel, L, Buckley, T. E., White, C. M.. "The Pharmacist Intervention in Colorectal Cancer Screening Initiative (PICCSI)." 14th Annual Hematology/Oncology Pharmacy Association Annual Conference. (March 22, 2018).

April 12, 2018 Holle, L, Joel, L, Buckley, T. E., White, C. M.. "The Pharmacist Intervention in Colorectal Cancer Screening Initiative (PICCSI)." International Society of Oncology Pharmacy Practitioners (ISOPP) XVI International Symposium on Oncology Pharmacy Practice, (April 12, 2018).

C.M. White, p.57

June 24, 2018 White CM, Schmidler-Sanders G, Butler M, et al. Understanding Health-Systems’ Use of and Need for Evidence to Inform Decisionmaking. Academy Health, Seattle, WA, June 24, 2018.

September 16, 2018 White CM, Guise JM, Schmidler-Sanders G. AHRQ EPC Pilot Project: Improving Health-Systems Access to High Quality Evidence. Cochrane Collaboration 2018 Annual Meeting. Edinberg, Scotland.

October 3, 2018 White, C. M. (2018, October). The Proposed Use of Quality Measure Indexing to Enhance Useability of AHRQ Reports by Health-Systems. Presentation for the AHRQ EPC Meeting, Bethesda, MD.

December 2018 White CM, Coleman CI, Banez L, Chang S. Indexing performance measure codes to enhance perceived value of EPC reports. ACADEMY HEALTH. Abstract #28366. Washington, DC.

December 2018 White CM, Martinez B, Coleman CI, Banez L, Chang S. Indexing performance measure codes to enhance perceived value of EPC reports.American Society of Health System Pharmacists Midyear Clinical Meeting. Anaheim, CA.

February 13, 2019 White CM. Methods Overview of an Applicability Tool for Health System Quality Improvement Studies.Presentation for the AHRQ EPC Virtual Meeting.

May 29, 2019 White CM. The Use of CBD for General Health, Relaxation and Pain Relief.CMI-NA Strategic Advisory Board. Portland, OR.

June 5, 2019 White CM. Utility of an Applicability Tool for Health System Quality Improvement Studies. AHRQ, Learning Health System Taskforce, Bethesda, MD.

Sept 24, 2019 White CM. General Overview of CBD’s Pharmacology and Pharmacokinetics.CMI-NA CBD Advisory Board, Denver, CO

Sept 24, 2019 White CM. Topical and Transdermal Delivery of CBD: Pharmaceutical Insights and Clinical Evidence.CMI-NA CBD Advisory Board, Denver, CO

Oct 4, 2019 White CM. We’ve Got… High HOPES.UConn President’s Inauguration, Inspirational Faculty Leaders Presentations, Storrs, CT

April 3, 2020 White CM, Hernandez-Diaz A, Roman Y. Evidence Review of Hydroxychloroquine and Chloroquine With or Without Azithromycin in COVID-19. American College of Physicians. Scientific Medical Policy Committee, Teleconference.

April 26, 2020 White CM, Hernandez-Diaz A, Roman Y. Evidence Review of Hydroxychloroquine and Chloroquine With or Without Azithromycin in COVID-19 – Update 1. American College of Physicians. Scientific Medical Policy Committee, Teleconference.

June 8, 2020 White CM. NDMA Contamination of Drug Products: Focus on Metformin.CVSCaremark National Clinical Advisors Call. Teleconference.

C.M. White, p.58

Research Funding

Federal Funding as PI: White CM, PI: EPC 3 Task Order 1. EPC Methods and Dissemination. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2007-10067-I. $15,000. August 2007.

White CM, PI: EPC 3 Task Order 2, Project 1. ACE inhibitor or Angiotensin II Receptor Blocker in Stable Ischemic Heart Disease Comparative Efficacy Review. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $299,900. October 2007.

White CM, PI: EPC 3 Task Order 3. Generalist Program. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I, $276,000. October 2007.

White CM, PI: EPC 3 Task Order 1. EPC Methods and Dissemination. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2007-10067-I. $75,000. August 2008.

White CM, PI: EPC3 Task Order 1, Project 2. Using Systematic Reviews in Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $15,000. October 2008.

White CM, PI: EPC 3 Task Order 2, Project 2a. Human Growth Hormone in Cystic Fibrosis Topic Refinement. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2007-10067-I. $15,000. January 2009.

White CM, PI: EPC Task Order 2, Project 3a. Epilepsy Topic Refinement. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2007-10067-I. $17,100. March 2009.

White CM, PI: EPC 3 Task Order 2, Project 2b. Human Growth Hormone in Cystic Fibrosis Comparative Efficacy Review. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $545,000. July 2009.

White CM, PI: EPC3 Task Order 1, Project 2. Educational Modules Project. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $36,000. August 2009.

White CM, PI: EPC 3 Task Order 2, Project 3b. The Comparative Effectivess of Antiepileptic Medications. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $577,982. January 2010.

White CM, PI: EPC Task Order 2 Project 6b. Comparative Effectivness of VTE Prophylactic Strategies in Orthopedic Surgery. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $375,000. May 2010.

White CM, PI: EPC Task Order 1. EPC Director’s Meeting Funding. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $60,000. July 2010.

White CM, Coleman CI (Co-PIs): EPC Task Order 3, Project 1. Transfusion in Renal Transplant Technology Assessment. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $187,000. September 2010.

White CM, PI:. EPC Task order 1, Project 5. General EPC Support: Methods and Dissemination. Agency for

C.M. White, p.59

Healthcare Research and Quality, Rockville, MD. HHSA-290-2007-10067-I. $32,695. July 2011.

White CM, Coleman CI (Co-PIs): EPC Task Order 3, Project 1. Transfusion in Renal Transplant Technology Assessment. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $187,000. July 2010.

White CM, Johnson B (Co-PIs): Effect Size Metric Choices. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2007-10067-I. $86,241. July 2011.

White CM (PI): Patient Engagement in Evidence-based Practice Center Key Informant Panels. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $30,000. August 2016.

White CM (PI): Assessment of Health-System Evidence Needs and Impressions of Valuable Evidence. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $30,000. February 2017.

White CM, Coleman CI (Co-PIs): Quality Measure Indexing for Health Systems. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $30,000. January 2018.

White CM (PI): Quality Improvement Systematic Review Methods Development. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $30,000. January 2019.

White CM (PI): Developing Methods Guide Training Modules. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $15,000. January 2019.

Federal Funding as Co-I:

Thompson P, PI: The Effect of Intramuscular Testosterone on Endothelial, Thrombotic, Fibrinolytic, and Muscular Parameters in Elderly Males. National Institute of Aging (R03 Grant). $73,900. December 2004. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Thompson PD. PI. The Effect of Statins on Skeletal Muscle Function. National Heart, Lung, and Blood Institute, Bethesda, MD. Grant # 1R01HL081893-01A2. $3,007,870. June 2007. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Ruano G, PI. DNA Diagnostic System for Statin Safety and Efficacy.National Heart Lung and Blood Institute SBIR Phase I – II Grant, Bethesda, MD. Grant # 1R44HL091697-01. $1,079,475. September 2007. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Thompson PD, PI: Coenzyme Q10 in Statin Myopathy. RC1 AT005836-01 (RFA-OD-09-003) – NIH-NCCAM. $2,500,000. 9/30/2009 - 9/29/2011. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Coleman CI, PI: EPC Task Order 2, Project 4. Comparative Effectiveness of Mechanical Thrombectomy Devices Versus PCI Alone in Acute Coronary Syndromes. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $550,000. September 2009. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Baker WL, PI: EPC Task Order 2, Project 5. Mechanical Thrombectomy for Treatment of Acute Stroke. Agency for

C.M. White, p.60

Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $200,000. September 2009. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: EPC Task Order 2 Project 6a. Comparative Effectivness of VTE Prophylactic Strategies in Orthopedic Surgery: Topic Refinement. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $150,000. December 2010. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: EPC Task Order 2, Project 7. Comparative Treatments for Psoriasis. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $200,000. March 2010. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: Indirect Comparisons in Comparative Effectiveness Reviews. Agency for Healthcare Research and Quality, Rockville, MD. HHSA 290-2007-10067-I. $139,964. July 2011. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Sobieraj DM, PI: Comparative Effectiveness of Pharmacologic Treatment Options for Asthma. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $250,000. June 2016. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Baker WL, PI: Assessment of Drug Therapy for Major Depressive Dirorder. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $350,000. September 2017. Role: Budget Management, Personnel Management, Report/Manuscript Writing, Liaison with AHRQ.

Sobieraj DM, Baker WL (Co-PIs): Acute Pain Management by EMS in the Prehospital Setting. Agency for Healthcare Research and Quality, Rockville, MD. HHSA-290-2013-10067-I. $355,000. September 2018. Role: Budget Management, Personnel Management, Liaison with AHRQ.

Hernandez-Diaz A (PI): Hydroxychloroquine or Chloroquine for the Treatment and Prevention of COVID-19. HHSA-290-2013-10067-I. $28,800. April 2020. Role: Idea Conceptualization, Data Analysis, Manuscript Writing and Editing, Presentation of Findings, Liaison with AHRQ.

Research Foundation Funding as PI:

White CM, PI: Connecticut Society of Health-System Pharmacists Annual Research Award Competition for 1998. $550

White CM, PI: Connecticut Society of Health-System Pharmacists Research Award Competition for 1999. $450.

White CM, PI: Ventricular Defibrillation Threshold Impact of Catecholamines. AstraZeneca Clinical Pharmacy Research Award Foundation. $15,000. Awarded 1998.

White CM, PI: Defibrillation Threshold Effects of Catecholamines (D-TECT) Trial. American College of Clinical Pharmacy Research Institute’s Merck and Company Cardiovascular Fellowship Grant. $22,500. Awarded 1999.

White CM, PI: A Randomized, Double-Blinded Evaluation of the Drug Interaction between Amiodarone and Fentanyl. American Society of Health-Systems Pharmacists Research and Education Foundation. $4,700. Awarded 1999.

C.M. White, p.61

White CM, PI: Atrial Fibrillation Suppression Trial II. American Society of Health-System Pharmacists Research and Education Foundation. $3,000. Awarded 2000.

White CM, PI: Connecticut Society of Health-System Pharmacists Annual Research Award Competition for 2000. $300.

White CM, PI: Connecticut Society of Health-System Pharmacists Annual Research Award Competition for 2001, Catch the Wave Meeting. $300.

White CM, PI: An Evaluation of Fibrinogen, PAI-1, VWF, t-PA, and hs-CRP with Atorvastatin Therapy. North Shore Heart Research Foundation, Sydney, Australia $17,700. Awarded 2001.

White CM, PI: Visiting Scholar Training Program. People’s Republic of China Government Support. $15,000. Awarded 2002.

White CM, PI: Connecticut Society of Health-System Pharmacists Annual Research Award Competition for 2002, Catch the Wave Meeting. $210.

White CM, PI: Cardiac Safety Evaluation of Bitter Orange. Pfizer Undergraduate Research Foundation. $1,800. Awarded 2003.

White CM, PI: Atrial Fibrillation Suppression Trial III. The Donaghue Medical Research Foundation, West Hartford, CT. DF03-008. $100,368. Awarded 2004.

White CM, PI: Adjuvant Magnesium Trial (AdMag). The Donaghue Medical Research Foundation, West Hartford, CT. $163,000. Awarded 2005.

White CM, PI: The Atrial Fibrillation Suppression Trial IV Pilot Study. Gustavus and Louise Pfeifer Research Foundation. $73,683. Awarded 2006.

White CM, PI: Rho Chi Clinical Research Scholarship. Fellowship Salary Support for Soyon Lee, Pharm.D. Rho Chi Society. $7,500. Awarded 2011.

Pharmaceutical Company Funding or Donated Supplies as PI:

White CM, PI: Granisetron Use to Prevent Vasovagal Syncope. SmithKline Beecham Pharmaceuticals. $1,200 Worth of Intravenous Granisetron. Awarded 1998.

White CM, PI: The Effects of Metoprolol and Glucagon with Metoprolol on Nuclear Perfusion Defects. Eli Lilly Pharmaceuticals. $400 Worth of Intravenous Glucagon. Awarded 1998.

White CM, PI: Comparison of the Bioavailability of Omeprazole and Omeprazole SOS. AstraZeneca Pharmaceuticals. $47,000. Awarded 1999.

White CM, PI: AstraZeneca Pharmaceuticals Equipment Purchase Grant. $2,500. Awarded 1999.

White CM, PI: An In-Vitro Evaluation of Esomaprazole Granule Delivery Through Nasogastic, Feeding, and Gastostomy Tubes. AstraZeneca Pharmaceuticals $7,985. Awarded 1999.

C.M. White, p.62

White CM, PI: The Atrial Fibrillation Suppression Trial II. Medtronic Corporation. $30,000 Worth of Pacing Wires/Pacing Units. Awarded 2000.

White CM, PI: The Atrial Fibrillation Suppression Trial II. Upsher-Smith. $45,000 Worth or Oral Amiodarone Tablets and Placebo. Awarded 2000.

White CM, PI: A 24-Hour Circadian Variation Comparison of Human Growth Hormone and Brain Natriuretic Peptide in Patients With Heart Failure or Normal Controls. Biosite Diagnostics, San Diego, CA. $7,600 worth of BNP Whole Blood Assay Kits. Awarded 2001.

White CM, PI: The Impact of Delaying Diabetes Mellitus on Patient Care, Quality of Life, and Healthcare Costs: A Markov Model. Novartis Pharmaceuticals. $20,000. Awarded 2002.

White CM, PI: Novartis Pharmaceuticals Unrestricted Undergraduate Research Support Grant. $1,000. Awarded 2003.

White CM, PI: Impact of Different Antipsychotics on Coronary Heart Disease Risk. Pfizer Corporation. PFI-14654. $8,500. Awarded 2003.

White CM, PI: Drug Therapy for Chronic Diseases: Meet the Experts. The Henry Low Heart Center Symposia. Sponsor: AstraZeneca Pharmaceuticals $13,500. Awarded 2004.

White CM, PI: Comparison of Antifibrillatory Effects of Carvedilol, Propranolol, Metoprolol, or Placebo in a Closed-Chested Rat Model. SmithKline Beecham Pharmaceuticals. $25,000. Awarded 2005.

White CM, PI: The Adjuvant Magnesium Trial (Ad-Mag) Pilot Trial: Free Magnesium Lactate Capsules (Mag-Tab SR) and Matching Placebo. Niche Pharmaceuticals. $15,000 Worth of Product. Awarded 2005.

White CM, PI: The Adjuvant Magnesium Trial (Ad-Mag) Pilot Trial: Free Intracellular Magnesium Concentration Assays. Intracellular Diagnostics. $38,000 worth of Assays. Awarded 2005.

White CM, PI: Adjuvant Magnesium Trial (AdMag). Intracellular Diagnostics, Inc. Free Assays worth $115,200. Awarded 2005.

White CM, PI: Adjuvant Magnesium Trial (AdMag). Niche Pharmaceuticals Free Drug + Placebo Worth $175,200. Awarded 2005.

White CM, PI: An In Vitro Study to Evaluate the Delivery of Esomeprazole Magnesium Enteric-Coated Pellets Suspended in a Thickening Agent Plus Water Through Nasogastric and Gastrostomy Tubes. AstraZenenca Pharmaceuticals. $7,958. Awarded 2006.

White CM, PI: Effects of Low and High Dose Atorvastatin on Exercise Induced Muscle Injury (Sub-Contract). Merck Pharmaceuticals. $22,002. Awarded 2006.

White CM, PI: General Research Support Grant. Upsher Smith Pharmaceuticals. $7,500. Awarded 2006.

White CM, PI: The Impact of Magnesium on Atrial Vulnerability Among Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation. Intracellular Diagnostics, Inc. Half Price Assays worth $28,800. Awarded 2006.

White CM, PI: Electrocardiographic Effects of Lansoprazole Subcontract. Takeda Pharmaceuticals. Subcontract C.M. White, p.63

Amount $2,000. Awarded 2006.

White CM, PI: Medical Fellow Training Grant. Saint Jude Medical Company, St Louis, MO $60,000. Awarded 2012.

White CM, PI: The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST). Gilead Pharmaceuticals. $207,308. Awarded 2015.

Intramural Funding as PI:

White CM, PI: Efficacy of Intravenous Granisetron in Suppressing the Bradycardia and Hypotension Associated with a Rabbit Model of the Bezold-Jarisch Reflex. Hartford Hospital New Investigator Grant. $10,000. Awarded 1997.

White CM, PI: The Effect of Prophylactic Amiodarone of the Incidence of Atrial Fibrillation in Open Heart Surgery Patients: The Atrial Fibrillation Suppression Trial (AFIST). Hartford Hospital Open Competition Grant. $76,000. Awarded 1998.

White CM, PI: An Evaluation of Prophylactic Magnesium to Reduce the Arrhythmogenic Potential of Ibutilide. Hartford Hospital Research Foundation. $10,000 New Investigator Grant. Awarded 1999.

White CM, PI: The Atrial Fibrillation Suppression Trial II. Hartford Hospital Department of Medicine. $12,500 for Equipment Purchase. Awarded 1999.

White CM, Maresh C, Co-PIs: Nitric Oxide Analyzer Machine. University of Connecticut Research Advisory Council. $14,685 Annual Equipment Grant Internal Award Program (joint purchase with kinesiology). Awarded 2000.

White CM, PI: The Atrial Fibrillation Suppression Trial II. Hartford Hospital Research Foundation $50,000 Open Competition Grant. Awarded 2000.

White CM, PI: A 24-Hour Circadian Variation Comparison of Human Growth Hormone and Brain Natriuretic Peptide in Patients With Heart Failure or Normal Controls. Hartford Hospital Small Grant Initiative. $10,000. Awarded 2001.

White CM, PI: An Assessment of the Raloxifene and Estradiol’s Impact on Brachial Artery Reactivity. Hartford Hospital Research Foundation. $10,000 Small Grant Initiative. Awarded 2001.

White CM, PI: A Comparison of the Hemostatic Effects of Three Extracts of Notoginseng. Hartford Hospital Research Foundation. $10,000 Small Grant Initiative. Awarded 2001.

White CM, PI: An Evaluation of Fibrinogen, PAI-1, VWF, t-PA, and hs-CRP with Atorvastatin Therapy. Hartford Hospital Research Foundation. $35,000 Open Competition Grant. Awarded 2001.

White CM, PI: An Evaluation of the Electrocardiographic, Hemodynamic, and Quality of Life Effects of Panax Ginseng. University of Connecticut Undergraduate Research Grant. $800. Awarded 2002.

White CM, PI: An Evaluation of the Electrocardiographic, Hemodynamic, and Quality of Life Effects of Panax Ginseng. University of Connecticut Small Grants Initiative. $600. Awarded 2002.

White CM, PI: An Evaluation of the Electrocardiographic Effects of Combining Magnesium with Ibutilide Therapy in Human Subjects with Atrial Fibrillation. Hartford Hospital Research Foundation $10,000. Awarded 2003.

C.M. White, p.64

White CM, PI: An Acute and Chronic Electrocardiographic and Hemodynamic Evaluation of Ginkgo Biloba. University of Connecticut Undergraduate Research Grant. $500. Awarded 2003.

White CM, PI: Treatment with Ibutilide and Magnesium Evaluation (TIME). Hartford Hospital Research Foundation. $7,000. Awarded 2003.

White CM, PI: Defibrillation Threshold Effects of Catecholamines Trial II (D-TECT-II). Hartford Hospital Research Foundation Small Grant Initiative ($9,240). Awarded 2004.

White CM, PI: Atrial Fibrillation Suppression Trial III. Hartford Hospital Research Foundation Open Competition Grant. $50,000. Awarded 2004.

White CM, PI: The Electrocardiographic and Hemodynamic Effects of Ephedra Free Metabolife. University of Connecticut Undergraduate Research Foundation. $250. Awarded 2004.

White CM, PI: The Adjuvant Magnesium (Ad-Mag) Pilot Trial: Hartford Hospital Research Foundation. $3,600. Awarded 2004.

White CM, PI: The Impact of Magnesium on Atrial Vulnerability Among Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation. Hartford Hospital Open Competition Grant. $50,000. Awarded 2005.

White CM, PI: Adjuvant Magnesium Trial (AdMag) Lipid, Hemodynamic Substudy. Hartford Hospital Open Competition Grant. $47,000. Awarded 2005.

White CM, PI: The Electrocardiographic and Hemodynamic Safety of Coenzyme Q10. University of Connecticut Small Grant Initiative. $900. Awarded 2005.

White CM, PI: The Use of N-Acetylcysteine to Prevent Cardiac Surgery Complications. Hartford Hospital Research Foundation. $5,500. Awarded 2006.

Non-Federal Funding as Co-I:

Chow MSS, PI. An Evaluation of the Alteplase-Nitroglycerin Interaction. Genentech Pharmaceuticals. $34,800. Awarded 1996. Role: Researcher, Data Analysis, Manuscript Writing.

Heller G, PI, An Evaluation of the Pharmacokinetic and Therapeutic Effects of Intravenous Estradiol. Hartford Hospital Research Foundation. $10,000. Awarded 1996. Role: Pharmacologic Support, Designed Individualized Dosing Regimens.

Heller G, PI: Impact of Pharmacokinetically Guided Intravenous Testosterone on Myocardial Perfusion and Reversibility in Elderly Men with Coronary Artery Disease. American Society of Nuclear Cardiology. $25,000. Awarded 1997. Role: Pharmacologic Support, Designed Individualized Dosing Regimens.

Heller G, PI: Impact of Pharmacokinetically Guided Intravenous Testosterone on Myocardial Perfusion and Reversibility in Elderly Men with Coronary Artery Disease. Fujisawa. $10,000. Awarded 1997. Role: Pharmacologic Support, Designed Individualized Dosing Regimens.

Thompson P, PI: The Effect of Intramuscular Testosterone on Endothelial, Thrombotic, Fibrinolytic, and Muscular

C.M. White, p.65

Parameters in Elderly Males. Hartford Hospital Research Foundation. $50,000. Awarded 1998. Role: Pharmacologic Support, Designed Individualized Dosing Regimens.

Heller G, PI: The Effects of Metoprolol and Glucagon with Metoprolol on Nuclear Perfusion Defects. Hartford Hospital Research Foundation. $10,000. Awarded 1998. Role: Designed Regimens, Data Analysis.

Thompson P, PI: The Effects of Atorvastatin on Preventing Endothelial Function Associated with High Fat Ingestion. Parke-Davis Pharmaceuticals. $120,000. Awarded 1999. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Thompson P, PI: The Effect of HMG CoA Reductase Inhibitor Therapy on Platelet-Thrombus Formation and Inflammation Among Patients with Coronary Disease. Bristol Myers-Squibb Pharmaceuticals. $95,000. Awarded 2000. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Duncan B/Heller G, PI: The Effect of Exogenous Human Growth Hormone Supplementation in NYHA Class II and III Heart Failure Patients. Hartford Hospital Research Foundation. $100,000. Awarded 2001. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Coleman C, PI: Cost-Effectiveness Analysis of Adenosine and Dipyriamole. Hartford Hospital Research Foundation. $10,000. Awarded 2002. Role: Study Design, Data Interpretation and Manuscript Writing.

Heller G, PI: Impact of Beta-Blockers on Dipyridamole Pharmacologic Stress Tests Using Gated SPECT Imaging. Hartford Hospital Research Foundation. $10,000. Awarded 2002. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Coleman C, PI: The Impact of Adding Prophylactic Amiodarone to the Hartford Hospital Critical Care Plan. American College of Clinical Pharmacy Outcomes Research Award. $10,000. Awarded 2003. Role: Study Design, Data Interpretation, Manuscript Writing.

Coleman CI, PI: Impact of a Communicating Prescription Device on Compliance, Patient Satisfaction, Quality of Life, and Diabetes Control in a Non-English Speaking Hispanic Population. Talking Rx Incorporated. $24,700. Awarded 2004. Role: Study Design, Data Analysis, Data Interpretation.

Thompson PD, PI: Skeletal Muscle Gene Expression in Patients with Statin-Induced Myalgia. The Donaghue Medical Research Foundation. West Hartford, CT $239,679. Awarded 2005. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Dyckman W, PI: Topical Administration of Pharmacologic Agents for the Treatment of Arterial Vasospasm in a Porcine Model. Hartford Hospital Research Foundation. $10,000. Awarded 2005. Role: Pharmacoloigc Support, Study Design, Data Interpretation.

Thompson PD PI: Effects of Low and High Dose Atorvastatin on Exercise Induced Muscle Injury. Merck Pharmaceuticals. $377,460. Awarded 2005. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Coleman CI, PI: Pharmacoeconomic Analysis of the Adjuvant Magnesium Trial (AdMag).Hartford Hospital Research Foundation. $10,000. Awarded 2006. Role: Study Design, Data Collection, Data Interpretation.

C.M. White, p.66

Caron MF, PI. Electrocardiographic and Hemodynamic Effects of Ephedra Containing TrimSpa Thermogenic Compound in Healthy Volunteers. Biomedical Research Infrastructure Network (BRIN) from the University of Rhode Island, Kingston, RI $25,000. Awarded 2006. Role: Mentor to Faculty Member, Involved in All Aspects of Study.

Coleman CI, PI. The Impact of ACE Inhibitors and Angiotensin II Receptor Blockers on the Development of Type-II Diabetes. ASHP Research and Education Foundation Drug Therapy Research Award 2006. $4,700. Awarded 2006. Role: Study Design, Data Interpretation and Manuscript Writing.

Coleman CI, PI. Systematic Review of Parkinson’s Disease Pharmacotherapeutic Options. Boehringer-Ingelheim Pharmaceuticals, Inc BI-45161453. $17,500. Awarded 2007. Role: Literature Review, Meta-Analysis, Data Interpretation, Manuscript Writing.

Coleman CI, PI: A Clinician’s Perspective on the Use of Meta-Regression in Systematic Review: Caveats and Cautions. Pfizer Pharmaceuticals. $45,000. Awarded 2007. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: A Clinician’s Perspective on Rating the Strength of Evidence in a Systematic Review.Pfizer Pharmaceuticals. $45,000. Awarded 2007. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: A Healthcare Decision-Makers Guide to Reviewing and Using Meta-Analysis: A White Paper of the Health Outcomes, Policy, and Economics Collaborative Group. Pfizer Pharmaceuticals. $25,000. Awarded 2008. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Baker WL, PI: Psoriasis Systematic Review. Pfizer Pharmaceuticals, $100,000. Awarded 2009. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Baker WL, PI: Use of Antiplatelet Therpay in Vascular Access Graft Preservation. Boehringer-Ingelheim Pharmaceuticals, Inc $50,000. Awarded 2010. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Ashaye A, PI. Psoriasis Systematic Review. Pfizer Pharmaceuticals. $17,500. Awarded 2011. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: Oral Hypoglycemic Agent Systematic Review. Takeda Pharmaceuticals. $58,500. Awarded 2012. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI. Stroke Prevention in Atrial Fibrillation White Paper. Boehringer Ingelheim. $141,000. Awarded 2012. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI. Warfarin Contraindications Project. Ortho McNeil. $149,999. Awarded 2013. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Scholle JS. Caregiver Burden with Warfarin Trial. Ortho McNeil. $190,987. Awarded 2014. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Rubino M, PI: Role of Medication in Fall Prevention Screening in a Tertiary Care Community Hospital. Hartford Hospital Research Foundation. $10,000. Awarded 2014. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

C.M. White, p.67

Baker WL PI: Psoriasis Comprehensive Systematic Review. Pfizer. $207,000.Awarded 2014. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Coleman CI, PI: Pharmacotherapy for Multiple Sclerosis in Patients Receiving Medicaid. Novartis. $125,000. Awarded 2015. Role: Literature Assessment, Data Extraction, Data Interpretation, Report/Manuscript Writing.

Holle, Lisa, Levine, Joel B (Co-PI). "Pharmacist Intervention in Colorectal Cancer Screening Initiative (PICCSI)". Sponsored by UConn CHIP, $15,000. Awarded 2015. Role: Study Design, Data Analysis, Data Interpretation, Manuscript Review.

Taylor, B, PI: "Near Infrared Spectroscopy to Diagnose Statin Myopathy". American Heart Association. $150,000 (July 1, 2018 – 2020). Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

Kwon OS, PI: “Curcumin To Reduce Statin Associated Muscle Symptoms”. CAHNR Challenge Grant. $40,000 and $8,500 in free curcumin and placebo capsules from OmniActive. (June 2020 - August 2021). Role: Designed Pharmacologic Rationale, Determine Dosing and Product to Use, Blinded and Randomized Study, Unblinded Study Administrator.

SUBMITTED: Kwon OS, PI: “Vitamin D3 Muscle Protection Project.” Grant Under Development. Role: Pharmacologic Support, Designed Regimen, Blinded and Randomized Study, Unblinded Study Administrator.

C.M. White, p.68

News Media Engagement

Recurrent Media Appearances2001 – 2009 NBC 30, 10 am Newscast. Bi-Monthly “Ask the Pharmacist” Segments, West Hartford, CT2013 – May 2019 FOX 61, 9 am Newscast. Weekly “Ask the Pharmacist” Segments, Hartford, CTMay 2019 – Present FOX 61, 10 am Newscast. 2 X Monthly “Ask the Pharmacist” Segments, Hartford, CT

Editorials and OpEdsThe Conversation OpEds – Number 2 Faculty Member at UConn for All Time Reads – 763,329June 6, 2017 Why Amazon should keep prescription drugs off its voluminous   shelves – 31,004 viewsJuly 5, 2017 The price of a miracle: Should we limit spending on lifesaving   drugs? – 8,676 viewsNovember 19, 2017 The dangers and potential of ‘natural’ opioid   kratom – 370,343 viewsJanuary 12, 2018 What Jeff Sessions doesn’t understand about medical   marijuana – 30,753 viewsAugust 29, 2018 Why synthetic marijuana is so   risky – 51,774 viewsDecember 27, 2018 Beware of natural supplements for sex gain and weight   loss – 77,418 viewsSeptember 27, 2019 Why cheaper drugs from Canada likely won’t cure what ails   US – 14,003 viewsDecember 4, 2019 Why your generic drugs may not be safe and the FDA may be too   lax – 49,296 viewsFebruary 18, 2020 Natural supplements can be dangerously contaminated, or not even have the specified ingredients – 116,532 viewsApril 15, 2020 No, CBD is not a miracle molecule that can cure coronavirus, just as it won’t cure many other maladies its proponents   claim – 17,314 views.May 28, 2020 Hydroxychloroquine for   COVID-19: A new review of several studies shows flaws in research and no   benefit – 14,256 views.

Largest Media Outlets (Covered Research, Interviewed for Stories, or Republished/Covered OpEds)Dr Oz Show, Today Show, Good Morning America, NBC Nightly News, USA Today, NY Times, Washington Post, BBC News, CBC News (BBC in Canada), CNN, WNPR, CBS Radio Network, Bloomberg News, The Scientist, Newsweek, PBS News Hour, Huffington Post.

News Media ContactJuly 26, 2000 WFSB, Channel 3 (CBS), Hartford, New Haven, CT: Featured in Story on UConn Pharm.D.

Program and Labor Demand for Pharmacists in Connecticut. December 7, 2001 American Society of Health System Pharmacists, National Press Release: Identified as

Recipient of the ASHP Drug Therapy Research Award. March 8, 2001 The Lancet, International Press Release: Results of AFIST Study Presented from The Lancet

Article.March 15, 2001 Theheart.org, Heart Wire Section: Results of AFIST Study Featured in News Article for

Cardiologist Web Site. E-mails Went Out to All Web Site Recipients Alerting Them to Feature Article on Web Site.

March 16, 2001 Reuters Health News Service: Results of AFIST Study Included in Featured Research of the Month.

March 19, 2001 MDConsult.com: Results of AFIST Study Featured in News Article for Physician Information Web Site.

April 10, 2001 Worldwide Internal Medicine Publications: Featured in Press Story About AFIST Study Presentation at American Heart Association 2000.

November 5, 2001 WVIT, Channel 30 (NBC), Hartford/New Haven, CT; Featured in the “Ask the Pharmacist” Special Segment. Live Interview on Anthrax Medications. 10AM Newscast

November 11, 2001 WFSB, Channel 3 (CBS), Hartford/New Haven, CT: Interviewed for Newsmagazine “Face the State”. Taped Interview on Anthrax Medications. 12 PM News Talk Show

2002 - 2003 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured 10 times in the “Ask the Pharmacist” Special Segment. Live Interview Answering Patients Questions. 10 AM Newscast.

C.M. White, p.69

February 18, 2002 University of Connecticut Advance Magazine [Volume 20 (20)]: Cited Under Newsmakers Section of Magazine for Appearing on NBC-30 in the “Ask the Pharmacist” Segment. 10AM Newscast.

March 11, 2002 University of Connecticut Advance Magazine [Volume 20 (22), Page 5]: Featured in Article Entitled “Pharmacy Professor’s Stellar Career Owes Start to McDonald’s.” This Article Written About Faculty of UConn Who Have Made Important Contributions in their Field.

July 15, 2002 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in News Story on Medical Implications of Pfizer/Pharmacia Merger. 5:30 PM Newscast.

July 15, 2002 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in News Story on Medical Implications of Pfizer/Pharmacia Merger. 6:00 PM Newscast.

December 2003 ASHP Midyear Meeting Highlight Video: Interviewed for ASHP Highlight Video.January 2002 Doctors Guide: ASHP abstract and Poster on On-Pump vs Off-Pump Cardiac Surgery

Featured as Article of the Week. Doctorsguide.com.November 9, 2003 American Heart Association Press Conference: Featured in News Media Press Conference

on the Results of Our Metabolife Study to be Presented in the Scientific Sessions.November 10, 2003 Reuters.com: Article on Our Metabolife Study Reported in the Monday, November 10,

2003 Health News Section of the Website. November 10, 2003 MSNBC.com: Article on Our Metabolife Study Reported in the Monday, November 10,

2003 Health News Section of the Website. November 10, 2003 Aljazeera.net: Article on Our Metabolife Study Reported in the Monday, November 10,

2003 Sci-Tech Section of the Website. November 10, 2003 WebMD.com: Article on Our Metabolife Study Reported in the Monday, November 10,

2003 Section.November 2003 TheHeart.org: Article on Our Metabolife Study Included in Website.November 2003 Science News Magazine, Washington, DC. Interview on Metabolife 356® Study. November

22, 2003. Under the section entitled “of note”.December 12, 2003 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in the “Ask the Pharmacist”

Special Segment. Live Interview Answering Patients Questions. 10AM Newscast.December 31, 2003 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in a Segment on Ephedra

Health Risks and FDA Justification for Removal. 10AM Newscast.January 13, 2004 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Interviewed on Metabolife 356® Study

by Carolyn Pennington, Health Correspondent.January 13, 2004 News 4 (NBC), Washington, DC: News Segment on Metabolife 356® Study Covered in

Health Segment.January 13, 2004 KIRO7, Channel 7, Eyewitness News, Seattle, WA: Segment on Metabolife 356 Study.January 13, 2004 NBC 5, Chicago, IL: News segment on Metabolife 356® study.January 13, 2004 NBC 10, Philadelphia, PA: Television Segment on Our Metabolife 356® study.January 14, 2004 CNN Television News, Atlanta, GA: National Broadcast of Healthbeat Segment Focused on

Our Metabolife Study and Implications for the Proposed Ephedra Ban.January 14, 2004 San Diego Union Tribune, San Diego, CA: Article Focused on Our Metabolife Study and

Implications on Ephedra Ban.January 14, 2004 Hartford Courant, Hartford, CT: Article Focused on Our Metabolife Study and Implications

on Ephedra Ban.January 14, 2004 Seattle Post, Seattle, WA: Article on Our Metabolife Study and Implications on Ephedra

Ban.January 14, 2004 New Haven Register, New Haven, CT: Article Focused on Our Metabolife Study and

General Herbs that Heart Patients Should Avoid.January 14, 2004 Atlanta Journal Constitution, Atlanta, GA: Article Focused on Our Metabolife Study and

General Herbs that Heart Patients Should Avoid.January 14, 2004 Capitol News 9, Albany, NY: Television Segment Focused on Metabolife Study Results

C.M. White, p.70

January 14, 2004 HealthCentral.com: Website Segment Focused on Metabolife 356® study.January 14, 2004 ScienceBlog.com: Website article reviewing our Metabolife 356 study.January 18, 2004 Radio 720 WGM, Chicago, IL: On Air Interview Segment on Metabolife 356® Study. Thirty

Minute Interview. Sunday Night Health Science Segment Called “To Your Health”.February 2, 2004 University of Connecticut Advance Magazine [Volume 20 (22), Page 3]: Pharmacy

Students Findings Stir Concerns about Weight Loss Supplement. Article About Metabolife 356® study and Our Research Groups Undergraduate Research Experience Program.

February 3, 2004 WJAC 6. NBC Affiliate. Johnstown/Altoona, PA. Television Segment on Our Metabolife 356® study.

April 15, 2004 American Journal of Health-System Pharmacists News Section.Title: Ephedrine Alkaloids Banned from Dietary Supplements: Quoted in News Article on Non-Ephedra Weight Loss Supplements. AJHP 2004;61:750-756.

June 2004 UConn Traditions Alumni Magazine [Volume 5 (2), Summer 2004, Page 14.]. School of Pharmacy: Student Findings Support FDA Ban of Ephedra.

October 1, 2004 The Day Newspaper. New London, CT. “Pfizer May End Up Benefiting From Merck’s Distress”. Interviewed In Article on Vioxx Removal and Implications for Other COX-2 Agents on the US Market.

October 10, 2004 Physician’s Weekly. “Pharmacotherapies for Heart Failure”. Interview Featured for Segment Entitled “In My Opinion…”. Reviewed new trends in drug therapy for heart failure.

December 18, 2004 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on COX-2 Inhibitor Risk and Alternative Treatments During the 9:00 AM Newscast.

January 17, 2005 Hartford Courant. Newspaper. Hartford, CT. “Execution Drugs are Borrowed from the Healers’ Catalog of Powerful Life Saving Medicines.” Interviewed on use of thiopental, pancuronium, and potassium chloride in medicine and lethal injection. Pages A1 and A4. Front Page Article

January 20, 2005 Fox 61 News at Ten. Hartford, CT. Interviewed for Story on Execution Drugs Use in Therapeutic Practice and What to Expect When the Drugs are Injected for Lethal Injection. Featured Story

January 22, 2005 Fox 61 Newsmagazine “Beyond the Headlines”, Hartford, CT. Live Interview and Panel Discussion on Lethal Injection.

February 25, 2005 The Day. Newspaper. “Celebrex Warning Labels Next Step for Pfizer.” Interviewed on Warning Labels and Their Impact on the Medical Community and Sales.

April 7, 2005 Fox 61 News At 10. Interviewed and featured in segment on Bextra removal from US market and boxed warning for Celelbrex. Discussed risks, implications, and alternatives.

April 12, 2005 The Day. Newspaper. “FDA Tells Pfizer, Other Drug Makers to Add Warning” Interviewed and featured in story on Bextra removal and new warnings for Celebrex. What are the business implications for the FDA decision.

May 12, 2005 Fox 61 News at 10. Interviewed on Michael Ross execution and the drugs involved. June 15, 2005 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in the “Ask the Pharmacist”

Special Segment. Live Interview on Mosquito Bite Prevention and Treatment.June 29, 2005 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in the “Ask the Pharmacist”

Special Segment. Live Interview on Tick Bite Prevention and Treatment.September 11, 2005 The News-Times, Danbury, CT. “Common Drugs May Prevent Diabetes Onset.” Our Meta-

Analysis on ACEIs and ARBs to Prevent Diabetes Mellitus Covered in the Local News Section.

September 13, 2005 Hartford Courant. Newspaper. Hartford, CT. “UConn Study: Drugs Do Double Duty” Our Meta-Analysis on ACEIs and ARBs to Prevent Diabetes Mellitus Covered in Story Under Medical Frontiers Segment.

September 28, 2005 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in the “Ask the Pharmacist” C.M. White, p.71

Special Segment. Live Interview on Results of Our ACEI/ARB Diabetes Preventing Study.October 31, 2005 Physician’s Weekly. Volume 22 (41). Article Reviewing Results of our ACEI, ARB to Prevent

Diabetes Article in Diabetes Care for a section on “Clinical Updates: Medications Help Reduce the Risk of Diabetes Onset.”

October 31, 2005 Physician’s Weekly, Emergency Department Edition. Volume 2, 11. Article Reviewing Results of our ACEI, ARB to Prevent Diabetes Article in Diabetes Care for a section on “Clinical Updates: Medications Help Reduce the Risk of Diabetes Onset.”

November 2005 Formulary News Capsules. Our Research Article was Summarized in Section of What’s New in Drug Research”. Title: ACEIs, ARBs Decrease New-Onset Type 2 Diabetes in Patients with Hypertension, CAD, and HF. Formulary 2005;40:396.

December 20, 2005 Reuters Health. Featured in Article on Our Study Presented at ICAAC Meeting in Washington, DC. “Long Term Ataznavir HIV Therapy Linked to Less Dyslipidemia”. www.emedicine.com/news.asp?name=20051220clinoo3.xml

December 21, 2005 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Featured in the “Ask the Pharmacist” Special Segment. Live Interview on Ethnic and Gender Differences With Drugs/Diseases.

January 3, 2006 TheHeart.org Website. “No Effect of Statins on Cancer, New Meta-Analysis Concludes.” www.theheart.org/printArticle.do?primaryKey=624083.

January 3, 2006 WVIT, Channel 30 (NBC), Hartford/New Haven, CT: Interviewed and Cancer Meta-Analysis Featured on 5:30 PM Newscast.

January 3, 2006 NBC Nightly News With Brian Williams, NY, NY: Cancer Meta-Analysis Results Presented in Nightly Newscast.

January 3, 2006 WNPR: Interview on Cancer Meta-Analysis Played over All Stations in WNPR.January 3, 2006 CNN Radio Network: Interview on Cancer Meta-Analysis Played over All Stations in CNN

Radio Network.January 3, 2006 CBS Radio Network: Interview on Cancer Meta-Analysis Played over All Stations in CBS

Radio Network.January 3, 2006 Eurekalert Webpage. “Statins Have Neutral Effect on Risk of Cancer.”

www.eurekalert.org/pub_releases/2006-10/jaaj-shn122905.php.January 3, 2006 Medpage Today Website. “Meta-Analysis Rules Out Statin Cancer Prevention”. Focused

on our meta-analysis in JAMA with direct quotes. www.medpagetoday.com/hematologyoncology/coloncancer/tb/2421.

January 3, 2006 ABCNews.go.com. Studies: “Statins: Don’t Lower Cancer Risk” Focused on our meta-analysis in JAMA with direct quotes.

January 4, 2006 Top Health Story on Google News, Wednesday, January 4, 2006 (306 stories total listed)January 4, 2006 Associated Press: Article featured cancer meta-analysis with direct interview and quotes.

Picked up by newspapers nationwide.January 4, 2006 News-Times Newspaper, Danbury, CT. “Study Says Statins Fail to Lower Cancer Risk: Best

Use for Miracle Drug is Reducing Cholesterol.” Focused on our meta-analysis in JAMA with direct quotes in the Local Section.

January 4, 2006 Los Angeles Times, Los Angeles, CA. “Two Studies Show Statins Don’t Cut Cancer Risk.” Focused on our meta-analysis in JAMA with direct quotes.

January 4, 2006 Hartford Courant, Hartford, CT: Front Page Article “Statins’ Benefit Only to Heart”. Focused on our meta-analysis in JAMA with direct interview.

January 4, 2006 Chicago Tribune, Chicago, IL. Cholesterol Drugs Don’t Affect Malignant Cells, 2 Studies Say. January 4, 2006 Boston Herald, Boston, MA. “Studies Dash Hopes for Use of Statin Drugs as Cancer

Fighters.” Focused on our meta-analysis with direct quotes. January 4, 2006 BreastCancer.Net News. “Statins Have Neutral Effect on Risk of Cancer.”

January 30, 2006 University of Connecticut Advance Magazine [Volume 24 (18), Page 5]: “Research Team Finds Statins Not Effective in Reducing Cancer Risk.” Article About Our Statins in Cancer JAMA Manuscript.

C.M. White, p.72

March 13, 2006 Fox61 News at 10PM. Interview News Segment on our Study Showing Attenuated Benefits for Women With Implantable Cardioverter-Defibrillators.

March 13, 2006 ACC Press Release and Press Conference: Our Study Showing Attenuated Benefits for Women With Implantable Cardioverter-Defibrillators.

March 16, 2006 ACC ’06 Meeting Highlights: Our study was noted at the closing ceremony as a highlighted paper in arrhythmia from the American College of Cardiology Meeting. by Stephen Markowitz, ACC Program Chair.

May 15, 2006 University of Connecticut Advance Magazine [Volume 24 (31), Page 6]. “Study Suggests Implanted Defibrillators Less Effective for Female Heart Patients.” Article Focusing on Our Research and Fellow Nickole Henyan, Pharm.D..

May 2006 UConn Traditions Magazine: Our Study on ACE/ARBs Delaying Onset of Diabetes Featured in University Wide Alumni Magazine.

June 2006 Hartford Courant. “Professor’s Comic Touches Help Students Learn”. Article expose on my teaching style and approach.

July 2006 Collaborations – Results Magazine, American Association for Cancer Research. “Cholesterol-Lowering Drugs for Cancer” Quoted in article on our research and that of others on statins impact on cancer incidence. Volume 1, Issue 2, Page 9.

August 16, 2006 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Our Newly Published Facilitated PCI Study During the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

September 20, 2006 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Novel Dosage Delivery Forms During the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

September 20, 2006 Reuter’s Health. Article Summarizing our Meta-Analysis on Echinacea “Echinacea Cuts Cold Incidence. Available at: http://today.reuters.com/news/ArticleNews.aspx?type=healthNews&storyID=2006-09-20T174002Z_01_COL063583_RTRUKOC_0_US-ECHINACEA.xml

October 30, 2006 University of Connecticut Advance Magazine [Volume 25 (10), Page 5]: “Clot busting drug helps reduce heart attack deaths, say researchers.” Interview on our study showing facilitated PCI reduced Hartford Hospital length of stay, major adverse cardiac events, and reduced costs versus PCI alone.

October 2006 UConn Traditions Magazine. “Prolific Researcher with a Passion for Teaching: Michael White Twice Named Uconn’s Teacher of the Year.” Article focused on my research and teaching focuses while at UConn for the university’s alumni magazine.

November 2006 www.vitasearch.com. Interviewed for online “Meet the Experts” session to discuss our meta-analysis of coenzyme Q10 and its clinical implications.

December 20, 2006 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Underuse and Underdosing of Cardiac Drugs During the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

December 20, 2006 NBC 30, NBC Affiliate in Hartford, CT. Taped Interviewed Underuse and Underdosing of Cardiac Drugs With Mortality Benefits for the 5 PM Newscast.

January 23, 2007 ClinicalTrialResults.org. AFIST III Study Selected as One of Three of the Main Clinical Trials in Cardiology that Week and Discussed for the Webcasted "This Week in Cardiology" feature hosted by Drs. C. Michael Gibson and Chris Cannon.

May 7, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Preventing Drug Errors for the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

June 13, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Avoiding Cough and Cold Medications for Infants Under 2 Years of Age for the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

May 29, 2007 United Press International. Picked up Story on our Study on Aprotinin Featured in Article With Interview. “Negative surgery drug report is questioned.”www.upi.com/NewsTrack/Science/2007/05/30/negative_surgery_drug_report_is_questioned/7850/

C.M. White, p.73

May 29, 2007 Spirit India. Study on Aprotinin Featured in Article With Interview “Study Questions Risks Of Anti-bleeding Drug During Heart Surgery”www.spiritindia.com/health-care-news-articles-10070.html

May 29, 2007 DentalPlans.Com. Study on Aprotinin Featured in Article With Interview “Study Questions Risks Of Anti-bleeding Drug During Heart Surgery”www.dentalplans.com/articles/18377/

May 29, 2007 Science Daily. Study on Aprotinin Featured in Article With Interview “Study Questions Risks Of Anti-bleeding Drug During Heart Surgery”www.sciencedaily.com/releases/2007/05/070529104700.htm

May 30, 2007 Innovation-Report.com. Study on Aprotinin Featured in Article With Interview “Study Questions Risks Of Anti-bleeding Drug During Heart Surgery”www.innovations-report.de/html/berichte/studien/bericht-84947.html

May 30, 2007 Monsters and Critics. Study on Aprotinin Featured in Article With Interview “Negative surgery drug report is questioned”news.monstersandcritics.com/health/news/article_1311318.php/Negative_surgery_drug_report_is_questioned

May 31, 2007 News-Medical.Net. Study on Aprotinin Featured in Article With Interview “Proper use of aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke”www.news-medical.net/?id=25762

June 3, 2007 Medical News Today. Study on Aprotinin Featured in Article With Interview “Risks Of Anti-Bleeding Drug During Heart Surgery Questioned By Study.” www.medicalnewstoday.com/medicalnews.php?newsid=72524

June 3, 2007 The Post Chronicle. Study on Aprotinin Featured in Article With Interview “Negative Surgery Drug Report is Questioned.” www.postchronicle.com/news/health/article_21283611.shtml

June 3, 2007 Heartzine.com. Study on Aprotinin Featured in Article With Interview “Anti-Bleeding Drug Not Risky During Heart Surgery.”www.heartzine.com/581-Anti-Bleeding-Drug-Not-Risky-During-Heart-Surgery.html

June 3, 2007 News-Medical.Net Study on Aprotinin Featured in Article With Interview “Study questions risks of aprotinin during heart surgery”www.news-medical.net/?id=25894

June 4, 2007 HULIQ.Com. Study on Aprotinin Featured in Article With Interview Questioning risks of anti-bleeding drug during heart surgerywww.huliq.com/23052/questioning-risks-of-anti-bleeding-drug-during-heart-surgery

June 24, 2007 NBC 30 News at 11 PM. Study on Echinacea Features in News Segment for Statewide Braodbast. Hartford, CT.

June 24, 2007 Fox 61 News at 10. Study on Echinacea Features in News Segment for Statewide Braodbast. Hartford, CT.

June 25, 2007 Good Morning America. Study on Echinacea Features in News Segment for National Braodbast.

June 25, 2007 CNN Radio. Study on Echinacea Featured on Health News Segment to Affilitated Radio Stations Around the Country.

June 25, 2007 USA Today. Study on Echinacea Featured in News StoryJune 25, 2007 LA Times. Study on Echinacea Featured in News Story “Echinacea Not to Be Sneezed at

After All.” Los Angelas, CA.June 25, 2007 Baltimore Sun. Study on Echinacea Featured in News Story. “Study Heats Up Old Cold

Herb”, Baltimore, MDJune 25, 2007 London Times Online. Study on Echinacea Featured in News Story. “Herbal Remedy Really

Does Cure a Cold.” London, UK. C.M. White, p.74

www.timesonline.co.uk/tol/life_and_style/health/article1980481.eceJune 25, 2007 Google.Com. Featured Article on Home page of Google.comJune 25, 2006 BBC News. Study on Echinacea Featured in BBc Health News Report. “Echinacea Can

Prevent a Cold.”June 25, 2007 The Seattle Times. Study on Echinacea Featured in News Story. “Echinacea for Colds? New

Study Says Yes.” Seattle, WA.June 25, 2007 Radio New Zealand. Study on Echinacea Featured in News Story “Echinace May Prevent a

Cold”June 25, 2007 Bloomberg News. Study on Echinacea Featured in News Story. “Echinacea Halves Risk of

Getting a Cold”June 25, 2007 Fort Worth Star Telegram. Study on Echinacea Featured in News Story. “New Study Says

Echinacea Helps With Common Cold”.June 26, 2007 Today Show. Study on Echinacea Featured in News Segment for National Broadcast.June 26, 2007 Reuters.com. Study on Echinacea Featured in News Segment for National Broadcast.June 26, 2007 WebMD.com. Study on Echinacea Featured in News Segment for National Broadcast with

Interview.Jun 26, 2007 CHQR Radio 770 AM, Rutherford Show. Live Radio Interview on Echinacea Study with Call

In. 30-Minute Segment. Calgary, Alberta.Jun 28, 2007 BBC Radio. Radio Stations Around the World. Radio interview on our Echinacea Study.

London, UK.Jil 2007 Formulary Journal: Our Aprotinin Study in the JTCVS Was Featured as a “News Capsule”

Article, Page 441. Jul 17, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Our Echinacea Study and Its

Implications for the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.Jul 24, 2007 New York Times. Study on Echinacea Featured in News Story. “Echinacea Helps Colds,

Major Review Shows”. New York, NY.Aug 7, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Medication Noncompliance for

the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.August 12, 2007 Prevention Magazine. Interviewed on Results of Our Echinacea Study.

September 17, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Proper Aspirin Dosing for Heart health during the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

October 25, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on MRSA during the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

November 5, 2007 Health Monitor. Interviewed for print publication about use of Echinacea to treat or prevent the common cold. The interview was based on our meta-analysis.

November 14, 2007 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on fish oil and heart health during the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

November 2007 American Association of Colleges of Pharmacy Newsletter. Article written on UCONN School of Pharmacy being named an Evidence-based Practice Center by AHRQ “UCONN Awarded new Federal Center.” Quoted in article as Director of Center.

January 2007 National Cancer Institute. Interviewed for PodCast on Statins and Cancer Based on New Study on Topic.

January 28, 2007 KVEC 92.0, Quantum Health. Half-Hour Interview on My Natural Product Research Program. Los Angelas, California.

February 2007 Pharmacy Practice News. Interviewed for article entitled “Lack of Awareness of Heart-Attack Signs May Cost Lives”.

April 4, 2008 ACC CV News Digest. Article on Statins Impact on ICD Patient Survival Included in the Digest of Highlights from the American College of Cardiology Meeting. “Statins Cut Mortality in ICD Patients.”

May 6, 2008 HealthCare News. Interviewed for Article on Our Meta-Analysis for Drug for Restless Leg C.M. White, p.75

Syndrome.May 14, 2008 National Association of Chain Drug Store e-ssential News. Our Study was Included into the

Noteable Studies Section with a Quote from Me on the Study Findings. 2004-2006 Pharmacy Practice News Stories Interviews.

1. Huff, C. ACCP urges more pharmacist to gain specialty certification. Pharmacy Practice News. 2006; 33(12).

2. Greene, J. Every-other-day statins keep side effects at bay. Pharmacy Practice News. 2006; 33(11).

3. Kean, C. Accutan, lipid rise seen in new study. Pharmacy Practice News. 2006; 33(09).

4. No Author. ACE inhibitor teratogenicity. Pharmacy Practice News.2006; 33(07).

5. Huff, C. Mandatory residency training on the horizon. Pharmacy Practice News. 2006; 33(07).

6. Buckley, B. Cardiac infraction: drug treatment gap seen, in and out of hospital. Pharmacy Practice News. 2006; 33(06).

7. Hurley, D. Lipid specialists urge statin label change. Pharmacy Practice News. 2006; 33(06).

8. Buckley, B. ASTEROID trial lands with a bang (sort of). Pharmacy Practice News. 2006; 33(05).

9. Huff, C. In heart failure, team approach scores best. Pharmacy Practice News. 2006; 33(02).

10. Huff, C. Statin drugs flex muscle against many cancer types. Pharmacy Practice News. 2005; 32(09).

11. Huff, C. Nesiritide renal toxicity spurs risk-benefit debate. Pharmacy Practice News. 2005; 32(08).

12. Frandzel, S. C-reactive protein debate heats up. Pharmacy Practice News. 2005; 32(07).

13. Hurley, D. Institute of medicine calls for regulatory overhaul of dietary supplement industry. Pharmacy Practice News. 2005; 32(07).

14. No Author, FDA panel: COX-2s can stay – for now. Pharmacy Practice News. 2005; 32(05).

15. Kean, C. FDA panel set to review safety of COX-2 inhibitors. Pharmacy Practice News. 2005; 32(03).

16. Prescott, L. Nesiritide improves renal hemodynamics in patients with congestive heart failure. Pharmacy Practice News. 2005; 32(03).

17. Bronstein, D and Frei, R. Painkiller toxicity data now include celecoxib, naproxen. Pharmacy Practice News. 2005; 32(02).

18. Frei, R. Beta-blockers reduce LOS, atrial fibrillation risk. Pharmacy Practice News. 2005; C.M. White, p.76

32(02),

19. Buckley, B. A to Z trial results raise questions on statin choice. Pharmacy Practice News. 2004; 31(11).

20. Prescott, L. Carvedilol survival advantage maintained regardless of dose, heat rate, BP. Pharmacy Practice News. 2004; 31(07).

2007-2011 Pharmacy Practice News Interviews.

21. Lowry, F. Experts ponder the role of statins in the ICU. Pharmacy Practice News. 2011; 38(05).

22. Huff, C. Studies: teamwork yields best results for chronic illness. Pharmacy Practice News. 2010; 37(11).

23. Shaw, G. Colchicine prevents rare heart surgery complication. Pharmacy Practice News. 2010; 37(10).

24. Lowry, F. Statin ‘loading’ cuts post-op MI risk. Pharmacy Practice News. 2010; 37(10).

25. Tilyou, S. PCI antiplatelet therapy gets more complicated. Pharmacy Practice News. 2010; 37(08).

26. Peeples, L. Targeting peri-op blood pressure pays off. Pharmacy Practice News. 2010; 37(06).

27. Lowry, F. For BP, when is low too low? Pharmacy Practice News. 2010; 37(04).

28. Lowry, F. American heart association 2009 roundup. Pharmacy Practice News. 2010; 37(01).

29. No Author. Antiplatelet switch study stirs debate. Pharmacy Practice News. 2010; 37(01).

30. Helwick, C. JUPITER subanalysis fuels debate over role of statins. Pharmacy Practice News. 2009; 36(06).

31. Bronstein, D. Bivalirudin monotherapy a cost saver in ACS patients. Pharmacy Practice News. 2009; 36(02).

32. No Author. ED pharmacists speed access to lifesaving treatment for MI patients. Pharmacy Practice News. 2009; 36(01).

33. Frandzel, S. JUPITER trial stirs debate on statins in ‘normal’ patients. Pharmacy Practice News. 2008; 35(12).

34. Kean, C. ASHP 2008 literature awards highlight pharmacists’ expanded areas of influence. Pharmacy Practice News. 2008; 35(11).

C.M. White, p.77

35. Tendler, L. and Carroll L. Vytorin debate reignited. Pharmacy Practice News. 2008; 35(11).

36. Carroll, L. Hitting BP ‘sweet spot’ improves post-op outcomes. Pharmacy Practice News. 2008; 35(10).

37. Smith, M. Heart failure clinic gets a boost from pharmacists. Pharmacy Practice News. 2008; 35(08).

38. Kean, C. Heart failure patients can benefit from pharmacist care. Pharmacy Practice News. 2008; 35(07).

39. Marcus, A. POISE data complicate peri-op beta-blocker therapy. Pharmacy Practice News. 2008; 35(07).

40. Kean, C. Lack of awaress of heart attack signs may cost lives. Pharmacy Practice News. 2008; 35(04).

41. Hurley, D. Study places new emphasis on stable CAD drug therapy. Pharmacy Practice News. 2007; 34(07).

42. Kean, C. New education aid helps improve patient compliance. Pharmacy Practice News. 2007; 34(07).

43. Kean, C. Should avandia cardiotoxicity date be taken to heart? Pharmacy Practice News. 2007; 34(07).

44. Huff, C. Statins may combat infection in critical care patients. Pharmacy Practice News. 2007; 34(05).

45. Kean, C. A tale of two studies: does aprotinin increase mortality? Pharmacy Practice News. 2007; 34(04).

46. Hurley, D. Three infant deaths prompt cough/cold drug warning. Pharmacy Practice News. 2007; 34(03).

August 8, 2008 WebMD. Common Spices May Help Diabetes. Our Meta-Analysis on Cinnamon’s Impact on Metabolic Syndrome Parameters Featured in News Story With Quote From Our Group (Bill Baker).http://diabetes.webmd.com/news/20080806/common-spices-may-help-diabetes

August 8, 2008 CBS News (Online). Common Spices May Help Diabetes. Our Meta-Analysis on Cinnamon’s Impact on Metabolic Syndrome Parameters Featured in News Story With Quote From Our Group (Bill Baker).http://www.cbsnews.com/stories/2008/08/07/health/webmd/main4327378.shtml

November 17, 2008 UCONN Advance Magazine. Our Study on Beta-blockers Featured in Edition. “Beta-blockers reduce risk of heart attack, increase stroke risk, large scale study confirms.”University of Connecticut Advance 2008;27:pgs 1 and 6. www.advance.uconn.edu

March 30, 2009 WFSB Channel 3 Eyewitness News. Interviewed for a segment entitled “Wake-up on Time, Is It Safe to Take?. I reviewed the ingredients and provided information of who may benefit and who could be harmed.

June 15, 2009 www.vitasearch .com Garlic meta-analysis included in database of evidence based natural product research.

C.M. White, p.78

June 22, 2009 Publix Green Wise Market Magazine. Interviewed on article based on our garlic meta-analysis.

June 23, 2009 IFAV Newsletter. Interviewed on article based on our garlic meta-analysis.April 26, 2010 NBC 30, NBC Affiliate in Hartford, CT. Interviewed Live on Medication Costs and

Communication With Doctors and Pharmacists during the 10:00 AM Newscast. Part of “Ask the Pharmacist Segment”.

October 5, 2010 LA Times Newspaper, LA, CA. Our group’s comparative effectiveness review on human growth hormone in cystic fibrosis was covered with a quote was featured in this article.

October 5, 2010 Hartford Courant, Hartford, CT. Front Page Article. Our group’s comparative effectiveness review on human growth hormone in cystic fibrosis was covered with a quote was featured in this article.

October 5, 2010 Dallas Morning News, Dallas, TX: Our group’s comparative effectiveness review on human growth hormone in cystic fibrosis was was featured in this story.

October 4, 2010 Fox 61 News, Hartford, CT: Our group’s comparative effectiveness review on human growth hormone in cystic fibrosis was was featured in this story.

October 5, 2010 Yahoo News, Mednews Today, Drugs.com, CysticFibosis.com, Phys.org: Our human growth hormone in cystic fibrosis study covered online at these media outlets.

November 8, 2010 The CT Mirror (www.ctmirror.org): “UCONN Center Reviews Science Behind Research”. Feature article in the November Magazine reviewing the Evidence-based Practice Center, Comparative Effectiveness, and Our Most Prominent Projects to Date.

January 19, 2011January 19, 2011

MedCAC CMS Presentation Streamed Live Via Bloomberg Business Network.MedCAC CMS Presentation Covered by Media Outlets Including:FDA News (http://fdanews.com/newsletter/article?articleId=133594&issueId=14393)MSNBC (http://www.msnbc.msn.com/id/41160615/ns/health/)Newsfeedresearcher.com (http://newsfeedresearcher.com/data/articles_m4/patients-kidney-esas.html)Trust.org (http://www.trust.org/alertnet/news/update-2-not-enough-data-on-anemia-drugs-transplants-us-panel/)Finanzachrichten.com (http://www.finanznachrichten.de/nachrichten-2011-01/19123929-update-2-not-enough-data-on-anemia-drugs-transplants-us-panel-020.htm.)

March 10, 2011 Hartford Courant (courant.com/health): Panelist on a live webchat on the topic “Effect of Pharmaceutical Companies Advertisements on People’s Health”. Hartford, CT

March 2012 Pharmacy Practice News. “Low Cost Strategy Improves Adherence to ACS Medication Guidelines.” Quoted in article on the role of the pharmacist in improving care of cardiac patients. (http://www.pharmacypracticenews.com/ViewArticle.aspx?d=Clinical&d_id=50&i=June+2012&i_id=853&a_id=20987)

April 2012 Pharmacy Practice News. In Warfarin Reversal, Consistency Could Improve Care. Interviewed on clinical implications of data on warfarin reversal. http://www.pharmacypracticenews.com/ViewArticle.aspx?d_id=50&a_id=20493&d=Clinical&i_id=829&i=April+2012&tab=RSS

August 1, 2012 NBC30, NBC Affiliate in Hartford, CT. Interviewed for story on lowering prescritption drug costs for the 11 PM newscast. Repeated on the August 2, 2012 morning news.

January 2013 Pharmacy Practice News. Heart Failure Programs Take Aim at Readmits. Interviewed for story on value of heart failure programs. http://www.pharmacypracticenews.com/ViewArticle.aspx?d_id=50&i=January+2013&i_id=921&a_id=22425

November 21, 2013 WNPR, Hartford CT. The Colin McEnroe Show. Interviewed over an hour on the Use and Abuse of Molly (MDMA/Ecstasy). Show Aired 1-2 PM and Re-Aired 8-9 PM.

March 24, 2014 Hartford Courant, Hartford, CT. Party Drug Exacts Price Days Later, UConn Researcher

C.M. White, p.79

Says. FRONT PAGE ARTICLE.May 2014 Pharmacy Practice News, May Edition. As Nitro Shortage Eases, Lessons Learned for the

Future. Quoted in Article as Cardiovascular Specialist. May Issue, Volume 41.May 16, 2014 FOX 61, FOX Affiliate in Hartford, CT. Griffin Hospital Insulin Pen Story. Interviewed live on

the story for the 5:30 PM News and then Interviewed in a taped segment for Prime Time and Nighlty News Coverage.

July 17, 2014 NBC 30 Connecticut, West Hartford, CT. Prescription for Savings at the Pharmacy Counter. Interviewed for article. http://www.nbcconnecticut.com/troubleshooters/Prescription-for-Savings-at-the-Pharmacy-269304761.html

Feb 24, 2015 Hartford Courant, Hartford, CT. After 11 OD, Wesleyan President Urges Students to ID Sellers. FRONT PAGE ARTICLE.

June 17, 2014 Psychiatry Advisor Web Site. Research Underway on Psychedelic Treatments for PTSD. Web artcle features my systematic review on MDMA for PTSD. http://www.psychiatryadvisor.com/ptsd-trauma-and-stressor-related/research-underway-on-psychedelic-treatments-for-ptsd/article/358948/

November 2015 Yahoo Health. The Generic Myth the Could be Costing you Money. https://www.yahoo.com/beauty/the-generic-drug-myth-that-1293764178829366.html

February 2016 Patriot Ledger Magazine. We're running out of prescription drugs — and the consequences could be 'disastrous'. Interviewed for Article. http://www.patriotledger.com/article/ZZ/20160217/business/302179928

February, 2016 Huffington Post and Grandparent.com: The Truth About Generic vs. Name Brand Medication. Interviewed for article on generic drug pricing. http://www.huffingtonpost.com/2015/02/22/generic-prescriptions_n_6730194.html

Febrruary 17, 2016 Business Insider. We're running out of prescription drugs — and the consequences could be 'disastrous'. Interviewed for Article. http://www.businessinsider.com/pharmaceutical-drug-shortages-are-a-disaster-2016-2

March 4, 2016 Investopia. Cancer and Other Drug Shortages. Interviewed for Article. http://www.investopedia.com/articles/personal-finance/030416/cancer-and-other-drug-shortage.asp

May 17, 2016 CTN Network. Live recording of the prescription drug price forum panel discussion which I participated in. http://ct-n.com/ondemand.asp?ID=12886

May 17, 2016 Connecticut State Medical Society. Listed as panelist for the forum with links to news stories on the forum. http://csms.org/2016/05/17/ct-pharmaceutical-forum-access-affordability-better-health/

May 18, 2016 WNPR Radio. Prescription Drug Price Forum. Coverage of event with quote from my speech. http://wnpr.org/post/hartford-forum-called-first-step-toward-more-affordable-prescription-drugs#stream/0

May 18, 2016 CTNewsJunkie.com. Prescription Drug Price Forum. Coverage of Forum and use of my quotes from the forum. http://www.ctnewsjunkie.com/archives/entry/discussion_on_prescription_drug_costs_leaves_panelists_looking_for_answers/

May 17, 2016 WSHU, NPR Radio. Prescription Drug Price Forum Coverage, I was a panelist at the forum. http://wshu.org/post/skyrocketing-prescription-drug-prices-focus-forum-hartford.

May 24, 2016 Universal Healthcare Foundation of Connecticut. Story written by Jill Zorn about high drug prices quoting me in the article. https://universalhealthct.org/the-burning-platform-of-high-drug-prices%E2%80%AF/

April 2013-Present FOX61, Fox Affiliate in Hartford, CT. “Ask the Pharmacist” Featured in over 250 live segments

C.M. White, p.80

2017-2018 "Want to Lose Weight?," Hartford Magazine. (June 2018).

"Kratom could be illegal before it gets a chance to solve the opioid crisis," Inverse.com. (June 15, 2018).

"Looking to Quit Smoking? Here's one way.," Fox61. (June 1, 2018).

"Perched on a Plateau," UConn Today. (May 15, 2018).

"The good, the bad, and the maybe, about kratom," Helio.com. (April 16, 2018).

"Kratom Recall 2018: What You Need to Know About the Drug's Safety," Inverse.com. (April 1, 2018).

"UConn Now: UConn Talks," UConn Magazine. (March 2018).

"State Offering Free Flu Shots Saturday," Fox61. (January 24, 2018).

"Kratom," The Dr Oz Show. (January 17, 2018).

"What Jeff Sessions Doesn't Understand About Medical Marijuana," Reported or published by over 40 various news outlets including NY Daily News, Market Watch, Salon, New Haven Register. (January 2018).

"Daily Ibuprofen usage associated with infertility," Fox61. (January 9, 2018).

"Yale effectively tests new HIV fighting drug," Fox61. (January 9, 2018).

"@NEJM Ask the Authors & Experts: Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia," Medestro NEJM. (December 18, 2017).

"http://www.nonpareilonline.com/opinion/our_view/editorial-safety-of-kratom-products-questioned/article_7e2bba0c-daf3-11e7-a14f-db73a585cc6b.html," Nonpareilonline. (December 7, 2017).

"What to do about Kratom," AlterNet. (November 20, 2017).

"The Dangers and Potential of Natural Opioid Kratom," The Conversation. (November 19, 2017).

"The Debate Continues over Nature's Opioid Kratom," Sign of the Times (SOTT). (November 19, 2017).

"What is Kratom?," Fox61. (November 15, 2017).

"6 Medications You Should Never Take While Driving," Grandparents.com. (October 10, 2017).

"The price of a miracle: Should we limit spending on lifesaving drugs?," The Conversation. (July 5, 2017).

"Have any back pains? Study says that some medications you think work, don’t," Fox61. (June 14, 2017).

"Why Amazon should keep prescription drugs off its voluminous shelves," Buzz Feed, CNBC, Connecticut Post, Newsweek, Paste Magazine, and PBS Newshour. (June 8, 2017).

2018-2019 “Why Synthetic Marijuana is so risky.” Over 25 various news outlets including CNBC, Public Radio Int., Houston Chlonicle, New Haven Register. (Aug 29, 2018)

Beware of natural supplements for sex gain and weight loss. Over 30 news outlets including Newsweek, Salon, Lee Enterprises (large group of newspapers), Daily Mail,

C.M. White, p.81

Idaho Press Tribune. https://theconversation.com/beware-of-natural-supplements-for-sex-gain-and-weight-loss-106484 (November 10, 2018)

My article on CBD is referenced in a NY Times article. Christina Caron. CBD Lures Stressed Out Parents Looking to Unwind. April 12, 2019. https://www.nytimes.com/2019/04/12/parenting/cbd-oil-safe.html.

C. Michael White Named 2019 School of Pharmacy Teacher of the Year. UConn Today. April 2019. https://today.uconn.edu/school-stories/c-michael-white-named-2019-school-pharmacy-teacher-year/.

“What naxolone can – and can’t – do, and when to use it.” Interviewed for Tim Lammer’s Story, FOX61 Nightly News. March 14, 2019. https://fox61.com/2019/03/14/what-naxolone-can-and-cant-do-and-when-to-use-it/.

“Denver may decriminalize hallucinogenic mushrooms.” Interviewed for Tim Lammer’s Story, Fox61 Nightly News. February 7, 2019. https://fox61.com/2019/02/07/denver-may-decriminalize-hallucinogenic-mushrooms/.

“Why the drug Flakka is especially dangerous.” Interviewed for Tim Lammers’ Story. Fox61 Nightly News. February 8, 2019. https://fox61.com/2019/02/07/why-the-drug-flakka-is-especially-dangerous/

“Health Watch: What is CBD oil used for?” Interviewed for Tim Lammers’ Story. Fox61 Nightly News. October 4, 2018. https://fox61.com/2018/10/04/health-watch-what-is-cbd-oil-used-for/.

McCook A. As Kratom Risk Grows, Call to Tread Cautiously. Pharmacy Practice News. May 7, 2019. Interviewed for article based on my past scholarship in this area. https://www.pharmacypracticenews.com/Clinical/Article/05-19/As-Kratom-Risks-Grow-a-Call-to-Tread-Cautiously/54789

Affordable alternatives to expensive EpiPens. Interviewed for Tim Lammers’ Story. Fox61 Nightly News. August 29, 2018. https://fox61.com/2018/08/29/affordable-alternatives-to-expensive-epipens/

“Alzheimer’s drug is promising, but not proven.” Interviewed for Tim Lammers’ Story. Fox 61 Nightly News. August 8, 2018. https://fox61.com/2018/08/18/alzheimers-drug-is-promising-but-not-proven/

“Calls to poison control centers from Kratom have risen, but why?” Interviewed for Tim Lammer’s Story, Fox61 Nighty News. February 26, 2019. https://fox61.com/2019/02/26/calls-to-poison-control-centers-from-kratom-have-risen-but-why/

“Miracle treatment or dangerous drug? Indonesia cashes in on Kratom” Source for Story. February 11, 2019. https://www.breitbart.com/news/miracle-treatment-or-dangerous-drug-indonesia-cashes-in-on-kratom-3/

“Is Soy a Superfood or Supervillain?”” C. Michael White Nutrition Blog. April 2019. C.M. White, p.82

https://blog.sivanaspirit.com/hh-soy-a-superfood-or-supervillain/

“The Top 15 Killers And Avoiding Premature Death”. C. Michael White Nutrition Blog. March 2019. https://blog.sivanaspirit.com/the-top-15-killers-and-avoiding-premature-death/

“Is Blue Spectrum Light A Savior Or Monster?” C. Michael White Nutrition Blog. February 2019. https://blog.sivanaspirit.com/hh-is-blue-spectrum-light-a-savior-or-monster/

“Now Might Be An Excellent Time To Take A Break From Your Diet.” C. Michael White Nutrition Blog. January 2019. https://blog.sivanaspirit.com/now-might-be-an-excellent-time-to-take-a-break-from-your-diet/

“Experts divided regarding impact from Trump’s plan to put drug prices in TV ads” Interviewed for this News Article. Healio.com. May 2019. https://www.healio.com/family-medicine/practice-management/news/online/%7Bd9681cbb-da4a-4743-ac31-9b180ca9e0a6%7D/experts-divided-regarding-impact-from-trumps-plan-to-put-drug-prices-in-tv-ads?fbclid=IwAR2Scg3bcoktIGob545f5Lw8EZWywFgm3ywHhIJVMNpxr7lbPlmY3xK0108 “Fact and Fiction About CBD Oil”. Interviewed for this News Story. UConn Today. June 2019. https://today.uconn.edu/2019/06/fact-fiction-cbd-oil/?fbclid=IwAR2B14YUBxp05E6N4x_TgLWNgcS4f97Frq-pIKhuC5Iiq45uGZKUPrO10HQ

“As Trump administration considers importing drugs from Canada, experts analyze risks, benefits”. Interviewed for this News Story. Healio.com. June 2019. https://www.healio.com/family-medicine/practice-management/news/online/%7B5a9c9d9e-1f0f-4a03-a9d2-b902a4593ced%7D/as-trump-administration-considers-importing-drugs-from-canada-experts-analyze-risks-benefits?utm_medium=social&utm_source=facebook&utm_campaign=sociallinks&fbclid=IwAR2mkxHaaLULBMkpsBmqXsPaj4ihaZF5GoRb622ch_B2ERvlFErDHxMBOEE “Smart Pills Help Monitor Cancer Patient’s Therapy.” Quoted in this Article. The Scientist. July 2019. https://www.the-scientist.com/notebook/smart-pills-help-monitor-cancer-patients-therapy-66092?fbclid=IwAR0kG02aHVJQAX3Yjfah-RQ9SBCNbXo-h8nY_Ojk9YZJPWhgdRkST_ETraM

“Drug Researchers Raise Concern Over "Misleading" Evidence in Kratom Studies.” Quoted in this News Story. Inverse.com. July 2019. https://www.inverse.com/article/57573-we-cant-really-say-whether-kratom-is-safe-or-not?fbclid=IwAR3Ne3y3YCoQYvW8gQlAXLUtuD7uHeZt0l2owDPrabCg64AeKrEE6fGEfew

King B. Here's what you should know about kratom — the controversial opioid-like plant. July 12, 2019. Interviewed for News Story. Philly Voice. https://www.phillyvoice.com/kratom-facts-controversial-opioid-plant/.

“Op-ed: To Lower Drug Costs, End Prescription Coupons.” UConn Today. August 2019. https://today.uconn.edu/2019/08/op-ed-lower-drug-costs-end-prescription-coupons/?utm_source=listserv&utm_medium=email&utm_campaign=daily&utm_content=uconn-today&fbclid=IwAR2TUZucv4wK_BomJOSLuophlhqqjYd3b7hUG_9obDJLVYHjtGELAdCnhwA

C.M. White, p.83

“Seeing Spots that Don’t Go Away? Multivitamin and Multimineral Supplementation for Macular Degeneration.” Authored article on macular degeneration. Blog.sivanaspirit.com/seeingspotsthatdontgoaway?

“Trump Administration Reveals Plan to Import Prescription Drugs from Canada.” Quoted in this news story. Daily Herald. August 2019. https://dailyheralds.org/family/trump-administration-reveals-plan-import-prescription-drugs-canada-08820028

“Can’t Stick to Your Diet?” My book and I are quoted in this article. August 24, 2019. https://www.pharmacypracticenews.com/Online-First/Article/08-19/Can%E2%80%99t-Stick-to-Your-Diet-/55725

“Guide ‘emphasizes facts, not falsehoods’ about CBD use.” Quoted in this news story. Helio.com. August 27, 2019. https://www.healio.com/family-medicine/pain-management/news/online/%7B0a67a133-952a-4be1-a52a-526c5ecdaed5%7D/guide-emphasizes-facts-not-falsehoods-about-cbd-use?utm_medium=social&utm_source=facebook&utm_campaign=sociallinks&fbclid=IwAR0EOOhGzUmiN1Ml5iIHClc-eAMI-txNe9qDKYoi4e3uQDfrauZctpBX-HM

“Op-ed: Why Cheaper Drugs from Canada Won’t Cure What Ails Us.” The Conversation. Sept 27, 2019. [Picked up by over 2 dozen media sites]

“What are the risks assocated with vaping and why do they occur.” Interviewed for “Ask the Pharmacist” Segment on Fox61. September 26, 2019.

“Why Prescription Drugs From Canada Won’t Lower America’s Drug Bill”. Interviewed for “Ask the Pharmacist” Segment on Fox61. October 14, 2019.

Hess K. A new kratom report maps one possible future for the drug"We have the opportunity this time around to do it the right way." Interviewed for story based on my publication in AJHP. 10/25/2019. https://www.inverse.com/article/60375-what-do-we-still-not-know-about-kratom

Lenharo M. “Should you be worried about the latest drug recall? Cancer causing chemicals in the popular heartburn drug Zantac. Elemental+”. 11/7/19. Interviewed for story basedon my publication in Annals Pharmacotherapy. https://elemental.medium.com/should -you-be-worried-about-the-latest-drug-recall-8c26ac4682e4

McCook A. Taking the latest cardiology research to heart. 11/14/19. Interviewed to discuss the impact of the newest cardiology research and implications for pharmacists. https://www.pharmacypracticenews.com/Clinical/Article/11-19/Taking-the-Latest-Cardiology-Research-to-Heart/56456

McClurg L. Some call kratom a miracle herb. But its safety is questionable. KQED/NPR Media. Interviewed for Story About Kratom based on My Research 11/18/19. https://nam01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.kqed.org%2Fscience%2F1950877%2Fkratom-is-a-lifesaver-say-opioid-addicts-but-its-safety-is-questionable&data=02%7C01%7Ccharles.white%40uconn.edu%7Ce151200e9b6e4964e52308d76c9b35e8%7C17f1a87e2a254eaab9df9d439034b080%7

C.M. White, p.84

C0%7C0%7C637097286187656308&sdata=VJvDWtD%2B%2F9k37cXA8rgbOZ%2BTS0MZFkSo5kyDu4dLMPM%3D&reserved=0

Editor. The Kratom Debate: Helpful Herb Or Dangerous Drug? Picked up by NPR stations across the country and others on January 13, 2020 including:

KNAU, KCLU, KOSU, KPR, KTEP. Northeast Public Radio, WXPR, Delmarva Public Radio, WRKF, KPBS, WCBE, Public Radio East, Radio America, Koahnic Braodcasting Station, Jefferson Public Radio, SDPB, KMUW, Maine Public Radio, Hawaii Public Radio, Omaha Public Radio, Iowa Public Radio, KERA – News, KCUR, WJCT, KRWG, WWNO, WVIF, WKAR, WYPR, New England Public Radio, Wyoming Public Radio, Tri-States Public Radio, The Cape Public Radio, Georgia Public Radio, Northern Public Radio, Indiana Public Radio, WLRN, KUNC, Boise State Radio, KCBX-FM.

MSN (Microsoft Network). https://www.wwno.org/post/kratom-debate-helpful-herb-or-dangerous-drug

White CM. Why Your Generic Drugs Might Not be Safe. OpEd Written for The Conversation. http://theconversation.com/why-your-generic-drugs-may-not-be-safe-and-the-fda-may-be-too-lax-125529 . OpEd Covered by:

Washington Post, Inverse, Yahoo News/National Interest, Houston Chronicle, Seattle Post, New Haven Register, Idaho Press Tribune, CT Post, Danbury News-Times, Stamford Advocate, Kiowa County Press.

2020-2021 Hillel J. Serious Concerns Raised Over FDA’s Capacity to Inspect Overseas Drug Makers. FairWarning.org January 8, 2020. Interviewed about new OIG report on FDA. https://www.fairwarning.org/2020/01/fda-pharmaceutical-makers-overseas-inspections/.

Miller J. Study Claims CDC Underestimates Number of Drug Oversdose Deaths. January 7, 2020. Helio.com. Interviewed and quoted on story. https://www.healio.com/primary-care/addiction/news/online/%7Ba148e95c-883c-4590-b51b-7c1be3b5c6a3%7D/study-claims-cdc-underestimates-number-of-drug-overdose-deaths.

Lektman A. Does the CDC Drastically Undercount US Overdose Deaths? January 9, 2020. Quoted in Story on Opioid Deaths. https://filtermag.org/cdc-undercount-drug-overdose-deaths/

Miller J. Kratom’s Risk Obscured by ‘Soft Data’. Helio.com. January 6, 2020. Interviewed for Story About Kratom Comparative Death Risk. https://www.healio.com/primary-care/addiction/news/online/%7Bed3f111e-1933-4e7f-988c-b639d9027208%7D/kratoms-risk-obscured-by-soft-data.

McClurg L. The Kratom Debate: Helpful Herb Or Dangerous Drug?. January 13, 2020. The Morning Addition, NPR News. Interviewed for radio newspiece on kratom. https://www.npr.org/sections/health-shots/2020/01/13/789145948/the-kratom-debate-helpful-herb-or-dangerous-drug.

Rose J. Live interview for “Top of Mind” radio show on SiriusXM 143 and BYUradio.com. January 14, 2020. https://www.byuradio.org/episode/7e8697c9-62bf-433a-8cea-2ab423266d36?playhead=1668&autoplay=true

Shah G. Stopping Aspirin Post-MI: A Matter of Timing. Pharmacy Practice News. January 14,

C.M. White, p.85

2020. Interviewed for story. https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.pharmacypracticenews.com%2FClinical%2FArticle%2F01-20%2FStopping-Aspirin-Post-PCI-A-Matter-of-Timing%2F56942%3Fsub%3D%26enl%3Dtrue%26dgid%3D--DGID--%26utm_source%3Dsocial%26utm_medium%3Dtwitter%26utm_campaign%3Dstopping_asprin&data=02%7C01%7Ccharles.white%40uconn.edu%7C424c4fa617b74a85711008d7a5a71db1%7C17f1a87e2a254eaab9df9d439034b080%7C0%7C0%7C637160009478380719&sdata=Q9h5MLw0me3ae9UauDr1ZTkZQO%2FJC%2FA%2FIAdXvKYyj7w%3D&reserved=0

Barisano D. Clinical Spotlight. Charles Michael White. Interviewed and Featured by ACCP Student News (StuNews). https://nam10.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.accp.com%2Fstunet%2Fnewsletter.aspx%3Fiss%3D0220%26aid%3D95&data=02%7C01%7Ccharles.white%40uconn.edu%7C0c4a976330484ea83c7108d7a5a7f6cc%7C17f1a87e2a254eaab9df9d439034b080%7C0%7C0%7C637160013122022026&sdata=M3Q0cOByVff3nbrxbA43kSWG%2FuQxpapgzWUPXOHctoM%3D&reserved=0

MacDonald N. Kratom Use in Canada. CBC (Canadian Broadcasting Channel). Interviewed for Story on Kratom Pharmacology, and Benefit and Risk Profile. In Progress.

Tilyu S. Updates on American Heart Association Clinical Trials. Pharmacy Practice News. Interviewed on the newest trials out of the AHA meeting and their implications for pharmacists. In Progress.

Schwartz M. Dietary Supplement Quality Issues and Consumer Health. Mother Jones”Bite” Podcast. Interviewed for podcast on dietary supplements quality. In Progress.

White CM. Natural supplements can be dangerously contaminated, or not even have the specified ingredients.

OpEd Covered by: PBSNewsHour, Salon, Inverse, Chicago Tribune, National Press, Flipboard, EcoWatch, Idaho Press, Times of Health, New Haven Register, Philly Voice, CT Post, Medicalxpress.

Levine B. Everything You Need to Know About Generic Medications. Blink Health March 3, 2020. https://www.blinkhealth.com/blog/everything-you-need-to-know-about-generic-medications. Featured interviewee for article on generic drug approval process and cost savings for consumers.

White CM. No, CBD is Not a Miracle Molecule that can Cure Coronavirus, Just as it Won’t Cure Many other Maladies it’s Proponents Claim.

OpEd Covered by: San Francisco Chronicle, Albany Times Union, Medicaxpress, Idaho Press Tribune, Fairfield Citizen, San Antonio Express-News, The Telegraph, Newsblur, Connecticut Post.

McCook A. Weighing the Cardiac Risks of Hydroxychloroquine. IDSE. April 21, 2020. Available at: https://www.idse.net/Covid-19/Article/03-20/Weighing-the-Cardiac-Risks-of-Hydroxychloroquine/58060

McCook A. Weighing the Cardiac Risks of Hydroxychloroquine. Pharmacy Practice News. C.M. White, p.86

April 21, 2020. Available at: https://www.pharmacypracticenews.com/Covid-19/Article/04-20/Pharmacists-Help-Weigh-Cardiac-Risks-of-Hydroxychloroquine/58050

Lammers T. Coronavirus: What We Know, What We Don’t Know. Fox61. May 27, 2020. https://www.fox61.com/article/news/health/coronavirus/hydroxychloroquine-what-we-know-what-we-dont-know/520-43d0e443-8644-4b83-a024-ef07685317bb?fbclid=IwAR3GBXYRzZBYbbESEULBk9kAjKEoSrlNjrCTIy26DRh_67l9KPLuVhVS7JY

White CM. Hydroxychloroquine for COVID-19: A new review of several studies shows flaws in research and no benefit May 28, 2020.

OpEd Covered by: Inverse, Snopes, Down to Earth, News Repblic, Flipboard, Medical Express, PennLive, New Haven Register, Global Economics International, Idaho Press-Tribune, Global Biodefense, Houston Chronicle, Newsify App, Albany Time-Union, Newsblur, The Telegraph, Inoreader, Fairfield Citizen, Seattle Post, Lee Enterprises, The Hour, Stamford Advocate, CT Post.

Freyer FJ. Everyone – including Trump – has an opinon about this potential COVID-19 treatment, and that’s making it hard to find out if it works. May 30, 2020. Boston Globe. https://www.bostonglobe.com/2020/05/30/metro/everyone-including-trump-has-an-opinion-about-this-potential-covid-19-treatment-thats-making-it-hard-find-out-if-it-works/?outputType=amp&__twitter_impression=true

Barnard C. ‘Weak and conflicting’ evidence on hydroxychloroquine benfits and harms for COVID-19. medwireNews. June 1, 2020. https://rheumatology.medicinematters.com/covid-19/hydroxychloroquine/weak-and-conflicting-evidence-hydroxychloroquine/18036950

Rosenthal M. 2 Papers About Drug Therapy in COVID-19 Retracted from Prestigious Journals. Infectious Disease Special Edition [AND] Pharmacy Practice News. June 5, 2020. https://www.idse.net/Covid-19/Article/06-20/2-Papers-About-Drug-Therapy-in-COVID-19-Retracted-From-Prestigious-Journals/58675?utm_source=Social&utm_medium=twitter&utm_campaign=0605drugpap [AND] https://www.pharmacypracticenews.com/Article/PrintArticle?articleID=58677

Rosenthal M. Hydroxychloroquine Considerations: A Conversation With C. Michael White. Infectious Disease Special Edition [AND] Pharmacy Practice News. June 18, 2020. https://www.idse.net/Multimedia/Article/06-20/Hydroxychloroquine-Considerations-A-Conversation-With-C-Michael-White/58796 [AND] https://www.pharmacypracticenews.com/Multimedia/Article/06-20/Hydroxychloroquine-Considerations-A-Conversation-With-C-Michael-White/58792

NON-RESEARCH PRESENTATIONSOct 10, 1995 Drug Induced Respiratory Diseases: Focus on Apnea and Bronchoconstriction.

Pharmacy Practice Institute: CE Program: Pharmacists: Albany, NYSept 30, 1996 Adverse Drug Reactions and Drug Interactions of Cardiovascular Drugs

Continuing Professional Education Service: CE Program: Pharmacists: Wethersfield, CTJuly 24, 1997 Recent Advances in Heart Failure

Connecticut Pharmacists Association: CE Program: Pharmacists: Rocky Hill, CT

C.M. White, p.87

Nov 15, 1997 Understanding the Pathophysiology and Pharmacotherapy of DepressionContinuing Professional Education Service: CE Program: Pharmacists: Wethersfield, CT

Apr 4, 1998 A Review of the Pharmacologic, Pharmacokinetic, and Therapeutic Differences of HMG CoA Reductase Inhibitors.Cardiology Noon Conference: St. Francis Hospital. Cardiologists, Medical Residents: Hartford, CT

Apr 7, 1998 The Role of Catecholamines and Their Blockade in Heart FailureConnecticut Managed Care Consortium: Managed Care Pharmacists, Disease Case Managers: Rocky Hill, CT

Jul 15, 1998 A Comprehensive Review of HMG CoA Reductase Inhibitors for Community Pharmacists. Western Massachusetts Pharmacy Conference: CE Program: Community Pharmacists: West Springfield, MA

Aug 18, 1998 HMG CoA Reductase Inhibitors: An Evolving class.CE Program: Clinical Pharmacists, Managed Care Pharmacists, Avon, CT

Jan 25, 1999 The Extrahepatic Pharmacological Effects of HMG CoA Reductase InhibitorsMedical Grand Rounds, Berkshire Medical Center, Berkshire, MA

June 10, 1999 The Pharmacologic and Pharmacokinetic Effects of HMG CoA Reductase InhibitorsNew York State Pharmacist’s Association. CE Program: Poughkeepsie, NY

June 28, 1999 Cytochrome P450 Drug Interactions with HMG CoA Reductase InhibitorsAlbany Veterans Administration Medical Center: Albany, NY

Sept 9, 1999 An Update on the Therapeutic Management of Heart Failure PatientsKentucky Society of Health-System Pharmacists: CE Program: Lexington, KY

Dec 4, 1999 Pharmacologic and Pharmacokinetic Comparison of ACE Inhibitors Post-Myocardial InfarctionASHP Midyear Meeting: Consensus Conference: Orlando, FL

Jan 20, 2000 A Review of CYP 3A4 Drug Interactions for the Pharmacist.Mid-Hudson New York State Pharmacy Council: CE Program: Newburgh, NY

Mar 10, 2000 ACEIs in the Treatment of CHF/Post-MI Sequelae.California Society of Health-System Pharmacists: CE Program: Oakland, CA

Mar 10, 2000 ACEIs: A Rationale for Formulary Decisions.California Society of Health-System Pharmacists: CE Program: Oakland CA

Mar 16, 2000 Evaluating the Drug Literature: Tips for Primary Care ProfessionalsContinuing Education Grand Rounds: The Institute of Living: Hartford, CT

Mar 21, 2000 A Review of the Pharmacologic and Pharmacokinetic Differences of HMG CoA Reductase InhibitorsConnecticut Society of Health-System Pharmacists March Meeting: CE program: Farmington, CT

May 25, 2000 A Review of the Pharmacologic Differences of HMG CoA Reductase InhibitorsGreater Bridgeport Pharmacy Council Meeting: CE Program: Bridgeport, CT

May 28, 2000 The Use of Intravenous Amiodarone in the Cardiac Arrest Patient.Wyndham Hospital Quarterly Emergency Department Meeting: EMTs, ED Physicians and Nurses: Wyndham, CT

Jun 24, 2000 Drug Interactions Between Cardiovascular Drugs and Over the Counter or Herbal Products.Connecticut/Mid-Hudson NY VNA Annual Meeting: CE Program: Newtown, CT

Aug 25, 2000 Review and Comparison of Thrombolytic Agents.Eastern Conference Health Network Pharmacists, Nurses, ED Physicians: Manchester Memorial Hospital: Manchester, CT.

Sept 19, 2000 A Pharmacokinetic and Safety Comparison of HMG CoA RIs.CE Program: Pharmacists: Norwalk, CT.

C.M. White, p.88

Oct 25, 2000 A Pharmacokinetic and Safety Comparison of HMG CoA RIs.CE Program: Physicians: Rye Brook, NY.

Oct 27, 2000 A Review of Thrombolysis in Acute Myocardial Infarction for Hospital Pharmacists.CE Program: Pharmacists: CSHP Catch the Wave Meeting: Meridan, CT

Jan 5, 2001 An Update on Research in the Arrhythmia and Cardiovascular Pharmacology Group.Cardiology Noon Conference: Cardiologists: Hartford Hospital, Hartford, CT

Jan 18, 2001 A Review of Pregnancy Drug Guidelines and Pregnancy Categories.Internal Medicine Morning Conference: Internists: Hartford Hospital, Hartford, CT

April 10, 2001 An Update on the Pharmacotherapy of Acute Myocardial Infarction. CE Program: Pharmacists, Hartford Hospital, Hartford, CT

April 17, 2001 An Update on the Pharmacotherapy of Congestive Heart Failure.CE Program: Pharmacists, Hartford Hospital, Hartford, CT

April 24, 2001 Moderator: Therapeutic Debates on (1) Implantable Defibrillators Versus Antiarrhythmics and (2) Use of Abciximab as First Line Therapy in PCI.CE Program: American College of Clinical Pharmacists Meeting. Salt Lake City, Utah

Dec 3, 2001 Moderator: A Review of Critical Differences Between Drugs Within Common Cardiovascular Drug Classes. CE Program: Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists. New Orleans, LA

Dec 3, 2001 A Review of Critical Differences Between HMG CoA RIs. CE Program: Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists. New Orleans, LA

Dec 4, 2001 QTc Prolongation, How Much is Too Much?CE Program: Part of the Cardiovascular Implications of Atypical Antipsychotics. American Society of Health-Systems Pharmacists Dinner Program. New Orleans, LA

Dec 11, 2001 Intravenous Amiodarone in Sustained Ventricular Tachyarrhythmias.CE Program: Registered Nurses, APRNs: Education Resource Center, Hartford, CT.

Jan 18, 2002 QTc Prolongation: How Much is Too Much?Psychopharmacology Grand Rounds, CE Program: Psychiatrists, Psychiatric Pharmacists, Nurses: Institute of Living, Hartford, CT.

Feb 14, 2002 An Update on New Pharmacologic Agents for Advanced Cardiac Life SupportPhysicians, Registered Nurses: Franklin Square Hospital, Baltimore, MD.

March 21, 2002 An Update on New Pharmacologic Agents for Advanced Cardiac Life SupportPharmacists, Registered Nurses: Physicians Community Hospital, Lanham, MD.

March 27, 2002 QTc Prolongation: How Much is Too Much?Pharmacists, Nurses, Psychiatrists, Capital Region Mental Heath Facility. Hartford, CT.

April 25, 2002 An Update on New Pharmacologic Agents for Advanced Cardiac Life Support Registered Nurses, Physicians, Hartford, CT

May 2, 2002 QTc Prolongation: How Much is Too Much?Physicians. Department of Psychiatry. Baystate Medical Center. Springfield, MA.

May 14, 2002 QTc Prolongation: How Much is Too Much?Psychiatrists, Psychiatric Nurses, Institute of Living, Hartford, CT.

Jun 24, 2002 QTc Prolongation: How Much is Too Much?Psychiatrist’s Monthly Meeting, Institute of Living, Hartford, CT.

July 10, 2002 An Update on New Pharmacologic Agents for Advanced Cardiac Life SupportPharmacists. Bristol Hospital, Bristol, CT.

July 17, 2002 An Update on New Pharmacologic Agents for Advanced Cardiac Life SupportEmergency Room, Critical Care Personnel. Waterbury Hospital, Waterbury, CT.

July 22, 2002 The Pharmacologic Management of Heart Failure.Pharmacists, Cardiac Nurses. New Britain General Hospital, New Britain, CT.

C.M. White, p.89

July 24, 2002 An Update on New Pharmacologic Agents for Advanced Cardiac Life SupportEmergency Department Grand Rounds: Emergency Department Physicians. Sinai Hospital, Baltimore, MD.

Aug 6, 2002 Administration of PPIs in patients Who Cannot Swallow.Pharmacy Department. Baystate Medical Center. Springfield, MA.

Oct 7, 2002 Administration of Proton Pump Inhibitors through Nasogastric Tubes.Teleconference: Eastern Medical Science Liasons. AstraZeneca Pharmaceuticals.

Oct 9, 2002 Administration of Proton Pump Inhibitors through Nasogastric Tubes.Teleconference: Western Seaboard Medical Science Liasons. AstraZeneca Pharmaceuticals.

Oct 17, 2002 New Choices for the Cardiac Patient.CE Program: American Heart Association. Connecticut Society for Cardiac Rehabilitation: Nurse Practitioners, Physician Assistants, Allied Health: Wallingford, CT

Nov 10, 2002 Racial Differences in Heart Failure Pharmacotherapy.CE Program: American College of Clinical Pharmacists. Salt Lake City, Utah.

Nov 19, 2002 Statin Induced Muscle Toxicity: Impact of Pharmacology and Pharmacokinetics.CE Program: CVS Pharmacy: Community Pharmacists: Danbury, CT

Dec 9, 2002 Moderator: Critical Differences of Cardiovascular Drugs IICE Program: Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists. Atlanta, GA

Dec 9, 2002 Critical Differences Between Beta-Blockers.CE Program: Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists. Atlanta, GA

Dec 10, 2002 Moderator: New Drugs with Patient Care ImpactCE Program: Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists. Atlanta, GA

Dec 10, 2002 RosuvastatinCE Program: Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists. Atlanta, GA

Jan 24, 2002 Atrial Arrhythmia Update 2002.Part of the Critical Care and Infectious Disease Pharmacotherapy Symposium. CE Program: Hospital Pharmacists: Dearborn, MI.

Jan 31, 2002 Statin Induced Muscle Toxicity: Impact of Pharmacology and Pharmacokinetics.Medical Grand Rounds: Phelps Memorial Hospital, NY

May 15, 2003 Drug-Drug Interactions: The Heart of the MatterMedical Grand Rounds: Middlesex Hospital, Middlesex, CT

July 17, 2003 To Take or Not To Take: Herbs in Cardiovascular Disease.Patient Education Seminar: Congestive Heart Failure Clinic Patients and Their Families.Hartford Hospital, Wethersfield Campus, Wethersfield, CT

Oct 16, 2003 Statin Induced Muscle Toxicity: Impact of Pharmacology and Pharmacokinetics.PharmaCE. CE Program: Community Pharmacists: LaGuardia Sheraton, Flushing, NY

Oct 25, 2003 Clash of the Titans: A Comprehensive Review of HMG CoA RIs.CME Program: Pharmacists, Physicians, Nurse Practitioners: Hartford Hospital Department of Cardiology: Rocky Hill Marriott, Rocky Hill, CT.

Nov 11, 2003 Drug-Drug Interactions: The Heart of the MatterMedical Grand Rounds: Mercy Medical Center, Springfield, MA

Nov 12, 2003 Statin Induced Muscle Toxicity: Impact of Pharmacology and Pharmacokinetics.PharmaCE. CE Program: Community Pharmacists: Farmington Marriott, Farmington, CT

Nov 12, 2003 Angiotensin Receptor Blockers: Around the World in 44 Minutes.PharmaCE. CE Program: Community Pharmacists: Farmington Marriott, Farmington, CT

Nov 18, 2003 The Rhythm is Gonna Get You! Research in Preventing and Treating Arrhythmias. C.M. White, p.90

Hewitt Pharmacy Research Symposium. University of Connecticut, Storrs, CTNov 29, 2003 State of the Art in Stable Angina Treatment.

Medical Grand Rounds: Stamford Medical Center: Stamford, CTDec 11, 2003 Critical Differences of Antiarrhythmic Agents.

CE Program: ASHP Midyear Clinical Meeting: New Orleans, LA.Jan 20, 2004 Drug-Drug Interactions: The Heart of the Matter.

CE Program: CSHP Hospital Pharmacists Monthly Meeting: Rocky Hill, CT.Feb 5, 2004 Advances in the Treatment of Hyperlipidemia.

CE Program: CPA Community Pharmacists: Annual Meeting: Southington, CTFeb 19, 2004 Advancing into a New Era of Anticoagulant Therapy.

CE Program: Anticoagulation Pharmacists/Nurses/Physicians. Edison, NJ March 11, 2004 Advancing into a New Era of Anticoagulant Therapy.

CE Program: Pharmacists/Nurses/Physicians. Hartford, CTMarch 16, 2004 Advancing into a New Era of Anticoagulant Therapy.

CE Program: Pharmacists/Nurses/Physicians. Newburgh, NYMarch 29, 2004 HMG CoA RI: Critical Safety Differences.

Physicians: Baystate Medical Center. Springfield, MA.May 13, 2004 New Anticoagulants For Cardiac and Vascular Disorders.

CE Program: Third Annual Henry Low Heart Center Nursing Symposium. Hartford, CTJune 21, 2004 Oral Anticoagulants: A Review of Current and Future Treatments.

CE Program. ASHP Annual Meeting, Las Vegas, NV.July 27, 2004 Statin Induced Muscle Toxicity: Innate Risk and Impact of Drug Interactions.

CE Program, Pharmacists. Hackensack University Medical Center, Hackensack, NJJuly 27, 2004 Statin Induced Muscle Toxicity: Innate Risk and Impact of Drug Interactions.

CE Program, Physicians, Nurse Practitioners. Saint Joseph’s Hospital, Hackensack, NJAug 14, 2004 Angiotensin Receptor Blockers: Around the World in 44 Minutes.

CE Program: Philippine-American Physicians/ Northeast Chapter Annual Meeting. Foxwoods, CT.

Sept 14, 2004 Statin Induced Muscle Toxicity: Innate Risk and Impact of Drug Interactions.CE Program, Physicians, Pharmacists: Federal Healthcare/Dept of Defense Lecture Series. Washington, DC.

Sept 17, 2004 Women and Cardiac Disease.CE Program, Pharmacists, Connecticut Pharmacists Association. Rocky Hill, CT

Sept 30, 2004 Impact of ARBs on Renal Function in Type 2 Diabetics.CE Program, Physicians, Nurses: Healthwise Medical Associates, Vernon, CT.

Oct 1, 2004 Oral Anticoagulants: A Review of Current and Future TreatmentsCE Program. CSHP Catch the Wave Meeting. Farmington, CT

Oct 15, 2004 Statin Induced Muscle Toxicity: Innate Risk and Impact of Drug Interactions.CE Program, Physicians, Pharmacists: Newark, NJ

Nov 2, 2004 Pharmacotherapy of Hypertension.CE Program, Pharmacists, PharmEd. Rocky Hill, CT

Dec 7, 2004 Critical Differences of ARBs. CE Program. Pharmacists: ASHP Midyear Clinical Meeting. Orlando, FL.

Dec 15, 2004 Statin Induced Muscle Toxicity: Innate Risk and Impact of Drug Interactions.Dinner Program. Physicians. Poughkeepsie, NY.

May 17, 2005 Hypertension: Epidemiology, Pathophysiology and Pharmacotherapy.Noontime Conference: Pioneer Valley Cardiologists. MA

May 18, 2005 Moderator: Critical Differences Between Cardiac Drugs.CE Program. Pharmacists. Schwarting Symposium. University of Connecticut. Storrs, CT.

May 18, 2005 Antiarrhythmic Drug Therapy.C.M. White, p.91

CE Program. Pharmacists. Schwarting Symposium. University of Connecticut. Storrs, CT.June 15, 2005 HMG CoA RI Therapy for Hyperlipidemia.

Dinner Program, Physicians & Nurse Practitioners, Providence, RI.Sept 16, 2005 Statins: Efficacy and Muscle Safety Comparisons.

CE Program: Pharmacists. Eugene Applebaum College of Pharmacy. Detroit, MIDec 6, 2005 Non-Pharmacologic Therapies for Atrial Fibrillation & Flutter.

CE Program: Pharmacists: ASHP Midyear Clinical Meeting. Las Vegas, NV. Dec 28, 2005 Advanced Technology for Cardiac Care.

CE Program: Pharmacists: CE Finale, University of Connecticut, Storrs, CT March 21, 2006 New Frontiers, The Use of Inhaled Insulin for Diabetes Mellitus.

CE Program: Pharmacists: CSHP Monthly Meeting: Manor Inn, Milldale, CTNov 8, 2006 Efficacy and Safety Implications of Intensive Lipid Lowering.

Physicians (Attendings, Fellows), Nurse Practitioners. St Vincent Hospital, Worcester, MA.Dec 2, 2006 Radiofrequency Ablation Therapy: Use of Anticoagulation.

CE Program, Pharmacists. 21st Annual Pharmacy Invitational Conference on Antithrombotic Therapy, Anaheim, CA.

Dec 27, 2006 New Frontiers in Herbal Pharmacotherapy & Research. CE Program, CE Finale. University of Connecticut, Storrs, CT.

March 10, 2007 Safety and Efficacy Implications of Statin Therapy.CE Program, Pharmacy Practice Institute, Albany College of Pharmacy, Albany Marriott, Albany, NY.

March 13, 2007 Treatment of Myocardial Infarction: PICCs Format CE Program. Connecticut Society of Health-System’s Pharmacists, Rocky Hill, CT

April 18, 2007 Acute Ischemic StrokeCE Program. Connecticut Pharmacists Association, Trumbull, CT

Sept 19, 2007 Keynote Address: Antiarrhythmic Drug Prophylaxis in the Open Heart Surgery Patient: Cost Effectiveness and Quality Issues.Twentieth Annual Heartbeats Symposia: The Forum Conference and Education Center, Cleveland, Ohio. [Note: The only Non-Physician Invited as Speaker. KEYNOTE SPEAKER]

Nov 16, 2007 Gregory Gousse Connecicut Residency Conference. Friday November 16, 2007CE Program, Pharmacists, Hartford, CT.

Nov 19, 2007 Dyslipidemia Treatment: An Evaluation of Available Agents.Physician’s Program. Pittsfield, MA

Dec 5, 2007 Treatment of Hyperlipidemia: Focus on Safety and Efficacy.CE Program. Connecticut Pharmacists Association, Cromwell, CT.

April 22, 2008 LDL-C and CV Risk: What we Know and Don’t Know. Clinical Epxert Interviewed on Lipid Management for National Teleconference (Broadcast/Webcast).National Teleconference CE ProgramSponsored by VHA, Inc.

April 30, 2008 LDL-C and CV Risk: What we Know and Don’t Know. Clinical Epxert Interviewed on Lipid Management for National Teleconference (Broadcast/Webcast).National Teleconference CE ProgramSponsored by VHA, Inc.

Sept 9, 2008 Comparative Effectiness Review Methods Guide: A New EPCs Perspective.Agency for Healthcare Research and Quality EPC Director’s Meeting, Bethesda, MD

March 15, 2009 A Clinician’s Guide to Using Meta-Analysis in Decision Making.CE Program: Academy of Manage Care Pharmacy, Orlando, FL.

Sept 16, 2009 Overview of Methods for Systematic Review. CE Program: Agency for Healthcare Research and Quality Annual Meeting, Washington, DC

Nov 9, 2009 Using Meta-Analysis in Medical Decision Making: The EPC Experience. CE Program: Hartford Hospital Research Day Symposium, Hartford, CT

Jan 19, 2010 Advances in Atrial Fibrillation. CE Program: Connecticut Society of Health System C.M. White, p.92

Pharmacists, Rocky Hill, CTFeb 4, 2010 The Role of the Pharmacist in Managing Hypertension. CE Program: Connecticut

Pharmacists Association, Plantsville, CTFeb 17, 2010 Use of Meta-Analysis in Evidence-based Practice. Connecticut Children’s Medical Center

Research Grand Rounds, Hartford, CTApril 10, 2010 Women’s Cardiac Health. Connecticut Pharmacists Association, Norwich, CT

June 3, 2010 Electronic Data Repository Lecture. Electronic Data Repository Working Group. Taj Hotel, Boston, MA

June 27, 2010 Literature Review and Evidence, Session 1 CE Program: AcademyHealth 2010 Annual Research Meeting, Boston, MA

Sep 24, 2010 Matters of the Aging Heart. CE Program: Northeast Pharmacy Convention. Mashantucket, CT

Oct 7, 2010 Applying Existing Evidence to Osteopathic Practice. National Web Conference: American Osteopathic Association.

Oct 25, 2010 Evidence-based Practice in Primary Care: National Primary Care Week Program. Storrs, CT. Oct 25, 2010 Why Pharmacists Require a Place on the Life Raft: First Annual University of Connecticut

Life Raft Debate. Storrs, CT. FINALISTNov 15, 2010 Chairman’s Address:

National EPC Director’s Meeting, Agency for Healthcare Research and Quality. Rockville, MD

Nov 16, 2010 Grey Literature Searching in Comparative Effectiveness Research:National EPC Director’s Meeting, Agency for Healthcare Research and Quality. Rockville, MD

February 3, 2011 New Advances in Atrial Fibrillation: Connecticut Pharmacists Association, Southington, CTNovember 17, 2011 EPC Pearls: Implications of Excluding Non-FDA Approved Products from CER Reviews:

National EPC Director’s Meeting, Agency for Healthcare Research and Quality. Rockville, MD

Dec 16, 2011 Update of Treatments for Atrial Fibrillation:CE Finale, University of Connecticut, Storrs, CT

Jan 19, 2012 Evidence-based Medical Practice:Cardiology Resident Noon Conference: Griffin Hospital, Derby, CT

Feb 15, 2012 Searching the Medical Literature.Cardiology Resident Noon Conference: Griffin Hospital, Derby, CT

March 12, 2012 Applicability of EvidenceCardiology Resident Noon Conference: Griffin Hospital, Derby, CT

March 27, 2012 The Role of Stakeholders in Comparative Effectiveness. PRIME, Inc and AHRQ. Ft Lauderdale, FL.

July 12, 2012 Searching for Harms: The UCONN Experience.National EPC Director’s Meeting, Agency for Healthcare Research and Quality. Rockville, MD

July 17, 2012 Thromboprophylaxis in Atrial Fibrillation: Device and Pharmacologic Approaches.Cardiology Grand Rounds. Hartford Hospital, Hartford, CT

July 31, 2012 Comparative Effectiveness Research in SurgerySurgery Noon Conference, Hartford Hospital, Hartford, CT

Aug 10, 2012 Evidence-based Medical Practice:Cardiology Resident Noon Conference: Griffin Hospital, Derby, CT

2012-2013 Module 4: Clinical Teaching Venues: Applying Pedagogy in a Big Wide World. University of Connecticut Office of Professional Development Teachg Certificate Program. Voice-Over PowerPoint Enduring Program given to all pharmacy residents and fellows in CT

C.M. White, p.93

and preceptors in the UCONN system.Feb 11, 2013 Searching the Medical Literature.

Cardiology Resident Noon Conference: Griffin Hospital, Derby, CTMarch 27, 2013 Applicability of Evidence

Cardiology Resident Noon Conference: Griffin Hospital, Derby, CTApril 9, 2013 Antiarrhythmic Medications: Pharmacology and Pharmacotherapy.

Connecticut Ambulance Corps Annual Meeting. East Hartford, CT2013-2015 Module 4: Clinical Teaching Venues: Applying Pedagogy in a Big Wide World.

University of Connecticut Office of Professional Development Teachg Certificate Program. Voice-Over PowerPoint Enduring Program given to all pharmacy residents and fellows in CT and preceptors in the UCONN system.

Oct 22, 2013 The Future of Pharmacy. University of Connecticut Health Center CE Day. UCHC, Farmington, CT

Dec 15, 2013 Pharmacy at the Crossroads: Transforming the Practice of Pharmacy. Rocky Hill Sheraton. CE Finale. Rocky Hill, CT

Feb 3, 2014 Comparative Effectiveness Review in Cardiology. Hartford Hospital Cardiology Grand Rounds. Hartford, CT.

Dec 12, 2014 Congestive Heart Failure Guideline Update. UCONN School of Pharmacy CE Finale. Rocky Hill Sheraton, Rocky Hill, CT.

May 6, 2015 Hypercholesterolemia Guideline Treament Update. PharmEd Conference. Crowne Plaza, Cromwell, CT

Dec 11, 2015 PCSK9 Inhibitors in Human Health. UCONN School of Pharmacy CE Finale. Rocky Hill Sheraton, Rocky Hill, CT.

May 13, 2016 State Comptroller’s “CT Pharmaceutical Forum: Access, Affordability & Better Health”,Expert Panelist. Legislative Office Building, Hartford, CT

Dec 15, 2016 Prescription Drug Cost Trends and Reasons. UCONN School of Pharmacy CE Finale. Rocky Hill Sheraton, Rocky Hill, CT.

Dec 15 & 21, 2017 Virtual-CE Finale Presentation, "Should LDL Goals Be Re-Established," Connecticut. (December 21, 2017).UConn CE Finale, "Should LDL Goals be Re-Established?" Connecticut. (December 15, 2017).

Dec 13 and 19, 2018 UConn CE Finale. “The Science Behind Weight Loss”. Connecticut December 13, 2018.Virtual-CE Finale Presentation, “The Science Behind Weight Loss”. Connecticut. December 19, 2018.

May 2, 2019 Advances in Hyperlipidemia. PharmEd Conference. Red Lion Inn, Cromwell, CT. October 29, 2019 Therapeutic Debate on Antiarrhythmics vs. Ablation for Ventricular Arrhythmias.

American College of Clinical Pharmacists. NY, NY. December 13, 2019 UConn CE Finale, ‘’Legal, Ethical, and Therapeutic Assessment of CBD.’’ Rocky Hill, CT.

February 6, 2020 National Honor Society. The Role of the Pharmacist in Clinical Practice and Research. Newington High School, Newington, CT.

SERVICE/COMMITTEE MEMBERSHIPSState of Connecticut

State of CT Committee Member: State of Connecticut Cardiovascular Health Workgroup, Department of Public Health, Hartford, CT. 2003-2004.

C.M. White, p.94

Affiliate: The Connecticut Center of Excellence for Eliminating Health Disparities among Latinos (CEHDL). 2007-2013

Chair: Legislative Panel on Value Based Pricing of Pharmaceuticals, CT State Legislature. (April 1, 2016 - December 30, 2017).

Advisor: Roundtable on Prescription Drug Pricing, State Comptroller and State Senate. (January 24, 2018).

UConn Committee on Use of Human Subjects, University of Connecticut. Member : 1999-2009 Vice Chair : 2006-2008 Chair : 2008-2009Large Grant Initiative, Research Advisory Council. University of Connecticut. Reviewer: March 2001, March 2002.Taskforce on Data Safety and Monitoring in Human Subject Research. University of Connecticut Office of Research Compliance. Chariman : 2004-2005.Faculty Promotion, Tenure and Reappointment Forum. University of Connecticut. Breakout Session Leader : April 7, 2006 Pharmacy Dean’s 5-Year Review Committee. University of Connecticut. Member : 2007-2008.Institute of Teaching and Learning/Center for Excellence in Teaching and Learning Teaching Assistant of the Year Selection Committee Member : 2006-2007, 2007-2008,

2011-2012. Teaching Fellow Selection Committee : 2008-2009. Advisory Board Member: 2008-Present. University Wide Teaching Initiative Member : 2012-2015. Lecturer: 3 lectures on “Why Teachers Fail in the Classroom” on Storrs Campus,

Broadcast to All UCONN Campuses. Teacher Mentor for “At Risk Faculty” Teaching Exemplar Network Member ITL Advisory Board : 2008 to 2014 CETL New Faculty Panelist . 2017. Asylum and Human Rights Clinic, University of Connecticut School of Law. Medical Case Examiner : 2008-2009.Ethel Donaghue TRIPP Center Grant Reviewer: 2009-2010.Taskforce to Integrate Hartford Hospital and the University of Connecticut Research Programs. Member : 2009-2010.CICATS Pilot Project Research Grant Reviewer: 2010-2011.Vision Committee: Health and Health Policy. Member : 2013-2014.CTSA Grant Submission Committee. Member: 2014-2015 OneHealth Tier I School of Pharmacy Representative Member: 2014-2015 InCHIP Internal Advisory Committee. Member: 2019-2020

C.M. White, p.95

UConn School of Pharmacy

Member: Physical Assessment Committee, Department of Pharmacy Practice. 1999-2000Member: Clinical Documentation Committee, Dept of Pharmacy Practice. 1999-2001 Coordinator: Hartford Hospital Clinical Site, School of Pharmacy. 1999-2012. Member: Admission Committee, School of Pharmacy. 1999-2002Member: ACPE Accreditation Visit – Faculty Committee, School of Pharmacy. 2000-2001Member: Search Committee for Department Head of Pharmacy Practice, School of

Pharmacy. 2000-2001Faculty Mentor: School of Pharmacy. Mentees: Prabashni Reddy, Pharm.D. [2000-2001];

Jennifer James, Pharm.D., [2001-2002], Jon Folstad, Pharm.D. [2000-2003], Craig Coleman, Pharm.D. [2003-2006], Jennifer Ellis, Pharm.D. [2003-2006], Lauren Schlesselmann, Pharm.D. [2004-2008], Fei Wang, Pharm.D. [2004-2008].

Committee Chairman: Non-Tenure Track Research Grant Advisory Council. Department of Pharmacy Practice. 2000-2001.

Committee Chairman: Residency and Fellowship Committee, Department of Pharmacy Practice. 2001-2003.

Graduate Program: Dissertation Prospectus Reviewer. Department of Pharmaceutical Sciences. Spring 2002

Committee Chairman: Mentoring Committee. School of Pharmacy. 2002-2003.Member: Mentoring Committee. School of Pharmacy. 2003-2006.Member: Dean’s PTR Advisory Council. School of Pharmacy. 2003-2009.Member: Dean’s Full Professor PTR Advisory Council. School of Pharmacy. 2010-2011.Committee Chairman: Dean’s Advisory Council. School of Pharmacy 2005-2006, 2008-2009.Committee Chairman: Search Committee for New Dept Head. Department of Pharmacy

Practice. 2003-2004.Committee Chairman: Search Committee for New Faculty Positions. Department of

Pharmacy Practice. 2003-2004, 2004-2005, 2005-2006, 2009-2010, 2010-2011.Committee Member: Associate Dean Search Committee. School of Pharmacy. 2004-2005.Working Group: Pfizer/UConn Department of Pharmacy Practice Collaborative

Relationship. 2005-2006Working Group: Bayer/UConn Department of Pharmacy Practice Collaborative

Relationship. 2005-2006.Member: Organization and Administration Self-Study Writing Committee. ACPE Self Study

Review. School of Pharmacy 2005-2006.Course Facilitator: PHRX 207 Drug Information II Course. School of Pharmacy 2005-2006.Committee Chairman: Curriculum Committee. School of Pharmacy. 2006-2007Committee Member: Curriculum Committee. School of Pharmacy. 2006-PresentCommittee Co-Chairman: Curriculum Implementation Oversight Committee. 2006-2007.Committee Member: Curriculum Implementation Oversight Committee. 2007 - Present.Interim Committee Chariman: Curriculum Committee. School of Pharmacy 2010-2011.Interim Committee Chairman: Curriculum Implementation Oversight Committee. 2010-

2011.Course Facilitator: PHRX 5040 Cardiology Module. School of Pharmacy 2007-2008.Assistant Department Head: Department of Pharmacy Practice. 2010-2011. Department Head: Department of Pharmacy Practice. 2011-Present.Faculty Advisor: Academy of Managed Care Pharmacy. 2014-2018.Committee Member: School of Pharmacy Organizational Restructuring Committee. 2014-2015.Committee Member: Search Committeee for Associate Dean of Student Affairs. 2014-2015.Committee Member: Search Committeee for Associate Dean of Academic Affairs. 2015-

C.M. White, p.96

2016.Committee Member: Search Committeee for Department Head of Pharmaceutical Sciences. 2018-2019. Committee Member: Palmer Professorship Renewal Committee. 2019.

Hartford Hospital Director and Facilitator: Journal Club, Hartford Hospital 1996-1998Member: Formulary Optimization and Partnering Committee, Hartford Hospital 1997-1998Ad Hoc Member: Pharmacy and Therapeutics Committee, DUE Committee, Hartford

Hospital 1997-2007Director: Brownstone Dental Clinical Pharmacology Series. 1999-2000Coordinator: Code Team Medication Committee, Hartford Hospital 1999-2003Member: Connecticut Simulation Center Educational Program Guidance Committee. 2004-

2008Member: Research Committee. Hartford Hopsital. 2005-2013Member: Hartford Hospital Taskforce on Research. 2010-2011

InternationalItalian Medicines Agency (AIFA)Member: AIFI Grant Review Panel. 2019-2020.

National Federal Government National Heart Lung and Blood Institute (NHLBI):

Member: National Heart Lung and Blood Institute of the NIH Clinical Trial Review Committee. 2008-2009.

VA: Member: Health Services Research and Development Service Scientific Merit Review

Committee (Review Panel C). 2009-2010.Member: Health Services Research and Development Service Scientific Merit Review

Committee (Pilot Trial Review Panel). 2009-2010.

Agency for Healthcare Research and Quality (AHRQ):Committee Chairman: Working Group on the Methods Guide for Comparative Efficacy

Review Chapter on the Use of Systematic Reviews in Comparative Efficacy Reviews. 2008-2009.

Member: Working Group on Translating the Methods Guide in Visual and Verbal Media. 2009-2010.

Key Informant: Comparative Effectiveness Review on the Use of ACE Inhibitors and ARBs in Hypertension. 2010-2011.

Committee Chairman: EPC National Director’s Meeting. 2010-2011. Expert Panelist: Future Research Needs for ACE Inhibitors and ARBs in Hypertension. 2011-2012.Member: Institute of Medicine Systematic Review Standards Methods Reconciliation

Group. 2011-2012.Expert Panelist: Pulmonary Arterial Hypertension Screening, Management, and Treatment.

2011-2012. Committee Member: Working Group on Conflict of Interest in Systematic Review. 2012-

2013.Committee Member: AHRQ Effective Healthcare Program National Partner Meeting. 2012-

2013. Expert Panelist: Antithrombotic Therapy in Orthopedic Surgery. 2015-2016.

C.M. White, p.97

Committee Member: Surveillence Taskforce on Renin Angiotensin Aldosterone System Medications for Hypertension. 2015-2016.

Expert Panelist: Best Practices for Patient Engagement in the Effective Healthcare program. 2015-2016.

Committee Chairman: Working Group on Evidence-Needs in Health-Systems. 2016-2017. Committee Member: Working Group on Health-System Engagement, 2017-2018.Committee Member: Working Group on Enhancing Reports for Health-Systems. 2018-2019.

National Library of Medicine and AHRQ:Member: Electronic Study Data Repository Working Group. 2010-2011.

AHRQ and American College of Physicians:Member: COVID-19 Hydroxychloroquine and Chloroquine Practice Points Taskforce. 2020.Acknowledged in: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in

Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1). Annals Intern Med 2020; https://www.acpjournals.org/doi/pdf/10.7326/M20-1998.

Food and Drug Administration/Duke Margolas Center for Health Policy:Panelist: Understandng how the public perceived and values pharmacetutical quality. National Press Club, Washington, DC. February 3, 2020.

National Organizations

American Society of Health-System Pharmacists (ASHP):

Meeting Program Associate: American Society of Health-Systems Pharmacists Midyear Clinical Meeting. 2001, 2002, 2003, 2004

Meeting Program Associate: American Society of Health-Systems Pharmacists Annual Meeting. 2004

Meeting Program Advisor: American Society of Health-Systems Pharmacists Midyear Clinical Meeting Research Foundation Symposia. 2005.

Grant Proposal Reviewer: American Society of Health-Systems Pharmacists Education and Research Foundation Nursing/Pharmacist Alliance Grant. April-May 2005, April-May 2006.

Position Statement Reviewer: Reviewer for Zillich AJ, Haines ST. ASHP Therapeutic Position Statement on the Treatment of Hypertension. AJHP 2006;63:1074-80. June 2006.

Textbook Proposal Reviewer: Reviewed a Proposal Submitted to ASHP for a Code Blue Textbook Geared to Pharmacists. September 2009.

C.M. White, p.98

Literature Awards Committee: Reviewed Applications for the 2012 Drug Therapy Research Award.

Grant Proposal Reviewer: American Society of Health-Systems Pharmacists Education and Research Foundation PPMI Grant. December 2013-March 2014, December 2014-March 2015, December 2015-March 2016, December 2016-March 2017.

Grant Proposal Reviewer: American Society of Health-Systems Pharmacists Education and Research Foundation Optimizing Technology Solutions Innovation Grant. March 2019 – June 2019.

Literature Awards Committee: Reviewed Applications for the 2014 Pharmacy Practice Literature Award. June to August 2014.

Literature Awards Committee: Reviewed Applications for the annual Drug Therapy Research Award. June to August 2015, 2016, 2017

Literature Award Committee: Reviewed Applications for the Sustained Contributions to the Literature Award. June to August 2018.

Grant Proposal Reviewer: American Society of Health-Systems Pharmacists Education and Research Foundation Pharmacy Practice Advancement Demonstration Grant. October 2015, 2016, 2017, 2018, 2019.

National Research Advisory Council: Provided Input on New Strategic Priorities for the ASHP Foundation. 2019-2020.

Grant Proposal Reviewer: American Society of Health-Systems Pharmacists Education and Research Foundation Optimizing Technology Advancements Grant. 2020.

American College of Clinical Pharmacy (ACCP Pharmacy)Member: American College of Clinical Pharmacists/European Society of Clinical Pharmacy

International Congress Steering and Development Committee. 2006-2009.Mentor: American College of Clinical Pharmacy Cardiology Practice & Research Network

Mentorship Program. 2014-2015.

American College of Clinical Pharmacologists (ACCP Pharmacology)Member: American College of Clinical Pharmacology (1) Membership Committee, 1998-

1999. (2) Education Committee, 1999-2000.

American Association of Colleges of Pharmacy (AACP)NIA Grant Review Committee Member: American Association of Colleges of Pharmacy.

2015-2016.

Schools of Pharmacy or Medicine

External Reviews for Faculty Promotion, Tenure, and Reappointment

PTR External Reviewer: Thomas J Long School of Pharmacy. University of the Pacific. July 2006.

PTR External Reviewer: School of Pharmacy. UMKC. July 2009.PTR External Reviewer: University of Massachussettes Medical School. September 2010, PTR External Reviewer: Thomas J Long School of Pharmacy. University of the Pacific.

September 2012.PTR External Reviewer: Massachussettes College of Pharmacy. October 2012.PTR External Reviewer: Oregon Health Sciences School of Medicine. October 2013.PTR External Reviewer: University of Illinios, Chicago. July 2014.PTR External Reviewer: University of Illinios, Chicago. July 2016.

C.M. White, p.99

PTR External Reviewer: University of Illinios, Chicago. July 2017.PTR External Reviewer: SUNY Stony Brook. June 2018.PTR External Reviewer: University of Mississippi. July 2018.PTR External Reviewer: Texas Tech University. July 2018.PTR External Reviewer: Virginia Commonwealth University. August 2018.PTR External Review: Dept of Pharmaceutical Sciences, UConn. November 2019.PTR External Reviewer: Brown University School of Medicine. November 2019.

National Foundations Grant Proposal Reviewer: South Plains Foundation, 511 Ave K, Lubbock, TX 79408-0228. July 2002.

Peer Review Institute Pharmaceutical Industry Material Reviews For Truthfulness and Balance: Peer reviewer of material produced by the Pharmacueticual Industry. Peer Review Institute. P.O. Box 1386, Blue Bell, PA 19422-1386. 2011-2017.

EDITORIAL BOARDS2011-2013 Associate Editor: Effective Healthcare Program E-Journal.

Sept 2003 – 2015 Hypertension Panel Chairman: The Annals of Pharmacotherapy.Sept 2015 – Present Contributing Editor: The Annals of Pharmacotherapy.

Nov 2004-Present Editorial Advisory Board: Pharmacy Practice News.Nov 2019 – Aug 2021 Guest Editor: Journal of Clinical Pharmacology - Supplement on Drugs of Abuse.

JOURNAL REVIEWER Annals of Internal Medicine (Award for Being in Top 30% For Reviewing 2008, 2009), Journal of the American Medical Association, New England Journal of Medicine, Journal of the American College of Cardiology, Pharmacotherapy, Critical Care Medicine, Annals of Pharmacotherapy, PharmacoEconomics, AJHP, Journal of Clinical Epidemiology, Life Science, (among others).

TEXTBOOK REVIEWER/BOOK REVIEWER

American Hospital Formulary Service Drug Information Book(1) Reviewed and sent comments to the editor of AHFS Drug Information regarding proposed

changes to the “Cardiovascular Drug” section of the book for 2003. September, 2002.(2) Reviewed and sent comments to the editor of AHFS Drug Information on the proposed new

section on “Thiazide Diuretics” for the 2004 book. October 2003.

American Hospital Formulary Service DI Essentials Book(1) Reviewed and sent comments to the editor of AHFS DI Essentials regarding proposed changes to the “Guanfacine (Systemic) monograph for 2009. April 2008.

Cardiac Safety of Noncardiac Drugs: Practical Guidelines for Clinical Research and Development. Morganroth J, Gussak I. (Eds). Humana Press, 2005.

(1) Provided a book review to the Ann Pharmacother on this book. (March 2005).

ASHP Best Practices for Hospital and Health-System Pharmacy. American Society of Health-System Pharmacists, Bethesda, MD

(1) Reviewer for the ASHP Therapeutic Position Paper on the Treatment of Hypertension (May 2005).

Contemporary Cardiology Cardiac Drug Therapy 7th Edition. Khan MG. Humana Press. 2007.

C.M. White, p.100

(1) Provided book review to Ann Pharmacother on this book. (August 2007)

Club Drugs. Cordelia T. Hawkins. Abdo Books. 2018.(1) Reviewer of the textbook for factual accuracy and content.

MEMBERSHIP IN ORGANIZATIONS

1994-2000 New York State Chapter of the American College of Clinical Pharmacists

1994-Present American College of Clinical Pharmacy and ACCP Cardiology Practice and Research Network (Full Membership Status Awarded 1999, Fellowship Awarded 2005)

1994-Present American Society of Health-Systems Pharmacists and ASHP Section on Clinical Specialties in Cardiology

1998-Present American College of Clinical Pharmacology (Full Membership Status Awarded 1999, Fellowship Awarded 2006)

1998-2002 &2011-2016, 2019-

Present

American Association of Colleges of Pharmacy

2001-20122004-2012

American Heart Association and the AHA Council on Cardiopulmonary and Critical CareFuture Forum – International Organization to Debate Therapy for Vascular Diseases.

2011-2012 & 2019-Present

Connecticut Pharmacists Association.

EXPERT PANELIST/ADVISORY BOARD MEMBERJun 6-9, 1999 Reducing Cardiovascular Risk in the New Millennium: One Heart at a Time.

Expert Panel Participant: Leesburg, VADec 3-4, 1999 ACE Inhibition in Contemporary Cardiovascular Therapy.

Presenter and Expert Panelist: American Society of Health-System Pharmacists Midyear Clinical Meeting, Orlando, FL

Mar 24-26, 2000 Cardiovascular Event Reduction StrategiesAdvisory Board Panelist: San Juan, Puerto Rico

July 14, 2000 Submission NDA 21-198: Pravastatin for Over the Counter StatusCompany Expert Panelist: Food and Drug Administration Meeting. Bethesda, MD.

Feb 27, 2001 A Review of ACE Inhibitors for Formulary Consideration.Independent Class Reviewer: Capital District Physicians Health Plan, Albany, NY.

Apr 19, 2001 Anticoagulants in Cardiovascular Medicine.Advisory Board Panelist: Connecticut Chapter of American Society of Consultant Pharmacists, Groton, CT

May 2, 2001 Meeting Today’s Hypertension Challenges: Focus on ARBsAdvisory Board Panelist: Hartford, CT

May 4-6, 2001 Cardiovascular National Consultants Conference.Expert Panelist: Miami, Florida

Sept 7, 2001 Independent Muscle Safety Review of Pravastatin Sodium.Independent Reviewer: Report Submitted to Europe, Asia, and FDA Regulatory Agencies.

Sept 29-30, 2001 Advances in Prevention through Optimal Lipid Lowering (APOLLO).Advisory Board Panelist: Manhattan, NY

Oct 16, 2001 Tikosyn Pharmacist Consultant Meeting.Advisory Board Panelist: Boston, MA

Dec 2, 2001 Abbokinase Re-Release Advisory Panel

C.M. White, p.101

Advisory Board Panelist: New Orleans, LAJan 11-13, 2002 Cardiovascular Effects of Antipsychotics Cardiologist Conference

Breakout Session Moderator: Miami, FLMarch 8, 2002 Vanlev Product Release.

Expert Panelist: Ft Lauderdale, FLApril 12, 2002 Abbokinase Re-Introduction Pharmacists Advisory Panel.

Advisory Board Panelist: Chicago, IL.April 16, 2002 Outcome Trials in Cardiac Risk Management.

Advisory Board Member: Hartford, CTDecember 7, 2002 Low Molecular Weight Heparins Advisory Meeting.

Advisory Panel Member: Atlanta, GA.April 29-30, 2003 Inspira Consultant Meeting.

Advisory Board Panelist: Kansas City, MO.June 24-25, 2005 Natrecor National Advisory Board

Advisory Board Chairman: San Francisco, CAMay 28-30, 2019 CMI-NA Strategic Advisory Board

Advisory Board Member: Portland, ORSept 22-23, 2019 CMI-NA Strategic Advisory Board

Advisory Board Member: Denver, COFebraruary 3, 2020 FDA/Margolas Center Panel on Pharmaceutical Quality.

Panelist: Washington, DC.

HEALTH SYSTEM DUEs

August 1995 Concentrated Potassium Chloride, Albany Medical Center, Albany, NYAugust 1995 Warfarin Safety, Albany Medical Center, Albany, NY

January 1996 Physician Adherence to Antibiotic Restriction, Stonybrook Medical Center, LI, NYJanuary 1996 Therapeutic Monitoring of Blood Levels, Stonybrook Medical Center, LI, NYOctober 1997 Adherence to Abciximab Guidelines, Hartford Hospital, Hartford, CT

September 1998 Effectiveness of Ibutilide in Elective Cardioversion, Hartford Hospital, Hartford, CTJune 1999 Evaluation of a Pharmacy Managed Epoetin Alpha Distribution and Dialysis Patient

Hematocrit Program, Hartford Hospital, Hartford, CTFebruary 2004 Evaluation of Aprotinin’s Ability to Reduce Post-Cardiothoracic Surgery Atrial Fibrillation.

Hartford Hospital, Hartford, CTApril 2004 Evaluation of Beta-Blockers Impact on Post-Cardiothoracic Surgery Atrial Fibrillation and

Stroke. Hartford Hospital, Hartford, CT/

HEALTH SYSTEM THERAPEUTIC GUIDELINESJanuary 1997 White CM. Carvedilol Use in Heart Failure, Hartford Hospital, Hartford, CTOctober 1998 White CM. Alteplase Guidelines in Acute Ischemic Stroke, Veterans Administration

Connecticut Health System, West Haven, CTMarch 2000 White CM. Update of Intravenous Amiodarone Guidelines for Non-Cardiac Arrest

Situations, Hartford Hospital, Hartford, CT July 2000 Goldman M, White CM. Dose Conversions for an ACE Inhibitor Automatic Substitution

Program, Hartford Hospital, Hartford, CTDecember 2000 White CM, Kluger J, Caron M. A Guide to the Use of New Antiarrhythmic Agents in Cardiac

Arrest. Hartford Hospital, Hartford, CTJanuary 2001 White CM. Alternative Agents and Dosing Regimens During the Isoproterenol Shortage,

Hartford Hospital, Hartford, CTMarch 2001 White CM, Goldman M. Weight Based Heparin Dosing for Acute Coronary Syndromes,

C.M. White, p.102

Hartford Hospital, Hartford, CT. February 2001 Goldman M, Quercia R, White CM. HMG CoA RI Conversion Protocol. Hartford Hospital,

Hartford, CT. August 2002 Mcbride B, White CM. Thrombolytic Guideline Revisions/Review. Hartford Hospital,

Hartford, CT.September 2002 White CM, McBride B. Nesiritide Protocol Review/Revision. Hartford Hospital, Hartford, CT.

March 2004 White CM. Digoxin Guidelines in the Cardiac Units. Hartford Hospital, Hartford, CT.March 2004 White CM. Digoxin Immune FAB Guidelines in the Cardiac Units. Hartford Hospital,

Hartford, CT.March 2004 White CM, Kluger J. Sotalol (Betapace AF) Guidelines at Hartford Hospital. Hartford

Hospital, Hartford, CTApril 2004 White CM, Kluger J. Intravenous Amiodarone Guidelines at Hartford Hospital. Hartford

Hospital, Hartford, CTJanuary 2004 White CM, Sander S, Goldman M. Nesiritide Outpatient Protocol. Hartford Hospital,

Hartford, CT.October 2005 Dale K, White CM. Intravenous Use of Amiodarone in Atrial Fibrillation. Hartford Hospital,

Hartford, CT.December 2005 Sander S, Kluger, J, White CM. Treatment Guidelines and Order Set for Preventing Post-

Cardiothoracic Surgery Atrial Fibrillation. Hartford Hospital, Hartford, CTMarch 2006 White CM. Intravenous Amiodarone Guidelines at Hartford Hospital, Revised. Hartford

Hospital, Hartford, CTNovember 2006 Dale K, Kluger J, White CM. Intravenous Ibutilide Guidelines at Hartford Hospital. Revised.

Hartford Hospital, Hartford, CT.November 2007 White CM, Goldman M, Udeh E. Treatment Protocol for Heparin Induced

Thrombocytopenia Identification and Management. Hartford Hospital, Hartford, CTMarch 2011 White CM, Goldman M, Hobbes L, Udeh E. Treatment Protocol for Heparin Induced

Thrombocytopenia. Hartford Hospital, Hartford, CTSpetember 2013 White CM, Tessier N. Treatment Protocol for Post-Cardiothoracic Surgery Atrial Fibrillation.

Hartford Hospital, Hartford, CTJune 2018 White CM, Hobbs L. UPDATE. Treatment Protocol for Post-Cardiothoracic Surgery Atrial

Fibrillation. Hartford Hospital, Hartford, CT.

HEALTH SYSTEM NEWSLETTERS

Aug 1994 Overview of Headlice Guidelines – Amsterdam Memorial Hospital, Amsterdam, NYAug 1994 Review and Comparison of Available Asthma Treatments - Amsterdam Memorial Hospital,

Amsterdam, NYJuly 1995 Enteral Nutrition Versus Parenteral Nutrition – Stratton VA, Albany, NYJuly 1995 Is There a Role for Amiodarone in CHF? - Stratton VA, Albany, NYJuly 1995 C. Difficile: Current Hospital Guidelines for Treatment - Stratton VA, Albany, NYAug 1995 TCA Overdosage: The Pharmacokinetics that Direct Emergent Therapy – Albany Medical

Center, Albany, NYAug 1995 Appropriate Use of Concentrated KCL Solutions in the ICU - Albany Medical Center, Albany,

NYJan 1996 Establishment of the Pharmacist Intervention Note - Mercy Medical Center, LI, NY.Jan 1996 Prevention of Multidrug Resistant Microbes - Mercy Medical Center, LI, NY.Jan 1996 TPA for Massive PE: Guidelines and Associated Treatment Algorithm - Mercy Medical

Center, LI, NY.July 1996 Weight Based Heparin Dosing Versus Standard Dosing – Hartford Hospital, Hartford, CTJun 1997 Role of Calcium Channel Blockers in CHF – Hartford Hospital, Hartford, CT

C.M. White, p.103

July 1997 Guidelines for the Optimal Use of Carvedilol – Hartford Hospital, Hartford, CTFeb 1998 Rational for Selecting Formulary ACE Inhibitors and HMG CoA Reductase Inhibitors –

Hartford Hospital, Hartford, CTSept 1999 A Comparison of Beta-Blockers Utilized in Heart Failure – Hartford Hospital, Hartford, CTOct 1999 Rational for Selecting ARB Agents for the Formulary – Hartford Hospital, Hartford, CTJan 2000 Chronic Oral Amiodarone Monitoring Parameters – Hartford Hospital, Hartford, CT

Mar 2000 Intravenous Amiodarone for Ventricular Arrhythmias – Hartford Hospital, Hartford, CTJuly 2000 Pharmacokinetic Implications for HMG CoA RIs – Hartford Hospital, Hartford, CTAug 2000 Dofetilide: An Effective but Complicated Agent for Atrial Fibrillation – Hartford Hospital,

Hartford, CTNov 2000 Withdrawing Antiarrhythmic Therapy Before Safely Initiating Dofetilide. – Hartford

Hospital, Hartford, CTDec 2000 An Update on Cardiac Arrest Pharmacotherapy. – Hartford Hospital, Hartford, CT

Jul 2002 A Review of QTc Prolonging Agents – Hartford Hospital, Hartford, CTOct 2002 A Review of Intramuscular Ziprasidone Induced QTc Prolongation – Hartford Hospital,

Hartford, CTJuly 2003 Racial Differences in Heart Failure Medication Response–Hartford Hospital, Hartford, CT

October 2003 Hawthorne: Evaluation of the Herb In Heart Failure. . Hartford Hospital, Hartford, CT.September 2005 Economic Impact of the Medication Assistance Program. . Hartford Hospital, Hartford, CT.

October 2005 Use of Intravenous Amiodarone in Atrial Fibrillation. . Hartford Hospital, Hartford, CT.August 2006 Intravenous Ibutilide Guidelines. Hartford Hospital, Hartford, CT.

June 2007 Beta-Blocker and Calcium Channel Blocker Bolus Use Protocol Outside the ICU. Hartford Hospital, Hartford, CT.

Sept 2007 Heparin Induced Thrombocytopenia Guidelines. Hartford Hospital, Hartford, CT

Public Engagement

1. Mitzvah Day/Community Tag Sale Fundraiser. Volunteer twice annually to sort and price items for the community fundraiser. 2011 – 2020.

2. Adaptive Climbing Event Volunteer. Coach and climbing mentor for adults with physicial disabilities or mental trauma. Once yearly event: 2013-2019.

3. Unified Sports Climbing Event. Sponsor and climbing mentor for children with special needs. One time event: 2015.

4. UConn Pharmact Student Health Clinics/Events. 2017 (Precepted 2 groups of students), 2018 (Precepted 6 groups of students), 2019 (Precepted 3 groups of students), 2020 (Precepted 4 students at Mansfield homeless shelter blood pressure clinic).

a. Health posters, blood pressure clinics, drug take back events, brown bag medication events, public presentations.

5. Migrant Farmworker Clinic. Pharmacist of Record and Preceptor of Pharmacy Students providing free medical services and products to migrant farmworkers in the State of CT. Attended two clinics in 2019.

6. Talks and Discussions at Community/High School Events. Periodic Presentations on Pharmacy Careers, Drug Treatments, and Research Findings. 2000, 2003, 2004, 2006, 2012, 2014, 2016, 2018, 2020 (See nonresearch presentations above).

7. Extensive Media Work (See above).

C.M. White, p.104